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1. INTRODUCTION 1
1. INTRODUCTION
Plants are living multicellular eukaryotic organisms that constitute one of the five kingdoms 
of life which includes thousands of different species prospering on land, in oceans and fresh 
water. They are capable to produce self-generated energy through photosynthesis, using 
sunlight to biosynthesize carbohydrates from water and carbon dioxide and releasing oxygen 
as a by-product. Due to this unique ability, plants or plant-derived products such as grains, 
fruits and vegetables represent the basis of the food chain for animals and humans. Especially 
cereals such as maize (or corn), wheat and rice have been domesticated by mankind for 
millennia and are forming the major energy source in human nutrition.
In contrast to organisms such as animals or bacteria, higher plants are however sessile 
and cannot simply escape from environmental stresses; consequently, they are steadily 
exposed to adverse environmental influences. Thus, plants have evolved many different and 
highly complex regulatory systems that allow them to still survive and even prosper in swiftly 
changing environmental conditions. A better understanding of these regulatory processes is 
therefore not only of scientific interest but due to their role in basic nutrition also of 
socioeconomic importance. The study of cellular processes in living plants therefore not only 
increases our basic scientific knowledge but may also open up new strategies for crop 
improvement.
Fostered by recent developments in chemistry, biochemistry, genomics, and molecular 
biology, chemical biology approaches have recently emerged that allow an alternative 
approach to study plant biology. The present thesis reports on such a chemical biology 
approach which was used to investigate the molecular mechanisms of plant growth. 
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2. THEORETICAL BACKGROUND
2.1 Arabidopsis thaliana as a model plant in plant biology 
research
Most of the basic classical and molecular genetic studies in plant biology have focused on 
crop species, such as corn, pea, tobacco, wheat and tomato. These plants are typically large in 
size, require a large growing area and have a long generation time (allowing only 2-3 
generations per year), and thus are inconvenient for some types of molecular genetic 
experiments. In fact, an ideal plant for molecular biological studies should feature a small size 
(for facile cultivation of large numbers in the lab), a short generation time and a small genome 
size. Such a plant was found in Arabidopsis thaliana which therefore rapidly became the most 
important model plant in plant biology. 
Arabidopsis thaliana (or thale cress) is a member of the mustard family (Cruciferae or 
Brassicaceae) with a broad natural distribution throughout Europe, Asia, and North America.
Many different ecotypes have been collected from natural populations and are available for 
experimental analysis. Of them, the Columbia and Landsberg ecotypes have become the gold 
standards for genetic and molecular studies. Arabidopsis has no direct importance in 
agriculture but meets all the requirements for a viable model plant and is used since the 1940s
as the major model organism in plant science.
1
Along these lines, Arabidopsis was therefore 
also the first plant with a completely sequenced genome.
2
The Arabidopsis genome consists 
of ca. 120 mega base pairs; therefore, Arabidopsis has one of the smallest plant genomes
which significantly facilitates all kinds of biological and in particular genetic studies. 
Several other advantages account for the role of Arabidopsis as the major plant 
biology model organism. For example, Arabidopsis possesses a relatively short generation 
cycle of only six weeks and generally produces many seeds that can be easily stored for long 
terms and still maintain their ability to germinate.
3
The small growth size of the plant is also 
beneficial for cultivation in laboratories and allows nurturing thousands of mature
Arabidospis plants in a normal lab space without special facilities. Moreover, young 
Arabidopsis seedlings and cells from cell culture are relative translucent and are thus well 
suited for (fluorescence) microscopy studies. Physiologically, Arabidopsis thaliana represents 
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a suitable model for the economically and scientifically most interesting higher plant species. 
Finally, Arabidopsis can be efficiently manipulated by genetics, using well-established 
methodologies. For example, plant transformation can be achieved with Agrobacterium 
tumefaciens, a bacterial vector that allows to insert DNA sequences into the plant genome.
4
Due to its major role in plant biology, much work has been done to assign functions to 
the ca. 27.000 genes and its corresponding gene products that are encoded in the Arabidopsis
genome.
5
To this puropose, genetic methods have mostly been used. Recently, post-genomic 
approaches such as chemical biology methodologies have however proven to be 
complementary and useful techniques that may provide novel and meaningful insights into the 
biology of living plants.
6; 7
2.2 Small molecules at the interface of Chemistry and Biology
Chemical biology may broadly be defined as the application of chemical methods for 
studying biological phenomena. Therefore, chemical biology consists of the use of small 
molecules to both interrogate and manipulate biology for investigating the behavior of 
biological systems, from the protein to the organismal and thus physiologically relevant level.
By definition, small molecules are organic molecules of low molecular weight 
(< 1000 Da).
8
Furthermore, they should harbor a biological activity resulting from their 
binding to a protein or in rare cases other biomolecules, commonly called as the “target”, 
which could for example be involved in distinct signaling or metabolic pathways. To exert 
bioactivity, the binding event is accompanied by a modulation of the protein’s function. In 
some cases, small molecules modulate the protein’s function by inactivating it which defines 
the molecule as an inhibitor.
9
In other cases, it activates the function of a protein or increases 
the activity of a certain enzyme. These compounds are then referred to as activators. There are 
many other ways of modulating the function of a protein, for example binding of a small 
molecule inhibitor to its target can also hinder a substrate from entering the enzyme’s active 
site or hamper the enzyme from catalyzing its reaction. 
The binding event can either be reversible or irreversible. Molecules that bind 
irreversible to their targets usually react with the protein, thereby changing it chemically. This 
mode-of-action is most often seen for enzymes. Such irreversible inhibitors modify catalytic 
key amino acid residues required for enzymatic turnover in a covalent manner which finally 
leads to a deactivation of the enzyme’s function. In contrast, reversible inhibitors bind non-
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covalently to their targets. For enzymes, different types of reversible inhibition are known. 
For example, reversible inhibitors can bind to the enzyme in a substrate competitive way 
(competitive inhibition)
9
or in a non-competitive fashion, which can for example come along 
with deactivating conformational changes (allosteric inhibition)
9
.
In contrast to unbiased screening methods and thus a more-or-less serendipity-based 
approach for identifiying bioactive small molecules, also rational, i.e. knowledge-based, 
approaches have been developed. For the rational design of small molecules the determination 
of the X-ray structure of the biological target which is feasible since the late 1950’s is greatly 
helpful.
10
With this information in hands, scientists are able to adjust the chemical structure of 
a molecule to the structural information of a biological target to affect its activity. 
Hence, the use of bioactive small molecules as biological probes with high affinity and 
specificity is clearly beneficial for studying biologically relevant processes. Despite these 
evident advantages, the widespread use of small molecules in chemical biological approaches 
to probe cellular signaling has however some inherent limitations: Such approaches require 
the availability of appropriate small molecules that target a certain enzyme or protein with 
high selectivity and affinity to trigger a desired phenotypic effect. To date, the number of 
proper small molecules still represents the bottle-neck of chemical biology approaches. To 
expand the scope of bioactive small molecules, synthetic efforts have focused on generating 
novel compound libraries.
11
This chemical toolboxes consists for example of collections 
derived from diversity-oriented synthesis (DOS), target-guided ligand assembly, (dynamic)
combinatorial libraries or annotated chemical libraries.
12
The goal of these strategies is to get 
a quick and efficient access to a large number of small molecules for screening and 
subsequent identification of those with interesting bioactivities.
2.2.1 Natural products as starting points for chemical biology approaches
A natural product is a chemical compound produced by a metabolizing, living organism. 
Many of these compounds feature a defined bioactivity to accomplish a distinct biological 
function. Such natural products are biosynthesized by living organisms for example to 
provide the organism with a natural selective advantage towards other competitive organisms. 
These bioactive natural products can therefore be considered as chemical scaffolds that were 
evolutionarily selected and approved for binding to particular target-proteins. 
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Their underlying chemical scaffolds are often chemically highly diverse. Because of their
broad spectrum of chemical and functional diversity, natural products have consequently seen 
a great impact upon drug discovery (Fig. 1).
13
Moreover, natural product-derived compound 
libraries have demonstrated enhanced hit rates in biological screens.
Figure 1: Natural product diversity (Adapted and modified from Hong et al.
14
)
To benefit from the evolutionary pre-selected structure of natural products and their enhanced 
hit rates, strategies like biology-oriented synthesis (BIOS) were developed.
15
Here, natural 
product scaffolds are used as a blueprint to generate structurally simplified natural product-
derived compound collections.
16
Another approach is the rational derivatization of natural 
compounds that allows detailed structure-activity mapping and can result in derivatives that 
possess even an enhanced bioactivity.
17
In this approach, the bottleneck is however the 
synthetic access to such a natural product but once it is established, this rational derivatization 
can even result in compounds with higher hit rates in screens (i.e. displaying a better ratio 
between hits and the number of screened compounds).
Beyond all doubt, besides the rational or combinatorial creation of small molecules,
the use of natural products for interrogation of biological systems had and still has a big 
impact, not only for the development of new chemotherapies (currently, more than 50% of all 
FDA-approved drugs are natural products or natural product derivatives) or of additives for 
agriculture, but also as chemical probes in scientific chemical biology studies.
18
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2.3 Chemical biological approaches in plant biology research
2.3.1 Traditional genetics vs. chemical genetics
Genetic approaches have played and still play a major role for elucidating the biology of 
living organisms, including plants. To this end, gene knock-outs or mutation strategies are 
used to silence gene-products. Two approaches are usually distinguished: In the classical 
forward genetic approach, random mutagenesis is used to produce a phenotype of interest
(Fig. 2). This often requires a generation of a huge number of mutants followed by an 
extensive screening for mutants with an either gain- or loss-of-function phenotype. In order to 
analyze the phenotypic response of distinct genes, reverse genetics is used (Fig. 2). Here, 
mutations or knock-outs are targeted to a particular gene and the role of the gene product is 
studied from the phenotype of the resulting mutant.
The advantage of such “traditional” genetic approaches is that they are highly specific 
as a single point mutation can be engendered by a single nucleotide change within 3 billion 
base pairs. Moreover, this approach is highly transferable as in principle any organism can be 
genetically modified. Nonetheless, there are also some general drawbacks of traditional 
genetics. Some gene knock-outs or loss-of-function mutations are lethal; consequently, 
genetic studies of such genes cannot be performed. Moreover, non-essential knock-outs can 
often be masked by gene redundancy. This issue is of particular importance in plant genetics
because extensive genome duplications have occurred multiple times in the evolutionary 
history of most plants. Therefore, most plant genes are part of gene families and single knock-
out plants consequently often lack a clear phenotypic response because the missing knocked-
out enzyme activity is compensated by other members of the related gene family. Thus, 
classical genetic approaches may fail to identify certain gene products that exist in gene 
families.
19
To overcome these limitations, a complementary approach commonly known as 
chemical genetics (thereby pronouncing its similarities to traditional genetics) has been 
established in the last decade. In this approach, small molecules are used to mimic 
mutagenesis and to elicit phenotypes of interests (Fig. 2).
12
To this end, chemical libraries of 
small molecules are screened on living systems. Suitable bioactive small molecules then
interfere in the cellular function of their target proteins resulting in an observable phenotypic 
effect that often resembles a mutant (e.g. knock-out) phenotype, thereby justifying the term 
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chemical genetics. This concept is called forward chemical genetics (Fig. 2). After 
identification of an interesting phenotype, the target of the small molecule is elucidated, 
thereby allowing correlation of the phenotype with a molecular mechanism. In the second 
approach, commonly referred to as reverse chemical genetics, small molecule modulators of 
proteins of interest (for example from a previous target-oriented drug discovery campaign) are 
used to disturb the function of the target protein of the small molecule probe in a living 
system. The analysis of the resulting phenotype then allows to gain insights into the function 
of the target protein in an in vivo system.
20
Chemical genetics offers many advantages to ‘traditional’ genetics: For example, 
small molecule modulators are able to distinguish between different protein forms produced 
by the same gene, e.g. zymogens or post-translational modifications.
21
Moreover, small 
molecules have the capacity to overcome the problems associated with gene redundancy 
because the proteins encoded by one gene family often share conserved binding sites 
susceptible to the same small molecule inhibitor. Thus, the activity of a whole gene family 
can be shut down with one small molecule probe, thereby causing a clear phenotypic response 
that single gene knockouts might miss. Furthermore, the biological effect from a delivered 
small molecule is principally tunable. This enables graded phenotypes by varying the
concentration of the bioactive small molecule. Furthermore, small molecule phenotypes are 
often reversible because small molecules can be removed from living organisms. Finally, 
small molecule modulation is conditional and can be spatially and temporally controlled and 
induced at any developmental stage of the studied biological system. 
Unfortunately, chemical genetics however also displays several disadvatages: First, 
the identification and availability of a bioactive small molecule that induces a phenotype of 
interest is a prerequisite for further investigations. To this end, either screening of large
compound libraries are required which is time and cost-intensive and sometimes fails to 
deliver potent small molecule probes. Moreover, the subsequent identification of cellular 
targets of bioactive small molecules is still a major challenge. Although several proteomic-
based methods such as affinity purification
22
, protein microarrays
23
, yeast-three-hybrid 
systems
24
, phage display
25
and the activity based protein profiling approach
26
are nowadays 
available, none of them represents a generic approach, turning target identification into the 
bottleneck of forward chemical genetics approaches.
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Figure 2: Schematic depiction of classical genetics versus chemical genetics. Classical genetics employs 
(random) mutagenesis strategies, like knock-outs, to target a (particular) gene and the role of the gene product is 
studied from the phenotype of the resulting mutant for elucidating the correlation between genes and observed 
phenotypes. In contrast, chemical genetics uses small-molecules to achieve this goal. A forward genetic study is 
a hypothesis-generating approach in which phenotypes of interest are provoked by small molecules, followed by 
elucidation of the gene/protein causing the phenotype. A reverse genetic study is a hypothesis-based approach in 
which genes or proteins are directly targeted by pre-selected small molecules to analyze their role via studying 
the resulting phenotype (adapted and modified from Kawasumi et al.
27
).
Beside the screening approach of chemical genetics, one can also employ pre-selected small 
molecules, such as natural products derived for example from plant pathogens that display a 
known plant specific phenotypic response, to investigate biological processes such as plant-
pathogen interactions or to get more insights into regulatory processes underlying the caused 
phenotype.
2.3.2 Examples for chemical genetics applications in plants
Plants offer an attractive platform for phenotypic screening in chemical genetics. Since all 
natural occurring known plant growth regulators are small molecules, the experimental 
protocols for analyzing chemical compounds can easily be adapted to unbiased chemical 
genetic srceens (Fig. 3).
19
Furthermore, the genome of the major model organism in plant 
biology, Arabidopsis thaliana, is already fully sequenced and a variety of classical genetic 
tools are available to the scientific community (c.f. Chapter 2.1).
5
Such a tractable genetic 
system therefore greatly facilitates the target identification process for the identified 
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compounds. Moreover, plant roots conveniently take-up small molecules, avoiding many of 
the permeability and transport issues in traditional chemical genetic systems. In fact, plants 
respond to, metabolize and produce a diverse range of small molecules. Examples are plant 
hormones, such as auxin, gibberellic acid, abscisic acid (ABA) and salicylic acid.
28
These 
compounds are a structurally unrelated collection of endogenous small molecules derived 
from essential metabolic pathways and are important regulators of plant growth as well as 
mediate additionally almost every aspect of plant life, from pattern formation during 
development to responses to both biotic and abiotic stresses. Besides, exogenous small 
molecules like herbicides, plant growth regulators from (pathogenic) microbial sources or 
other bioactive compounds identified from screening chemical libraries are examples of the 
suitability of plants to respond to small molecule treatments.
Figure 3: A typical forward chemical genetics screening approach in plants. Multiple seedlings are grown in 
well-plates and incubated with a set of compounds. Plants demonstrating a phenotype of interest are selected. 
The very last step is the identification of the protein causing the phenotypic effect.
Therefore, chemical genetics approaches in plant biology are highly rewarding and have led 
to the identification of innumerous bioactive small molecules. In addition to their importance 
as essential agrochemicals, such elucidated small molecules may serve as powerful research 
tools to address questions at all levels of biological complexity from protein function to plant 
biotic interactions. In certain contexts, such chemical tools are complementary or even 
preferred to genetic analysis, since not all experimental systems are accessible for genetic 
dissection in plants. For example, plant mutants impaired in oxygen sensing cannot easily be 
recovered.
29
Pharmacological and chemical genetics approaches therefore represent rewarding 
methodologies to study such genetically intractable systems.
19
In Figure 4 are depicted some 
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examples of exogenous small molecules identified from either screening campaigns or by pre-
selection due to their plant-specific activity. These compounds are examples of chemical 
probes nowadays used in plant biology research. 
Pyrabactin (Fig. 4) was identiﬁed in a chemical genetic screen aiming at identifying
germination inhibitors.
30
Pyrabactin has received high attention as it served as the major 
chemical tool for investigating the ABA signaling pathway in plants. In fact, a screen for 
Pyrabactin-insensitive mutants allowed the identification of insensitive alleles of PYR1 
(Pyrabactin Resistance 1), a member of a novel 14-member gene family of previously 
unknown function. In the presence of Pyrabactin, PYR1 interacts with protein phosphatase 
HAB1, a key negative regulator of abscisic acid (ABA) responses. In contrast to pyrabactin, 
which is selective for PYR1 in seeds, ABA interacts with all PYR1-like homologs, which 
causes redundancy in the ABA signalling pathway, thereby hampering its investigation by 
traditional genetics methods. Thus, the application of a chemical compound that shows 
selectivity to some genes of the ABA signalling cascade enabled the identification of key
signalling components which was not possible by classical forward genetics.
30
Morlin (Fig. 4) was discovered in a phenotypic chemical genetic screen of 20,000 
compounds.
33
Morlin stimulated morphological defects in Arabidopsis, such as right handed 
helical root growth at low concentrations and radial swelling in elongating roots, and 
hypocotyls at high concentrations (>5 μM). Live-cell imaging of fluorescently labeled 
cellulose synthase (CESA) and microtubules showed that Morlin acts on cortical microtubules 
and alters the movement of CESA. Morlin caused a novel syndrome of cytoskeletal defects, 
characterized by cortical array reorientation and compromised rates of both microtubule 
elongation and shrinking.
33
In a phenotype-based chemical genetic screen using Arabidopsis seedlings, the small 
molecule Bikinin (Fig. 4) was identified as it caused an increase in hypocotyl length, the 
formation of long and bending petioles, and the emergence of blade-shaped, pale-green
leaves.
34
It was shown that Bikinin activates brassinosteroid (BR) signaling downstream of 
the BR receptor via direct binding to glycogen synthase kinase 3 (GSK3) BIN2 as well as 
inhibiting the activity of six other Arabidopsis GSK3s. 
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Figure 4: Examples of bioactive small molecules nowadays used in plant research and identified through 
different approaches. (A) Compounds identified from chemical genetic screens using combinatorial libraries. 
(B) Compounds identified from chemical genetic screens using natural product-based screens. (C) Natural 
compounds from plant pathogens. For more examples see Ref. [31] and [32].
Yokonolide B (YkB; also known as A82548A), a spiroketal-macrolide (Fig. 4), was isolated 
from Streptomyces diastatochromogenes B59 in a screen for inhibitors of auxin responses in 
Arabidopsis.
35
YkB was shown to inhibit the expression of auxin-inducible genes after 
stimulation with native and synthetic auxin promoters. YkB-treated Arabidopsis seedlings 
thereby displayed similar phenotypes as dominant AUX/IAA mutants. Further studies on the 
underlying molecular mechanism have however not yet been reported.
To identify circadian clock effectors in planta, a natural product library was screened 
in the model plant Arabidopsis thaliana. Two compounds, Prieurianin and Prieurianin acetate
(Fig. 4), were identified as causing a shorter circadian period. It was shown that Prieurianin
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primarily affects actin filament flexibility in vivo, resulting in reduced severing and filament 
depolymerization. This stabilization of the actin cytoskeleton is accompanied by impaired
vesicle trafficking. Again, the underlying molecular mechanism is however unknown so far. 
Fusicoccin A (Fig. 4) is produced by the fungus Fusicoccum amygdali which is a plant 
pathogen of mainly almond and peach trees. Application of Fusicoccin A on plants causes 
wilting of the leafs due to a uncontrolled loss of water through the stomatal pores which are
localized in the leaf epidermis.
36
Several biological studies have discovered that this effect is 
based on the binding of Fusicoccin A to a protein complex consisting of the (plasma 
membrane-) H
+
-ATPase (PMA) and 14-3-3 proteins.
37
The (plasma membrane) H
+
-ATPase is 
an integral membrane protein that transfers protons (H
+
) from the cytoplasm into the 
extracellular space. Activation of the H
+
-ATPase results in an opening of the stomata, while 
deactivation leads to its closing. Fusicoccin A has been shown to enforce stomatal pore 
opening by binding to the edge of the interface of the activated H
+
-ATPase/14-3-3 complex, 
thereby stabilizing the interaction between H
+
-ATPase and 14-3-3 proteins. This stabilization 
then causes a permanent activation of the H
+
-ATPase and thus irreversible opening of the 
stomata, thereby causing wilting of the plant due to the high transpirational water loss.
Syringolin A (Fig. 4) is a potent and selective inhibitor of the eukaryotic 20S 
proteasome of plants.
38; 39
It acts by irreversible modification of the active site residue, an N-
terminal threonine moiety located at the catalytically active subunits β1, β2 or β5. Inhibition 
of the plant proteasome leads to an impairment of the plant immune system. Thereby, 
Syringolin A is an important virulence factor for certain phyto-pathogenic Pseudomonas 
syringae strains.
40
Coronatine (Fig. 4) is a phytotoxin also produced by the plant pathogen Pseudomonas 
syringae. Coronatine mimics the endogenous small molecule phytohormone JA-Ile and 
promotes opening of stomata for bacterial entry and disease symptoms in plants.
41
It was 
shown that Coronatine stabilizes the interaction between the F-box protein COI1 and JAZ 
proteins. Thereby, direct recognition of coronatine by COI1 is coupled to ubiquitin-mediated 
degradation of JAZ proteins and leads subsequently to depression of primary response 
genes.
42
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2.4 Activity based protein profiling (ABPP) for functional
proteomics in plants
The application of activity based protein profiling (ABPP) is a relatively new approach in 
plant science as the active plant proteome has so far been mined with only a limited number 
of probes. However, several initial ABPP studies on plants, mainly launched by van der 
Hoorn and coworkers, demonstrated the versatility and robustness of ABPP to study plant 
enzymes. These studies illustrated the potential of ABPP as a discovery tool to detect 
differential protein activities and inhibitors also in plant species.
2.4.1 Basic principle of ABPP
The elucidation of the proteome, i.e. the entire inventory of all proteins including their 
posttranslational modifications, at a given time point in an organism is challenging and often 
referred to as “proteomics”.
43; 44
Consequently, many different proteomic techniques have 
been developed in the last years to quantitatively determine protein levels on a proteomic 
scale.
45
For enzymes, the determination of protein level is however not always correlating 
with its proper activity as the activity state of enzymes are regulated by various post-
translational and other mechanisms e.g. by regulated proteolysis of inactive protease 
precursors (zymogenes). Therefore, it is important to have a proteomic technology available
that is able to distinguish between enzyme abundance and activity.
46
Activity based protein 
profiling (ABPP) has emerged as such a methodology and is based on the application of
target-based small molecules to characterize enzyme activities directly in native biological 
systems which may even be whole living organisms.
47
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Figure 5: Concept of activity-based protein profiling (ABPP). Proteomes are incubated with activity-based 
probes, which address distinct active enzymes. The probe-labeled proteome is resolved and enzyme activities are 
visualized, for example by fluorescence or blotting.
In a typically ABBP experiment, proteomes are exposed to a certain type of an activity-based 
probe either in vitro or in vivo resulting in a covalent modification of active enzymes at their
active-site residues by the activity-based probes (Fig. 5). As the activity-based probes react 
with the catalytic amino acid residue in the active site of the enzyme, only active forms and 
not the inactive precursor-enzyme or even inhibited enzymes are addressed.
21
In the most 
classical approach, the probe-labeled proteome is then resolved by gel-electrophoresis, 
followed by visualization of probe-labeled by either in-gel fluorescence scanning (for 
fluorescent probes) or by Western-blots (for biotinylated probes). By the use of active site-
directed chemical probes it is possible to visualize distinct activities of anticipated enzymes or 
enzyme subclasses and thus to obtain a direct correlation or distinction of the visualized 
activity and the proper abundance of certain enzymes.
48
2.4.2 Composition and design of activity-based probes (ABP)
ABPP is based on the use of active-site-directed activity based probes (ABPs) which depict 
enzyme functions of specific subsets of enzymes in complex proteomes. For a quantitative 
readout of the functional state of probe-targeted enzymes, a covalent and irreversible bond 
between the active-site directed probe and the enzyme has to form. Activity-based probes 
thereby often target a large, but workable subset of the proteome, regularly defined by shared 
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homological features of the targeted enzymes. An ABP consists of three general core 
elements (Fig. 6):
Figure 6: Schematic structure of an activity based probe which contains a reactive group (blue), a spacer region 
(black) and a reporter tag (red), surrounded by examples of chemical structures for each structural element.
First, a reactive group - often deduced from known irreversible enzyme inhibitors. Hydrolytic 
enzymes are particular suited for the development of ABPs as these enzymes are catalyzing 
this reaction often via a covalent intermediate. To this end, the catalytically active amino acid 
residue is attacking an electrophilic entity on the ABP resulting in a covalent modification of 
the active-sites. The target specificity of individual probes is thereby based on mechanistic 
differences of the various classes of enzymes. For example, threonine, serine and cysteine 
proteases are using different catalytically active amino acids and thus display a specific
reactivity towards different reactive groups. 
The second component is the spacer or linker region which has the role to provide 
sufficient space between the reporter and the reactive group to prevent undesirable steric 
hindrances. In addition, variation of the chemical composition of the spacer has influence on 
the solubility and membrane permeability of the probes. The spacer region often consists of 
alkane chains or polyethylene glycol units. It also allows the incorporation of ‘specifity 
elements’ to more selectively target a distinct enzyme or family of enzymes, e.g. proteases.
49; 
50
Third, a reporter tag for detection and/or isolation of probe-labeled enzymes from 
proteomes. Examples of reporter tags involve fluorophores, such as rhodamine or bodipy, 
biotin or radioactive labels for the detection of covalently modified target-enzymes.
Fluorescent and the much less used radioactive tags can be detected easily (in contrast to a 
biotin-tag, where western-blot approaches are necessary) by direct scanning of the resolved 
SDS-gels with a fluorescence or radioactivity scanner. Despite these advantages, biotin is still 
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often used because this tag allows to both perform gel-based ABPP and gel-free ABPP 
applications via affinity purifications of labeled enzymes using (strept)avidin-beads (c.f. 
Chapter 2.4.5).
49
2.4.3 Classes of ABPs
2.4.3.1 Directed probes
ABPs can be classified as either mechanism-based or affinity-based depending on the mode 
by which the covalent linkage with the enzyme is established. Mechanism-based ABPs (also 
known as directed ABPs) are mainly based on irreversible enzyme inhibitors (or suicide 
inhibitors) and use electrophilic warheads that specifically react with catalytic residues in the 
enzyme’s active site.
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A beneficial feature of direct ABPs is that they ideally possess 
excellent target selectivities within a family of enzymes sharing cognate mechanism and 
function and minimal interfamily cross-reactivity. Several directed probes for various enzyme 
classes are known so far, including ABPs for serine-hydrolases
52
, several protease families
53; 
54
, phosphatases
55
, glycosidases
56
, etc.. Many of them have also been used in plant research
(Fig. 7). 
Serine hydrolases can be addressed with ﬂuorophosphonates (Fig. 7) that react with 
the catalytic serine residue in this class of enzymes. Due to their high reactivity, 
fluorophosphonate-probes have emerged as powerful tools to study serine hydrolase activities 
in plants.
57
The epoxide probe DCG-04 (Fig. 7), originally derived from the natural product E-64, 
selectively targets papain-like cysteine proteases in plants.
58
The acyloxymethyl ketone electrophile (Fig. 7) is known to target cysteine proteases.
59
This type of electrophile is equipped with low reactivity towards weak nucleophiles and thus 
is efﬁciently addressed by catalytically active thiol residues located in the active site of 
cysteine proteases. The direct AOMK probe depicted in Figure 7 has for example been used 
to profile the cysteine protease AvrPphB, an effector of the plant pathogen Pseudomonas 
syringae, which is injected into the host plant cell to cleave specific kinases for disrupting 
immune signaling.
60
Of note, a number of other AOMK probes containing either a single 
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amino acid or an extended peptide sequence have been shown to target other cysteine 
proteases like caspases, legumains, gingipains and cathepsins in human cells.
59
Figure 7: Examples of established directed probes that have been used in plant research. Reactive groups are 
colored in blue, reporter tags are highlighted in red and spacers and selectivity-providing groups are colored in 
black.
2.4.3.2 Non-directed probes
Another possibility to develop new reactive groups for ABPP is the non-direct approach, in 
which combinatorial chemistry libraries of molecules equipped with general electrophilic 
entities are screened towards a certain target enzyme. These reactive groups often possess 
new and unpredictable chemical features and sometimes contribute to the discovery of new 
ABPs for new enzyme targets. By following this concept, multiple non-directed probe 
libraries for several mechanistically distinct enzyme classes were developed. This approach 
has significantly expanded the scope of ABPP for those enzyme classes that lack obvious 
susceptible catalytic residues and was recently also used in in plant research.
53
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Such non-directed β-lactone probes were for example generated for monitoring protease 
activities in plant extracts (Fig. 8). Unexpectedly, this probe resulted in labeling of the N-
terminus of PsbP, a non-proteolytic protein of photosystem II. Inhibitor studies and reverse 
genetics led to the discovery that this unusual modiﬁcation was mediated by a single plant-
speciﬁc, papain-like cysteine protease called RD21. In cellular extracts, RD21 accepted both 
β-lactone probes and peptides as donor molecules and ligates them, probably through a 
thioester intermediate, to unmodiﬁed N-termini of acceptor proteins.
61
Figure 8: Examples of established non-directed probes for ABPP. Reactive groups are colored in blue, reporter 
tags are highlighted in red and spacers are colored in black.
The α-chloroacetamide group also has features that are beneficial for undirected ABPP
(Fig. 8). Its small size does not bias binding elements towards a specific class of enzyme, and 
it possesses reactivity towards a broad variety of nucleophilic amino acid residues. Upon 
screening of an α-chloroacetamide-based library in a mouse model system many enzymes 
previously unadressed by directed ABPP probes were uncovered.
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Of all the non-directed ABPP reactive groups, the MICHAEL acceptor system is 
probably the most frequently used (Fig. 8). This chemical entity is found in many natural 
products, often displaying mechanism-based activity via the 1,4-addition of cysteine residues, 
the preferred reacting partner of MICHAEL-acceptors in the proteome. Pitscheider and Sieber 
synthesized an undirected ABPP library based on cinnamic aldehydes as the reactive group 
(Fig. 8). Using this probe library, a virulence-associated secretory antigen from MRSA strains 
was identified.
63
As noted, ABPP with electrophilic ABPs is only applicable to protein targets that 
possess nucleophilic active site residues (mainly Ser, Cys or Lys) susceptible to covalent 
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labeling. For enzymes with different enzymatic mechanisms, strategies have been developed 
in which photoreactive ABPs are used. These probes contain for example an additional photo-
reactive crosslinker (Fig. 9), which is conjugated to a probe that tightly binds to an active site
of the protein target.
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Upon UV irradiation, these chemical groups are able to form highly 
reactive intermediates. Subsequently, these reactive species form covalent bonds with all 
types of protein residues that are in close spatial proximity. 
Figure 9: Examples of photo-reactive groups that can be incorporated into activity-based probes.
In a typical photo-reactive probe, the warhead is substituted by the incorporation of such a 
photo-crosslinker, in addition to a selectivity generating motif that is required to avoid 
random labeling. The integration of photo-reactive crosslinkers into natural products that lack 
electrophilic entities is also often used to elucidate the direct target of these compounds.
65
Finally, photo-reactive groups can also be used in a non-directed approach that has been 
termed as screening with “fully functionalized” small molecules.
66
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2.4.4 Two-step ABPP
A common limitation of in vivo applications of ABPP stem from the relative bulky nature of 
the reporter tags (e.g. biotin or rhodamine). The enlargement of the probes through these
reporter tags often restricts the cell permeability and/or the distribution of the probes within 
the cells. The introduction of a two-step ABPP labeling strategy has allowed overcoming
these difficulties. To this end, the reporter group is substituted with a small bioorthogonal 
chemical entity (mostly either alkyne or azide) which does not disturb membrane 
permeability.
26; 67
Figure 10: Principle of two-step ABPP. In contrast to standard ABPP, two-step ABPP enables the profiling of 
living cells and organism by treating them with “tag-free” azide- or alkyne-modified probes, which are 
subsequently conjugated in vitro forming a stable triazole product to visualize probe-labeled proteins.
Consequently, a reporter tag equipped with orthogonal functionalization (either alkyne or 
azide) is then attached to the probe after the labeling-experiment using for example the Cu-
(I)-catalyzed version of HUISGEN’s [2,3] cyclcoaddition to form a stable triazole product 
(Fig. 10).
68
This reaction is conducted using the whole, unpurified and probe-labeled 
proteome by applying TCEP as reducing agent, TBTA as stabilizing ligand and Cu-(I) as a 
catalyst. This approach has been widely used, for example to determine distinct activities of 
serine-hydrolases overexpressed in human cancer cell lines, which refused detection under in 
vitro conditions.
47
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2.4.5 Analytical platforms for ABPP
2.4.5.1 Gel-based approaches
Traditional ABPP approaches are gel-based methods because electrophoresis is the simplest 
method to resolve complex protein mixtures. Accordingly, all components of an ABP have to 
be stable at the conditions used for gel-electrophoresis. In gel-based ABPP approaches, the 
complex proteome is incubated with an ABP, resulting in covalent labeling of enzymes that 
are accessible for the probe. This complex mixture is then resolved by gel-electrophoresis and 
directly visualized using in-gel-fluorescent-scanning (fluorescent probes) or avidin-blotting 
(biotinylated probes). Two step ABPP approaches often apply both modes of detection, ﬁrst 
using the attachment of ﬂuorescent tags for rapid gel-based screening of proteomes and then 
linking biotinylated tags to allow avidin affinity chromatography, trypsin digest and mass 
spectrometry analysis for the identification of probe-labeled enzymes. In gel-based 
approaches, labelling patterns can be compared between samples but the elucidation of 
protein identies requires isolation of individual protein spots, their digestion and finally 
analysis of their mass, for example by MALDI or ESI mass spectrometry. The measured 
peptide masses are then compared against predicted mass values from a theoretical digestion 
of proteins, using a sequence database, resulting in the identification of a protein by a 
statistically significant number of matches.
2.4.5.2 Gel-free approaches
A gel-free approach is the Multidimensional Protein Identification Technology (MudPIT) that 
eliminates gel separations.
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To this end, biotinylated probes are used and the labeled 
proteome is affinity-purified using avidin beads (Fig. 11). The affinity-purified fractions 
containing many proteins are then directly digested and the enormous number of generated 
peptides are separated by 2-dimensional liquid chromatography before entering the MS.
70
The 
procedure employs tandem mass spectrometry, i.e. after the mass of a peptide is measured, the 
peptide is fragmented using a collision-induced dissociation cell and the masses of the 
fragmentation products are also determined.
71
Extensive computational efforts then allow
transforming this data into an amino acid sequence. Consequently, one identified peptide is 
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often sufficient to elucidate a target protein. This connotes a sensitivity advantage that allows
identification of minor proteins in a biological fraction that conceivably cannot be detected by 
gel-based ABPP approaches. ABPP-MudPIT approaches were applied for example to profile 
enzyme activities in primary human breast tumors, resulting in the identification of more than 
50 probe-labeled enzymes in a single experiment.
72
MudPIT approaches do however not 
enable a straightforward identification of the probe-labeled peptides. Consequently, a second 
concept known as the ASPP strategy was furthermore developed.
73
In this approach, the 
probe-labeled proteome is trypsin-digested before affinity-purification with beaded avidin. 
Therefore, only the probe-labeled peptides are subjected to the LC-MS/MS analysis and a 
direct determination of the binding site and thus of the catalytic amino acid can be ensured.
Figure 11: General procedure for gel-based and gel-free (MudPIT) ABPP experiments. (Adapted and modified
from Overkleeft et al. 
74
)
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In order to quantify the mass spectrometrical analysis of ABPP experiments, novel 
approaches (that originally stem from quantitative mass spectrometry approaches) have also 
been introduced in ABPP. To this end, stable isotope labels are incorporated into proteins. 
Stable isotopes preserve the physico-chemical characteristics of proteins and thus do not bias 
the activity. However, they differ in mass which enables their simultaneous detection and 
relative quantification. Mann and coworkers established a quantitative proteomic approach, 
the so called stable isotope labeling by amino acids in cell culture (SILAC).
75; 76
SILAC 
makes use of the requisition of mammalian cells for essential amino acids. Hence, cells are 
cultured either under normal conditions (natural abundant amino acids) or supplemented with 
isotope labeled essential amino acids (e.g. 
13
C labeled L-arginine and 
13
C, 
15
N labeled L-
lysine), which are fully integrated into cellular proteome. Different lysates are used for the 
pulldown with the active (“heavy” isotope labeled lysate) and with the inactive control probe 
(“light” lysate). The eluted proteins from both experiments are combined, processed and 
analyzed by MS. The use of isotopically labeled amino acids leads to a similar retention time 
for each peptide but to a difference in the molecular mass detected by MS. Therefore, a 
relative quantity of the “heavy“ to the “light” peptide can be deduced from the ratio of the ion 
intensities. SILAC was for example used in the identification of tubulin and CSE1L as targets 
of tubulexins.
77
Morever, MT-ND1 and epoxide hydrolase 1 (EPHX1) were identified as 
primary targets of an antiproliferative 5-benzoylindole derivative in cancer cells by using the 
SILAC approach.
66; 78
Another approach for quantitative proteomics is the use of isotope-coded affinity tags 
(ICAT).
79
The ICAT probe contains an affinity tag (e.g. biotin), an isotopically labeled linker 
and a reactive group (warhead). The principle of ICAT comprises again two separate 
experiments (with two lysates treated independently with one of “heavy” and “light” probe) 
with subsequent pooling of the two different treated proteomes followed by digestion, affinity 
purification and relative quantification via MS. The ICAT approach was used for example to 
identify cytosolic MDHs as potential protein targets of the E7070 class of anticancer agents.
80
2.4.6 Comparative ABPP
In a comparative ABPP approach, samples of proteomes obtained under different conditions
are directly compared. For example, proteomes of healthy organisms can be compared with 
proteomes from diseased organisms via ABPP, resulting in different signal patterns.
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Nowadays, many examples of this ABPP technology can be found in literature. As a 
prominent example, comparative ABPP has been used to identify some serine hydrolases that 
are dysregulated in aggressive cancer cells.
81
2.4.7 Competitive ABPP
This versatile ABPP approach has also been developed to screen for enzyme inhibitors. To 
this end, a competitive ABPP experiment is performed which relies on determining enzyme 
activity states after pre-incubation with prospective enzyme inhibitors. A competitive ABPP 
approach offers several advantages towards the conventional screening of inhibitors. For 
example, targeted enzymes are tested in their native environment which ensures that potential 
post-translational modifications required for enzyme-activity are also considered. Moreover, 
this approach renders the recombinant expression and purification of proteins unneccessary
due to use of whole native proteomes. Furthermore, there is the possibility to characterize 
simultaneously reversible
82
as well as irreversible inhibitors
83
against various enzymes. This 
approach is also suitable for those enzymes with unknown substrates as long as the enzyme is 
accessible to probe-labeling. Reversible inhibitors must be screened under kinetically 
controlled conditions, whereas the analysis of irreversible inhibitors is more straightforward 
and can even be performed in living organisms.
84
2.4.8 ABPP with natural product-derived probes
Furthermore, the design of reactive groups may also makes use of protein-reactive natural 
products as starting point for novel selective probes.
85
Natural-products (NPs) are often very 
specific towards a particular enzyme and are therefore well suited for the design of probes, for 
which no mechanism-based inhibitor is available. For performing ABPP approaches with 
NPs, the target identification is undoubtedly the key step. To this end, the natural products 
need to be modified with an appropriate reporter-tag for transforming them into prospective
probes. The corresponding reporter-tags can be incorporated into NPs either by total synthesis 
or via a regioselective modification (e.g. by alkylation, acylation etc.) of the NP. Such
reporter-tagged NPs (tagged for example with biotin and/or alkyne/azide) can then be 
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incubated with proteomes. The corresponding target proteins are labeled by the NP-probes 
and enriched using for example immobilized (strept)avidin. Such affinity-purified proteins are 
then passed to either gel-based or gel-free identification techniques, mass spectrometry 
analysis and database searches for identifying labeled proteins (c.f. Fig. 11). For NPs that lack
obvious electrophilic moieties for form covalent bonds, photo-reactive groups are often also 
attached (c.f. Fig. 9).
Figure 12: Examples of reporter-tagged natural products. Reactive groups are colored in blue, reporter tags are 
highlighted in red. The respective major protein targets are depicted in brackets.
To illustrate this NP-based approach, some examples will subsequently be given: 
Thiostrepton is a natural product isolated from various Streptomyces strains and has caused a 
great deal of scientific attention due to its potent antibiotic but also antiproliferative activity in 
human cancer cells. For pull-down experiments, the natural product thiostrepton was 
modified via 1,4 MICHAEL-type addition of a thiol-linked biotin tag to form a bioactive 
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probe (Fig. 12). In subsequent ABPP pull-down experiments, the transcription factor FOXM1 
was found to be a direct target of thiostrepton in MCF-7 breast cancer cells.
86
Wortmannin is a natural product that belongs structurally to the furanosteroids and is 
produced by the fungus Penicillium wortmannii. The capability of Wortmannin as a bioactive 
lead structure has inspired the development of Wortmannin-derived probes (Fig. 12). 
Attachment of fluorescent labels (bodipy and rhodamine) to the Wortmannin scaffold through 
esterification of a deacetylated alcohol side chain has enabled the identification of the binding 
partners of Wortmannin. Such an approach has allowed Yee and coworkers to confirm the 
reactivity of Wortmannin against phosphatidyl-inositol 3-kinase and related enzymes.
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HUN-7293 is a fungal cyclodepsipeptide that inhibits the expression of vascular cell 
adhesion molecule (VCAM). HUN-7293 associates irreversible to its protein targets and thus 
does not become covalently bond, which hampers target identification. Therefore, 
MacKinnon and coworkers generated a photoaffinity probe by incorporation of a 
photoleucine instead of leucine residue during chemical synthesis of HUN-7293 (Fig. 12). 
This probe was then able to covalently bind to HUN-7293 binding partners through 
photoactivation of the photoreactive diazirine group of photoleucine after UV irradiation.
Additionally, an alkyne group was also introduced in HUM-7293, thereby enabling 
visualization of the target protein after a click reaction with rhodamine azide after UV 
irradiation of the probe-labeled proteome. This protocol enabled the identification of Sec61α 
as the direct target protein of HUN-7293. Sec61α participates in the forming of translocation 
channels at the beginning of the secretion pathway for all proteins in the endoplasmic 
reticulum. Hence, the molecular target of HUN-7293 could be directly detected by using 
ABPP.
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The marine natural product symplostatin 4 has been attracting many scientists due to 
its potent antimalarial properties. By adding a propargyl moiety to its N-terminus, this natural 
product was transferred into a natural product-derived probe (Fig. 12). Subsequent ABPP 
experiments revealed that plasmodial falcipains were the direct targets of symplostatin 4.
88
2.5 Solid phase supported synthesis
Solid phase peptide synthesis (SPPS) has reached a major place in polypeptide synthesis since 
its invention by Merrifield in the early sixties of the 20
th
century and was awarded with the 
Nobel Prize in 1984.
89
Today, solid phase peptide synthesis has become an integral part for 
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the structure elucidation and total synthesis of natural products having a peptidic structure 
such as hormones, antibiotics, or plenty of other bioactive peptides. The definition of a 
peptide is not strict; most often, the benchmark for a peptide is a maximum of 50 amino acids 
and larger polypeptides are correspondingly then called proteins. Nowadays, synthetic 
peptides synthesized via solid supported methods have found widespread application in all 
areas of biomedical research.
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2.5.1 Peptide bond formation
Peptide synthesis relies on the controlled formation of a peptide (amide) bond between two 
amino acids with concurrent release of one water molecule, thus turning polypeptide synthesis 
into a repetitive condensation reaction. The condensation reaction however cannot proceed
spontaneously but requires a pre-activation of the carboxyl component (A) of one amino acid, 
which holds additionally a selectively blocked N-terminus (Fig. 13). The N-terminal primary
amine of the second amino acid (B), which possesses vice versa a selectively blocked 
carboxyl function, attacks the activated carboxyl component via a nucleophilic attack to give 
the dipeptide A-B. After selective deblocking of either the N-terminal or C-terminal 
protection group, the dipeptide A-B can enter again into the cyclic reaction flow.
Figure 13: The multi-step process of peptide synthesis (adapted and modified from Ref. [91]).
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To overcome unintentional side reactions during peptide synthesis, all additional reactive 
functional groups have to be blocked by protection groups. Hence, peptide bond formation
can be regarded as a three-step procedure:
1. The preparation of a selectively and partially protected amino acid which results in 
a non-zwitter ionic amino acid derivative.
2. The formation of the peptide bond. To this end, the carboxyl function of the N-
protected amino acid has to be transformed into an activated intermediate capable 
of reacting with the nucleophilic amine of the second amino acid.
3. The chemoselective cleavage of the protecting groups. To this end, two different 
deprotection approaches are differentiated. At the end of the synthesis, a complete 
deprotection of all protection groups of the peptide has to be performed. In 
contrast, during iterative assembly of the different amino acid building blocks, a 
selective cleavage of the N-terminal or C-terminal amino acid protection is 
required (Fig 13).
For activating the carboxylic acid of the carboxyl component (A), a broad spectrum of 
methods is nowadays available and often used in practical synthetic applications.
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For 
example, acyl azides
93
, mixed anhydrides
94
, carbodiimides
95
and active esters
96
of HOBt or 
HOAt which are often indirectly derived from phosphonium or guanidinium/uronium type 
coupling reagents are often used.
Figure 14: Mechanism of peptide bond formation via activation of guanidinium/uranium salts of 
hydroxybenzotriazole derivatives.
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These HOBt and HOAt-based coupling reagents predominantly exist in the guanidinium or N-
form, which is less reactive than the uronium O-form.
97
However, mechanistically the 
guanidinium reagents like HBTU are nucleophilically attacked by the carboxylate of the N-
protected amino acid which results in an O-acylisouronium salt intermediate (Fig. 14). This 
highly reactive intermediate is then attacked by hydroxybenzotriazole to yield the 
corresponding active ester. This intermediate is then susceptible for the nucleophillic attack 
by the amine of the second amino acid (B) thereby finally leading to the peptide bond (A-B).  
2.5.2 Protecting group strategies
The entire process of peptide synthesis is however complicated by the presence of additional 
functional groups in the side chain of half of all proteinogenic amino acids which makes a 
further selective protection indispensable (Table 1). Due to the different synthetic demands
with respect to selectivity, a precise distinction must be made between the transient and semi-
permanent (side chain-) protection groups. The transient protection groups are required for 
temporary protection of the amino function involved in subsequent bond formation. These 
transient protection groups must be cleaved selectively under conditions which do not impair
the stability of the peptide backbone already present or the stability of the semi-permanent 
protection groups at the amino acid side chains. The semi-permanent protection groups are 
commonly cleaved after assembly of the desired peptide chain or, once in a while, also at an 
intermediate stage to perform e.g. regio-selective reactions with amino acid side chain. In 
these deprotection reactions, only those deblocking reagents can be used that do not harm the 
final product. The selection of protecting groups must also be carried out in accordance with 
the envisaged synthesis strategy. Normally, orthogonal protecting group strategies are used in 
peptide synthesis. Orthogonal protecting groups can be cleaved selectively while all other 
protecting groups stay intact. To this end, the chemical cleavage mechanisms of the different 
protecting groups should be chemically different to achieve an optimum degree of 
orthogonality. For instance, the application of Boc as the transient protection group excludes 
the use of semi-permanent protection groups at amino acid side chains with comparable acid-
lability. Hence, semi-permanent protection in Boc tactics must avail protection groups that 
remain intact during the recurring acidic Boc cleavages. In contrast, Fmoc as the transient 
protection group is cleaved after each coupling step by treatment with secondary amine bases. 
In this case, side chain protection may apply tert-butyl or Boc-like protection groups. 
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Consequently, this tactic is denoted in literatue as the Fmoc/tBu or Fmoc/Boc or as the 
SHEPPARD-strategy.
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Special protection schemes may also be required, for instance if a 
certain peptide strand needs to be branched via side chain funtionalization or for subsequent 
cyclization reactions. In small scale applications such as laboratory peptide syntheses, the 
Fmoc/tBu strategy is nowadays mostly used since it is more applicable than the Boc-tactics 
due to the avoidance of irritant chemicals (e.g. HF) used in the synthesis. As the name 
denotes, Fmoc-chemistry uses the Fmoc group for N-amino protection, which is usually 
removed by piperidine or DBU in DMF. Fmoc-compatible side chain protecting groups are 
primarily ether, esters or urethane-type derivatives of tert-butanol (Table 1). In the course of a 
common Fmoc-based peptide synthesis, the side chain protecting groups are ideally removed 
at the same time as the corresponding cleavage from the resin, often by the use of TFA as the 
cleavage reagent.
Table 1: Selected protecting group schemes for the maximum protection approach using the Fmoc/tBu protocol.
Fmoc/tBu
protocol
Transient protection group Fmoc
Semi-permanent protection groups
Asp/Glu OtBu
Arg Pbf
Lys Boc
His Trt
Cys Trt
Ser tBu
Thr tBu
Tyr tBu
Trp Boc
Asn/Gln Trt
Examples of important amino-protecting groups used in SPPS are given in the subsequent 
paragraphs.
2.5.2.1 The tert-Butoxycarbonyl protecting group
The tert-Butoxycarbonyl group (Boc) is attuned with the majority of the most common
coupling methods to accomplish peptide bond formations. It can be cleaved using mild acidic 
conditions and is robust towards many reaction conditions like catalytic hydrogenation, 
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alkaline hydrolysis and diverse reductive conditions. The frequently used deprotection 
procedure is the treatment with pure or diluted TFA which efficiently cleaves Boc groups
giving the free amine together with simultaneous elimination of carbon dioxide and isobutene 
(Fig. 15).
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Figure 15: Mechanism of the introduction and of the acidolytic cleavage of the tert-butoxycarbonyl group.
The installation of the Boc-protection group on an amine is easily achieved by reaction with
di-tert-butyldicarbonate (Boc2O) (Fig. 15). To this end, amino acid salts are for example 
treated with Boc2O in an aqueous sodium bicarbonate solution often containing solubilizing 
additives such as dioxane. 
2.5.2.2 The 9-Fluorenylmethoxycarbonyl group
The 9-Fluorenylmethoxycarbonyl group (Fmoc) is the only amine urethane type protection
group of practical significance that enables a cleavage under mildly basic conditions.
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The 
practical benefit of the Fmoc-protection group is its particular sensitivity towards secondary 
amines, which allows deprotection of the amino group with dilute solutions of piperidine or 
diethylamine in DMF; for example, 20% piperidine in DMF is usually used in solid phase 
peptide synthesis. The deprotection reaction procceeds according to an E1cB mechanism, i.e. 
after an initial proton abstraction, the formed carbanion (a stabilized dibenzocyclopentadienyl
anion), which is the conjugated base of the substrate eliminates in a second step from the 
substrate. The so formed dibenzofulvene subsequently reacts with piperidine to give a stable 
adduct as a by-product of the cleavage reaction (Fig. 16). This piperidine adduct has a unique 
UV absorption with a maximum at λ = 301 nm which allows to monitor the cleavage reaction 
by photometric measurements. The reagents Fmoc-Cl and Fmoc-OSu (9-Fluorenylmethyl-N-
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succinimidyl carbonate) are mostly used for the installation of the Fmoc protecting group. The 
acid stability, combined with the mildly basic cleavage conditions, allows the application of 
acid-labile semi-permanent protecting groups (such as Boc) to mask side chain functionalities.
Figure 16: Mechanism of Fmoc introduction and base induced cleavage.
2.5.2.3 The N-Allyloxycarbonyl group 
The N-Allyloxycarbonyl group (Alloc) is completely orthogonal to Boc and Fmoc and finds 
therefore application in syntheses in which a third orthogonality is needed, e.g. the syntheses 
of cyclic peptides or selective cross-links at side chain functionalities. The deprotection step 
involves palladium(0)-catalyzed allyl transfer to nucleophiles such as amines or organosilanes
(Fig. 17).
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Figure 17: Mechanism of introduction and cleavage of Alloc-protecting groups.
The installation of the Alloc protecting group is quite similar to the introduction of the Fmoc 
protecting group. Thus, this protecting group is mostly introduced with a SCHOTTEN-
BAUMANN-like reaction, i.e. an acylation of the primary amine by an acid chloride of a 
corresponding formic acid derivative.
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2.5.3 The principle of solid phase supported peptide synthesis (SPPS)
Despite some remarkable solution phase peptide synthesis of even whole proteins, solution 
phase peptide synthesis is generally highly elaborate and time-intensive due to the need to 
separate all interim peptide-intermediates from potential by-products as well as from coupling 
reagents. In addition, the solubility of the growing peptide chain is often an indispensable 
problem. Therefore, solid phase peptide synthesis has more and more become the standard 
method for the generation of all types of peptides. Solid phase peptide synthesis begins with 
the coupling of the first amino acid of the peptide via its carboxyl group to an insoluble 
polymer resin. The linkage to a solid matrix allows an easy separation of the resin-bound 
product from either reagents or dissolved product by simple filtration. To this end, an amino 
acid which is protected at its N-terminus is reacted with the functional group of the linker to 
form a covalent linkage (Fig. 18; Step 1). Subsequently, the N-terminal transient protection 
group is removed (Fig. 18; Step 2) and the next amino acid component is coupled (Fig. 18; 
Step 3). Steps 2 and 3 are then repeated until the required peptide sequence has been 
assembled. Finally, the covalent bond between the linker moiety and the peptide chain is 
cleaved. In many cases the permanent side chain protecting groups may be simultaneous 
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removed (Fig. 18; Step 4). The insoluble polymeric support is then separated from the cleaved 
product, for example by filtration (e.g. by suction through a frit). 
Figure 18: Process of solid phase peptide synthesis. Tpg = transient protecting group; Ppg = permanent 
protecting group; R = aa side chains; X = Cl
Thus, during the synthesis, the reaction products (i.e. intermediates or final product) remain 
covalently linked to the solid support during the whole synthesis, whereas by-products and the 
excess of coupling reagents are removed by filtration. This simple technical operation and the 
potential for automation of this “Merrifield synthesis” have revolutionized peptide chemistry.
The solid polymer support thereby plays a key role for a successful outcome of any 
SPPS. The polymeric support must fulfill several inevitable requirements. It has to be 
chemically inert, mechanically stable and completely insoluble in organic solvents, thereby 
allowing simple reagent separation by filtration. Moreover, it must comprise an appropriate
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quantity of reactive sites to which the first C-terminal amino acid of the peptide is usually
anchored. Finally, non-covalent interactions between the resin and the growing peptide chain 
should be as minimal as possible. 
Similar to a carboxyl-protecting group, the resin linkage must be orthogonal to the transient 
protecting group utilized during synthesis and has to be stable under all employed chemical 
conditions throughout the whole synthetic process. Furthermore, cleavage under mild 
conditions without harming the fully assembled peptide backbone must also be possible. 
Commonly, a copolymer of polystyrene with 1% divinyl benzene as cross linker is used as a 
resin in SPPS. Therefore, the dry resin beads are normally 20-80 µm in diameter, and are 
capable to swell to its five- or six-fold volume in different organic solvents (e.g. DCM or 
DMF which are frequently used in SPPS). Thus, the polymeric resin after suspension in these 
solvents should not be considered as a static solid matrix but more as a well-solvated gel with 
mobile polymeric chains. This situation eases diffusional access of the reagents to all reaction 
sites. The heterogeneous reaction systems utilized in SPPS are typically two- or three-fold 
slower than comparable homogenous solution reactions.
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The reaction sites are evenly
distributed within the polymeric resin, and the reaction rates of the early coupling and 
deprotection steps are commonly similar to those at the end of a synthesis. The growing mass 
ratio of peptide/resin material does not regularly diminish the efficiency of further chain 
elongations, although the swelling performance in nonpolar solvents can be decreased.
The installation of anchoring groups on the polymeric resin is another pre-condition 
for their application in peptide synthesis. There are numerous different linker systems 
currently available for SPPS and solid-phase organic synthesis. As linkers must be considered 
as protecting groups for the C-terminal carboxyl group of the synthesized peptide, their design 
and implementation has to reflect these chemical properties. For example, different anchor 
groups are used if the C-terminus of the anticipated peptide should be obtained as a ’free’
carboxylate, a carboxamide or an alcohol. As for most peptide syntheses, a ‘free’ carboxylate 
C-terminus is required, the first amino acid is mostly connected to the resin via an ester bond. 
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3. AIMS OF THE PHD THESIS 
The aim of this PhD thesis was the generation of small molecule modulators for functional 
chemical biology investigations in plants. 
To this end, several approaches were followed. The main project of this thesis was 
focused on the chemical synthesis of bioactive plant growth-modulating natural products and 
their subsequent evaluation as potential chemical probes to decipher root growth biology. The 
acquisition of water and nutrients by plant roots is a fundamental aspect of agriculture and 
strongly depends on adequate root branching. The plant root system consists of a primary root 
originating from the plant embryo and of lateral roots, resulting in a branched root system to 
provide continuous access to new soil resources for nutrients and water. Within this thesis, 
new synthetic molecules that modulate the process of root development and that can be used 
as chemical probes should be discovered and characterized. To this end, a natural product 
approach was followed, i.e. derivatives of natural products with known plant growth 
modulatory properties were synthesized and derivatized for structure-activity relationship 
(SAR) -studies as a starting point for subsequent target identification studies.
Along these lines, a first total synthesis of Rotihibin A should be established. This 
lipopeptidic natural product features a vast array of non-proteinogenic amino acid (in fact, 
only one of the six amino acids is a regular proteinogenic amino acid) and this natural product 
was described in literature as a potent root-growth inhibitor in plants (Fig 19).
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The 
synthesis should be conducted via solid phase supported synthesis after previous amino acid 
building block synthesis.
Figure 19: Chemical structure of the plant growth-modulating natural product Rotihibin A.
3. AIMS OF THE PHD THESIS 37
Subsequently, a whole series of derivatives should be synthesized to elucidate the underlying
structure-activity relationships. To determine the bioactivity of these compounds, gene-
reporter assays with transgenic plants should be carried out.
In a second project, related to the chemical synthesis of plant growth-modulating 
natural products, it was envisaged to synthesize a focused library of derivatives of the 
Brevicompanine natural product family (a class of reverse prenylated hexahydropyrrolo [2,3-
b]indole alkaloids); these natural products were also reported as plant growth regulators. To 
this end, a focused library of Brevicompanine derivatives should be synthesized and used to 
study the structure-activity relationships and to get initial insights into the mode-of-action of 
this compound class (Fig. 20).
103; 104
R =
BrevA BrevB BrevC
Figure 20: Chemical structures of Brevicompanine A, B and C.
In a third, slightly different project, novel activity-based probes should be synthesized to 
expand the scope of ABPP approaches in plants. To date, only a limited number of probes for 
this purpose are available and this subproject aims to expand the chemical toolbox into this 
direction. Therefore, in the first part of the thesis the outreach of acyl-phosphate probes, for 
profiling protein kinases and other ATP binding proteins in plants, should be expanded by 
directed synthesis of functional derivatives of a recently published biotinylated adenosine acyl 
phosphate probe.
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Figure 21: General structure of envisaged acyl phosphate probes. Probes are built up from ATP, an acyl 
phosphate warhead (blue), an alkyl linker and a reporter tag (red).
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These probes represent an ATP-derivative which is modified with a reactive acyl phosphate 
group at the γ-phosphate followed by an appropiate reporter-tag (Fig. 21). This type of probes
was previously shown to act by binding to the P-loop (phosphate binding domain) of ATP-
binding proteins. At this binding site, it is cleaved by a conserved lysine residue, thereby 
inducing irreversible ATPase inhibition and transfer of a reporter group to the protein. The 
synthesized acyl phosphate probes should be utilized to launch a new approach to explore the 
ATP-binding proteome of the model plant Arabidopsis thaliana.
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4. RESULTS AND DISCUSSION
4.1 Studies on Rotihibin A, a plant growth regulator from 
Streptomyces graminofaciens
In a screening campaign for plant growth regulators from bacterial origin, the group of Suzuki
and coworkers found that a culture filtrate of Streptomyces graminofaciens (strain 3C02) 
inhibited the growth of lettuce seedlings. The strain 3C02 was isolated from a soil sample 
collected in Bunkyoku, Tokyo, Japan. Based on analytical data, the active substances were 
identified as lipo-peptidal compounds (Fig. 22A), named Rotihibin A (1) and B.
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Rotihibin A (1) is thereby by far the major bioactive secondary metabolite, while Rothibin B 
was isolated in only low amounts.
Figure 22: (A) Chemical structures of Rotihibin A (1) and Rotihibin B. (B) Schematic depiction of chemical 
components of Rotihibin A (1).
Lipopeptides (LPs) are characterized by a lipid tail linked to a short linear or cyclic 
oligopeptide. LPs represent a structurally diverse group of metabolites produced by various 
bacterial and fungal genera including for example Aspergillus, Streptomyces and 
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Pseudomonas.
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LPs have received considerable attention for their antimicrobial, cytotoxic, 
antitumour, immunosuppressant and surfactant properties.
Intensive analytical studies including various NMR experiments and MS/MS analyses 
revealed that 1 is mainly build up from non-proteogenic, highly modified amino acids and 
amino alcohols including D-citrulline, L-diaminobutyric acid, L-allo-threonine, L-threo-β-
hydroxyasparagine and L-amino-hydroxybutanamide (L-asparaginol) in addition to a 
lipophilic chain (Z)-dec-2-enoic acid and L-serine as the only common proteinogenic amino 
acid (Fig. 22A, B).
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The high ratio of non-proteinogenic amino acids within Rotihibins 
suggests that the biosynthesis of these compounds could be non-ribosomal as it is already 
known for several other lipopeptides like surfactin
108
or fengycin
109
. In fact, most LPs are 
biosynthesized by large nonribosomal peptide synthetases (NRPSs) via a thiotemplate 
process.
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Interestingly and in contrast to other LPs, Rotihibin A (1) displayed no relevant 
antimicrobial activity against several bacterial and fungal strains.
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Although many LPs from 
microbial origin furthermore show antitumor activities, Rotihibin A (1) also did not 
demonstrate any effect on mammalian cells. In contrast, 1 was reported to display a strong 
bioactivity on plants. In particular, Rotihibin A (1) inhibited the root growth of lettuce 
seedlings at a dose of 1-2 ppm (1-2 µg/ml), while Rotihibin B was significantly less active.
Rotihibin A (1) application was however not lethal up to a concentration of 150 ppm (150 
µg/ml). Moreover, Rotihibin A-treated plants were reported to recover to their normal growth 
after they were transferred into fresh media lacking 1.
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Since Rotihibin A (1) was found to be the major and most active metabolite, the focus 
of the following synthetic work and biological assessment was therefore put on Rotihibin A 
(1). To the best of our knowledge, no synthesis of Rotihibin A (1) has been reported so far.
4.1.1 Synthetic considerations towards Rotihibin A
In contrast to a laborious solution synthesis, a more straightforward solid-phase strategy that 
also enables easy derivatization of Rotihibin A (1) was envisioned. For the synthesis of 
Rotihibin A (1), a solid phase Fmoc-based strategy was envisaged. To this end, an orthogonal 
protection group strategy was designed involving various protection groups that enabled the 
usage of three different complementary deprotection procedures.
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Figure 23: Schematic representation of the employed protection group strategy for SPPS of Rotihibin A (1). Red 
arrows: acid labile protecting groups (tBu = tert-butyl; Trt = triphenyl methyl; Boc = tert-butoxycarbonyl; resin 
= 2-chlorotrityl chloride resin), blue arrow: base labile protecting group (Fmoc = 9-Fluorenylmethyl-
oxycarbonyl), green arrow: Pd
0
mediated cleavage (Alloc = Allyloxycarbonyl).
As the transient protecting group for the primary α-amine of the N-terminus of each amino 
acid building block, the base-labile Fmoc (9-fluorenylmethyloxycarbonyl)-protecting group
was chosen (Fig 23). The Fmoc method allows for a mild deprotection procedure, which uses 
basic conditions, usually 20% piperidine in DMF for removal the Fmoc group.
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In contrast 
to acid labile protecting group such as Boc, the basic cleavage of Fmoc leads to neutral amine 
residues and no additional neutralization of the peptide-resin is necessary. The Fmoc group is 
stable towards acidic conditions and is removed via base-induced β-elimination. The removal 
of the transient α-amine protecting group (Fmoc) under mild basic conditions therefore 
enabled the simultaneous use of acid-labile protecting groups, such as tBu, Boc and trityl 
(permanent protection groups) as protecting groups for side-chain protection of functional 
groups. Consequently, the permanent protection groups guarding side chain functionalities 
were orthogonal towards the stability of the transient α-amine protection group. This 
orthogonal protecting group strategy is common in organic synthesis.
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Figure 24: Projected synthetic route towards Rotihibin A (1).
The installation of Boc-L-allo-threonine on the γ-amine of the diaminobutyric acid side chain 
required a third orthogonal protection group, which needed to be stable towards acidic and 
basic conditions (Fig. 23). For that reason, the Alloc protecting group was chosen. This
protecting group is removed by a palladium-mediated (usually Pd(PPh3)4) transfer of the allyl 
unit to nucleophiles such as morpholine and is therefore mechanistically different (and 
orthogonal) to basic and acidic deprotection conditions.
As the natural product Rotihibin A (1) features an amino alcohol on its C-terminus, a 
direct anchoring of such an alcohol represents the most convenient method for immobilizing 
of the peptide to the solid support. To allow this, the resin needed to have a suitable 
functionality that allows the attachment of a primary alcohol as well as feature acid lability to 
enable deprotection of the permanent protecting groups and cleavage from the resin in one 
single step. Thus, a 2-chlorotrityl chloride resin was selected, which is known to enable on the 
one hand the anchoring of primary alcohols and on the other the cleavage under acidic 
conditions.
4. RESULTS AND DISCUSSION 43
Before starting with the final total solid phase synthesis (Fig. 24) of Rotihibin A (1), the 
amino acid building blocks equipped with suitable protecting groups first have to be available. 
The corresponding amino acid derivatives are shown in Figure 25.
Figure 25: Chemical structures of the required building blocks for the solid-phase synthesis of Rotihibin A (1) 
via Fmoc-based strategy. 
From these different amino acid derivatives, only Fmoc-L-Ser(OtBu)-OH and Fmoc-L-
Dab(Alloc)-OH were commercially available. The remaining building blocks were chemically 
synthesized as descripted in the following paragraph. 
4.1.2 Synthesis of required building blocks 
- Synthesis of (Z)-dec-2-enoic acid (2):
The lipophilic tail in Rotihibin A (1) features a Z-configured α,β-unsaturated carboxylic acid 
entity. For the preparation of this building block 2, classical carbonyl olefination reactions 
were considered and the HORNER-WADSWORTH-EMMONS (HWE) variation of the WITTIG
olefination that is a commonly used reaction for the preparation of α,β-unsaturated esters was 
chosen.
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To this end, phosphonates such as methyl phosphonoacetates are deprotonated with 
strong bases. The resulting phosphonate anions are strongly nucleophilic and react readily 
with carbonyl compounds under mild conditions. Nevertheless, this reaction preferentially 
gives more stable E-olefins.
112
Still and Gennari have however developed a modification of 
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this olefination reaction that provides access to Z-alkenes with excellent stereoselectivity.
113
To this end, phosphonates with electron-withdrawing groups such as trifluoroethyl residues 
and strongly dissociated base systems like NaH or KHMDS are used which enables the 
preparation of nearly exclusive Z-alkenes. The Z-alkene is preferably formed because the 
reaction proceeds through a sterically less hampered and thus thermodynamically more stable 
(erythro) transition state.
Scheme 1: Preparation of (Z)-dec-2-enoic acid (2). (a) Methyl-P,P-bis(2,2,2-trifluoroethyl)phosphonoacetate, 
NaH, THF, -78°C, 1 h, 90%. (b) LiOH, H2O, THF, MeOH, 0°C50°C, 5 h, 98%.
The synthesis of 2 therefore started with commercially available octanal which was converted 
through methyl-P,P-bis-(2,2,2-trifluoroethyl)-phosphonoacetate into the α,β-unsaturated 
methyl ester 7 with the desired (Z)-configuration (Scheme 1). The formation of the (Z)-
configuration was confirmed by an examination of the corresponding coupling constants in 
the 
1
H-NMR spectrum. Finally, the methyl ester 7 was hydrolyzed with aqueous lithium 
hydroxide, thereby yielding the desired building block (Z)-dec-2-enoic acid (2).
- Synthesis of Fmoc-D -Cit-OH (3) and Boc-L-allo-Thr-OH (4)
The preparation of Fmoc-D-Cit-OH (3) and Boc-L-allo-Thr-OH (4) was easily accomplished
by protecting the corresponding free amino acids with Fmoc-OSu and Boc2O, respectively
(Scheme 2).
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Synthesis of both building blocks (3, 4) occurred smoothly without any special 
incidents and they were subsequently used for the solid phase synthesis of Rotihibin A (1).
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Scheme 2: Synthesis of building blocks 3 and 4 (a) Boc2O, NaHCO3, H2O/dioxane, 0°Crt, 16 h, 93%. (b) 
Fmoc-OSu, NaHCO3, H2O/dioxane, 0°Crt, 16 h, 85%.
- Synthesis of orthoganally protected L-threo-β-hydroxyasparagine (5)
The preparation of the non-proteogenic L-threo-β-hydroxyasparagine derivative (5) that was
fully compatible with Fmoc-solid phase synthesis was a key step in the synthesis of 
Rotihibin A (1). A few methods for the preparation of L-threo-β-hydroxyasparagine have 
been described in the literature.
115; 116; 117; 118
We first compared three of these strategies to 
gain on overview which one would be best suited. As the required building block was needed
in rather large quantity, we particularly considered the overall yield and the temporal effort 
for its synthesis. A short overview of the selected literature reports is given below. 
A synthesis of othoganally protected L-threo-β-hydroxyasparagine was reported from 
Cardillo and Guzmán-Martinez.
115; 118
It is based on the regioselective deprotonation of N-
benzoyl dimethylaspartate at the β-position, followed by a diastereoselective iodocyclization 
for generation of a trans-oxazoline. Acidolytic hydrolysis of this trans-oxazoline in 6 N HCl 
under reflux then yields the L-threo-hydoxyaspartate 8. The published synthetic protocol also 
included the attachment of the protecting groups, i.e. the transformation of 8 to the desired 
building block 5, which was achieved in 8 steps and an overall yield of 22% (Fig. 26).
118
.
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Figure 26: Synthesis of orthogonally protected L-threo-hyAsn as developed by Cardillo and Guzmán-
Martinez.
115; 118
An alternative synthesis was developed by Boger and coworkers.
116
In their approach, the 
proper stereochemistry was introduced through a SHARPLESS asymmetric aminohydroxylation 
(AA) of a 4-methoxycinnamate methyl ester (Fig. 27).
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Figure 27: Synthesis of orthogonally protected L-threo-hyAsn as developed by Boger et al.
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The synthesis by Boger and coworkers comprises as a key step a SHARPLESS AA followed by 
various protection groups exchanges, amidation of the γ-carboxylate residue and oxidation of 
the aromatic system to a C-terminal carboxylic acid using ruthenium tetraoxide. In total, this 
synthesis consists of nine synthetic steps with an overall yield of 10%.
A third synthetic route was developed by Bionda and coworkers.
117
This approach 
includes an enantioresolution of commercial available racemic D,L-threo-hydroxyaspartate to 
yield enantiomerically pure L-threo-hydroxyaspartate. The subsequently required decoration 
of 8 with appropriate protecting groups can be achieved by adapting the synthetic route of 
Guzmán-Martinez (Fig. 28).
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Figure 28: Synthesis of orthogonally protected L-threo-hyAsn as developed by Bionda and Guzmán-
Martinez.
117; 118
A comparison of these different routes (Table 2) reveals that the combined synthesis from 
Bionda and Guzmán-Martinez should be the most efficient one, featuring seven synthetic 
steps in total and a calculated overall yield of 22%.
Table 2: Comparison of three published syntheses towards 5.
Reference Total steps Overall yield
[115] + [118] 8 22%
[116] 9 10%
[117] + [116] 7 22%
Therefore, the synthetic route was put into practice as illustrated in Scheme 3. First, an 
enantioresolution of commercially obtained D,L-threo-hydroxyaspartate by co-crystallization 
with an equimolar amount of salt-free L-lysine was performed and resulted in a precipitation 
of enantiomerically pure L-threo-hyAsp*L-Lys salt from a solvent mixture of water and 
methanol, whereas D-threo-hyAsp*L-Lys remained in the mother liquor. The precipitated 
crystals were isolated by filtration and L-lysine was subsequently removed by ion exchange 
chromatography yielding pure L-threo-hyAsp (8).
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Scheme 3: Synthetic route towards orthogonally protected L-threo-β-hydroxyasparagine 5. (a) L-lysine, H2O, 
MeOH, 40°C4°C, o.n. (b) ion exchange chromatography using DOWEX 1x4-50, eluent: 2 M AcOH, 63% 
(over 2 steps). (c) i) HCl, MeOH, reflux, 3 h, ii) Boc2O, 10% Na2CO3, dioxane, 0°rt, o.n., 98%. (d) 7 N NH3 in 
MeOH, rt, 4 d, 98%. (e) BnBr, NaHCO3, DMF, 0°Crt, 24 h, 66%. (f) i) 4 N HCl in dioxane, rt, 2 h, ii) Fmoc-
OSu, NaHCO3, dioxane, H2O, 0°Crt, o.n., 98%. (g) Trt-OH, H2SO4 (cat.), Ac2O, AcOH, 50°C, 2.5 h, 74%. (h) 
1 atm. H2, Pd/C, EtOH, rt, 1 h, 76%.
In the following two-step sequence, L-threo-β-hydroxyaspartatic acid (8) was first treated 
with methanolic hydrogen chloride to give the side chain mono-methylester followed by a 
treatment with di-tert-butyl dicarbonate to protect the N-terminus, thereby yielding the Boc-
protected mono-methylester 9. Subsequent aminolysis of 9 using 7 N ammonia in methanol 
provided the carboxamide 10. The carboxyl group at the C-terminus of 10 was transferred 
into the corresponding benzyl ester 11 using benzyl bromide and standard alkylation 
conditions. At this point, the required protection group exchange of the N-terminal protection 
group was performed. Hence, compound 11 was deprotected with 4 N hydrogen chloride in 
dioxane and reprotection of the free amine group was achieved using Fmoc-OSu and aqueous 
sodium bicarbonate in dioxane yielding the Fmoc-protected benzyl ester 12. As unprotected 
carboxamide groups of asparagine residues are susceptible to side reactions during peptide 
couplings (e.g. deamidation, L-succinimidyl formation etc.),
120
the carboxamide was 
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subsequently protected with a trityl protecting group. To this end, 12 was treated with 
triphenylmethanol and catalytic amounts of sulfuric acid in a mixture of acetic anhydride and 
acetic acid, thus providing compound 13. Finally, hydrogenolysis of benzyl ester 13 was 
performed. Therefore, 13 was hyrdogenated with a palladium/coal catalyst under an hydrogen 
atmosphere which led to the desired target compound L-threo-Fmoc-β-hyAsn(Trt)-OH (5) in 
an overall yield of 22%.
- Synthesis of Fmoc-Asnol(Trt) (6)
The preparation of the 1,2-amino alcohol 6 was easily conducted in one step via reduction, 
using as a start material commercially available Fmoc- and trityl-protected asparagine
(Scheme 4).
Scheme 4: Synthesis of building block 6. (a) IBCF, NMM, THF, H2O NaBH4, -10°C, 0.5 h, 94%.
Reduction of a carboxyl group of N-protected amino acids to an alcohol function is known to 
be possible by sodium borohydride reduction of a mixed anhydride intermediate in THF. 
Therefore, the N-protected amino acid was first reacted with isobutyl chloroformate to form 
the mixed anhydride; next, sodium borohydride was added, thereby reducing the latter to the 
corresponding primary alcohol 6 which was used as a building block in the solid phase 
synthesis of Rotihibin A (1). 
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4.1.3 Total synthesis of Rotihibin A
With all building blocks in hands, the first total solid phase synthesis of Rotihibin A (1) was 
then established and conducted according to Scheme 5. To this end, commercially available 
chloro-2-chlorotrityl resin with an initial loading of 0.3 mmol/g was manually loaded with the 
amino alcohol 6. Since primary alcohols are more difficult to deprotonate than carboxylic 
acids (which are more often loaded on such resins), a suitable base was required for the 
loading reaction. Conseqently, the loading was conducted using an excess of amino alcohol 6
and pyridine as a base resulting in an attachment of the amino alcohol to the solid phase via 
an ether bond. The loading reaction was terminated after 16 h by adding methanol to remove 
any remaining reactive chlorine-functionalities. An Fmoc-loading assay subsequently 
revealed that this procedure resulted in a loading of 0.3 mmol/g (loading yield of 25%) which 
is well within the range of comparable amino alcohol loadings.
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The loaded resin 14 was then used for the stepwise manual assembly of the natural 
sequence of Rotihibin A (1). Correspondingly, the transient N-terminal Fmoc-protection 
group was cleaved via base induced β-elimination using the standard procedure. The amide 
couplings of the following two building blocks were then performed using standard coupling 
reagents (HBTU, HOBt, DIPEA) with a Fmoc-cleavage in between. For the installation of 
Boc-L-allo-threonine (3) onto the Dab side chain, the Alloc-side chain protecting group had to 
be removed first. This was achieved by Pd(PPh3)4 as a catalyst and morpholine as a 
scavenging nucleophile; the reaction was furthermore performed in degassed dichloromethane 
under an inert atmosphere. In order to remove the catalyst after the reaction, a more stringent 
washing procedure was required after Alloc-cleavage. The following iterative assembly of the 
next four building blocks was once more performed via standard coupling conditions (and in 
between Fmoc-cleavage) and yielded the fully assembled resin-bound peptide. Treatment of 
the resin-bound peptide with TFA (95%) then cleaved all permanent side chain protecting 
groups as well as the relase from the resin. Such strong acidic conditions for final cleavage 
were necessary since the ether bond is more acid-resistant than the more often used ester bond 
linkage which can already be cleaved by acetic acid. The mixture was filtrated, diethyl ether 
was added to precipitate the crude lipo-peptide and the residue isolated and purified by
preparative RP-HPLC purification.
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Scheme 5: Total solid phase supported synthesis of Rotihibin A (1). (a) i) 6, pyridine, DCM, rt, 16 h, 25%. ii) 
MeOH, rt, 30 min. (b) 20% piperdine in DMF, rt, 2 x 15 min., (c) 5, HBTU, HOBt, DIPEA, DMF, rt, 2 h. (d) 
20% piperdine in DMF, rt, 2 x 15 min., (e) Fmoc-Dab(Alloc)-OH, HBTU, HOBt, DIPEA, DMF, rt, 2 h. (f) 
Pd(PPh3)4, morpholine, DCM, rt, 1.5 h. (g) 4, HBTU, HOBt, DIPEA, DMF, rt, 2 h. (h) 20% piperdine in DMF, 
rt, 2 x 15 min., (i) Fmoc-Ser(OtBu)-OH, HBTU, HOBt, DIPEA, DMF, rt, 2 h. (j) 20% piperdine in DMF, rt, 2 x 
15 min., (k) 3, HBTU, HOBt, DIPEA, DMF, rt, 2 h. (l) 20% piperdine in DMF, rt, 2 x 15 min., (m) 2, HBTU, 
HOBt, DIPEA, DMF, rt, 2 h. (n) TFA, TIS, H2O, rt, 2 h, 31% overall yield.
All recorded analytical data matched to those of isolated Rotihibin A (1), thus proving that the 
total synthesis of this natural product was successfully established in eight total steps. After 
purification, a single product was obtained with an overall yield of 31%, (based on the initial 
loading of 0.3 mmol/g) and the identity of this compound was established by mass 
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spectrometry and NMR experiments (Fig. 29). All recorded analytical data matched to those 
of isolated Rotihibin A (1), thus proving that the total synthesis of this natural product was 
successfully established in eight total steps.
Figure 29:
1
H- and 
13
C-NMR spectra of Rotihibin A (1) and assignment of the signals in accordance with
Suzuki and coworkers.
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(Astericks indicate solvent residual peaks of DMSO and H2O)
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4.1.4 Synthesis of Rotihibin A derivatives for SAR studies
By application of the antecedent synthesis route, a straightforward access to Rotihibin A 
analogues was also possible via simple exchange of building blocks (Scheme 6).
Scheme 6: Synthesis of Rotihibin A derivatives using the previously established synthetic conditions (cf. 
Scheme 5). (a) i) 6, pyridine, DCM, rt, 16 h, 25%. ii) MeOH, rt, 30 min. (b) TFA, TIS, H2O, rt, 2 h. R
1
-R
6
= cf. 
Table 3.
Different derivatives were generated to investigate which residues (R
1
-R
6
) were essential for 
the observed biological activity and thus to gain insight into the underlying structure-activity-
relationships (SAR). As a side effect, these studies also allowed to elucidate which positions 
of Rotihibin A are amenable for modification, thereby offering suggestions for the design of a
Rotihibin A-derived activity-based probe for identification of its cellular targets.
One exciting modification was the replacement of the α,β-unsaturated fatty acid tail by 
a saturated lipophilic tail (15). α,β-Unsaturated carboxamides are principally susceptible to
1,4-MICHAEL-type additions by nucleophiles such as for example active site cysteine 
residues, thus potentially leading to a covalent reaction product; this substitution was 
therefore performed to test if Rotihibin A potentially acts via an irreversible, covalent 
mechanism.
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The modification of compound 16 was the inversion of the stereogenic center at the α-C
position of the citrulline residue to explore whether the stereochemistry at this position is 
required for the biological activity (Table 3). 
Table 3: Chemical structures of synthesized derivatives 15-24. Structural modifications to the natural product 
Rotihibin A are highlighted in red (in 17, 22 and, 24, one amino acid has been left out).
Chemical structures of derivatives 15-24
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The derivatives 17 and 18 were synthesized to examine the impact of the unusual β-
hydroxyasparagine residue for biological activity. Consequently, in compound 17 the β-
hydroxyasparagine was not incorporated into the final sequence. In compound 18, the β-
hydroxyasparagine residue was substituted by the standard proteogenic L-asparagine residue 
and thus was bearing no β-hydroxy group on this position. It is known, that additional 
hydroxyl groups at the β- or γ-position of amino acids could mimic the tetrahedral transition 
state during the hydrolysis of peptide bonds.
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Therefore, it is of great interest to examine the 
biological task of this particular structural element.
The derivatives 19 and 20 were generated by modifying the primary amine of the L-
allo-threonine residue from Rotihibin A (1). Since the free N-terminus of the L-allo-threonine 
is the only primary amine residue in Rotihibin A (1), this particular reactivity could be easily 
exploited to react selectively with either acetic anhydride (thus yielding the acetyl derivative 
20) or rhodamine-isothiocyanate (to obtain the fluorophore tagged derivative 19). These 
modifications allowed to explore the relevance of the primary amine for bioactivity. 
Furthermore, the rhodamine-tagged derivative 19 could be used for imaging studies if it 
retained its bioactivity.   
Compounds 21 and 22 were generated to probe the function of the L-serine residue in 
Rotihibin A (1). These compounds featured a standard L-alanine residue instead. As serine is 
an amino acid known to be often post-translational modified, e.g. by phosphorylation, it was 
interesting to study its significance for bioactivity. In derivative 22, this substitution was 
furthermore accompanied by a deletion of the β-hydroxyasparagine residue. 
Finally, the biological significance of the amino acid D-citrulline was investigated. 
Thus compound 23 was synthesized in which D-citruline was substituted by the bulky 
aromatic amino acid L-phenylalanine. In compound 24, this substitution was furthermore 
complemented by a deletion of L-threo-β-hydroxyasparagine.
4.1.5 Biological evaluation of Rotihibin A and derivatives thereof
4.1.5.1 Growth inhibitions studies with Arabidopsis seedlings
The biological evaluation was conducted in close collaboration with the Kombrink group 
(MPI for Plant Breeding Reseach in Cologne). First, biological experiments were performed
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to confirm that synthetic Rotihibin A (1) displayed the reported bioactivities. As Arabidopsis 
thaliana is the best-established model organism in plant science and due to the fact that there 
are many mutants of this organism available, this plant system was chosen for the biological 
evaluation.
123
The general phenotype of Rotihibin A (1) treated Arabidopsis seedlings were 
manifested in a universal retarded plant growth (Fig. 30). This was particularly noticeably in a 
delayed growth behavior of the cotyledons as well as in a hampered growth of the primary 
root. Besides this, a reduced number of lateral roots were also observed. Therefore, the 
observed phenotype matched with the reported root growth impairment. 
Figure 30: Phenotypic response of Arabidopsis seedlings ecotype Col-0 WT towards 30 µM of Rotihibin A (1).
Consequently, the corresponding plant growth phenotypes were also determined for all other 
derivatives 15-24. To this end, Arabidopsis seedlings were grown in well plates containing 
media with various concentrations of derivatives 15-24. Ten days after germination (DAG),
the size of the cotyledons, the primary root length (PRL) and the lateral root density (LRD) 
were microscopically assigned. The size of the cotyledons of Arabidopsis seedlings in 
response to different concentrations of all derivatives 15-24 is depicted in Figure 31. The
cotyledon size of the seedlings treated with Rotihibin A (1) is decreasing when probe 
concentrations are increased. At 100 µM of 1, the average size was reduced to approximately 
20% of the size of untreated seedlings. For compound 15 together with 16, 17, 18, 19, 20, 22
and 24, a weaker effect was observed. Although also these compounds show a decreased 
cotyledon size at higher concentrations, the absolute size shrinkage was much less. In 
contrast, a substantial decline of the cotyledon size was also observed for compound 21. 
Already at a concentration of 10 µM of 21, the cotyledon size was shrinking to 30% in 
DMSO 1
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comparison to the control (DMSO). 21 showed an even stronger effect than the actual natural
product Rotihibin A (1). Compound 23 also displayed the expected dose-activity relationship 
and at a concentration of 100 µM, the cotyledon size was reduced around 80% compared to 
the size of the control experiment. In contrast, the closely related compound 24 showed no 
significant effect. 
Figure 31: Cotyledon size of Arabidopsis seedlings ecotype Col-0 WT [DAG10] in the presence of various 
concentration of Rotihibin A (1) and 15-24 (100% ≡ 20.88 mm
2
). Error bars indicate the standard deviation of at 
least three independent experiments.
Next, the length of the primary roots of the Arabidopsis seedlings after treatment with 
compounds 15-24 was determined (Fig. 32). Also in this assay, Rotihibin A (1) induced a 
growth inhibiting effect. At 100 µM, the root length was 70% less than non-treated roots. A 
similar outcome was observed with 15 which displayed a similar inhibitory potency as 
Rotihibin A (1). This finding is somehow surprising as 15 did not induce a comparable effect 
on the cotyledon size. In contrast, compounds 16, 17, 18, 19, 20, 22 and 24 showed only a 
negligible inhibitory potency on root growth inhibition. Of note, compound 21 displayed the 
strongest inhibitory effect, at 100 µM, the root length was decreased by 98%. Nevertheless, 
none of the compounds was generally toxic as the seedlings showed no signs of lethality after 
compound treatments up to a concentration of 100 µM. A particular case was compound 23
which showed an inhibitory effect only at a concentration of 100 µM where a root length 
reduction of 80% was observed.
4. RESULTS AND DISCUSSION 58
Figure 32: Primary root lengths of Arabidopsis seedlings ecotype Col-0 WT [DAG10] after treatment with 
varying concentrations of Rotihibin A (1) and derivatives 15-24 (100% ≡ 26.44 mm). Error bars indicate the 
standard deviation of at least three independent experiments.
By using the same root growth assay, the lateral root density was next determined by relating 
the absolute number of lateral roots with the length of the primary root (Fig. 33). A strong 
effect on the lateral root density was observed after treatment with Rotihibin A (1). At 100 
µM, the lateral root density of the treated seedlings was reduced to 3% if compared to the 
control. Compound 15 showed a quite similar inhibitory effect at 100 µM, displaying a lateral 
root density reduction of 90%. As expected from the root length and cotyledon size 
measurements, compounds 16, 17, 18, 19, 20, 22 and 24 showed also only a minor inhibitory 
effect on the lateral root density. Compound 21 however showed once again the strongest 
effect. Already at 30 µM, lateral root formation was completely inhibited. Finally, compound 
23 revealed a relevant inhibitory effect on lateral root density only at a concentration of 
100 µM. 
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Figure 33: Lateral root density of Arabidopsis seedlings ecotype Col-0 WT [DAG10] after treatment with 
varying concentrations of Rotihibin A (1) and the derivatives 15-24 (100% ≡ 3.42 No/cm). Error bars indicate
the standard deviation from at least three independent experiments.
Taken together, these experiments indicate that the hydroxyasparagine residue seems to play a 
crucial role for bioactivity. Compounds such as 17, 22 or 24 which lack this moiety were 
completely inactive in the performed assays. The reduced bioactivity of compound 18 in 
which the hydroxyasparagine residue is replaced by an asparagine moiety, resulting in a 
derivative in which only the OH-group of this residue has been removed further supports this 
hypothesis. Surprisingly, the α,β-unsaturated amide system (i.e. a Michael system) of the 
lipophilic tail does not seem to be particulary important for bioactivity because compound 15
which lacks the corresponding double bond showed almost the same inhibitory effect than
Rotihibin A (1). In contrast, the unusual D-stereochemistry of the citrulline residue appears to 
be essential for the growth inhibitory effect. The derivative with the reverse stereochemistry 
at this position, i.e. compound 16, produced a far less distinctive growth inhibited phenotype. 
Moreover, a modification at the primary amine of the L-allo-threonine residue also does not 
seem to be tolerated as indicated by the observed phenotype after treatment with compounds
19 and 20. The substitution of the L-serine residue with an L-alanine moiety as featured in 
compound 21 produced a remarkable inhibitory effect. Already at a concentration of 10 µM 
the cotyledon size, the primary root length and the lateral root density was decreased by more 
than 50%. Nevertheless, also in this case, the plant showed no lethal phenotype. Compound 
23 in which the D-citrulline residue was replaced by an L-phenylalanine moiety, showed only 
an inhibitory effect at 100 µM; although this was not further investigated, a closer inspection 
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of the compound treated seedlings suggests that that this unusual effect might be caused by an 
undesirable toxic effect that is however rather weak as it was only observed at high 
concentrations.
4.1.5.2 Cell proliferation studies with Arabidopsis cell cultures
Whole plant growth inhibition studies are relatively easy in handling and generate a facile 
readout. Nevertheless, an accurate quantification of growth inhibition is hampered by a large 
variation as plant growth depends on many factors. In addition, two more-or-less independent 
processes contribute to the overall plant growth, i.e. cell division and cell elongation.
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To 
better characterize the observed growth effects, additional proliferation experiments with 
Arabidopsis cell cultures were therefore next performed. One of the major advantages of such 
a cell culture-based growth inhibition assay is the unmatched consistency and reproducibility 
of experimental results. Moreover, plant cell cultures can be synchronized by means of 
blocking the cell cycle at one particular phase. Conditions constrictive for cell proliferation at 
one stage lead to accumation of cells at that phase. Once the restrictive stimulus is removed, 
all cells resume cell division in a synchronous way.
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Figure 34: Measurement of cell proliferation in presence of Rotihibin A (1) and its derivatives. Arabidopsis cell 
cultures (Col-0) were incubated with 10 µM of 1 and 15-24 for 72 h and the increase in OD was determined by 
measuring the ratio between the OD after 72 hours and at the time point 0. Asterisks indicate the active 
derivatives with an OD increase of less than 0.2. Error bars indicate the standard deviation of at least three 
independent experiments.
4. RESULTS AND DISCUSSION 61
The effect on proliferation can thereby easily be determined by measuring the optical density 
(OD) of the cultures. The outcome of the treatment of cell cultures of Arabidopsis cells with 
10 µM of every derivative (1 and 15-24) is displayed in Figure 34. The results obtained by 
this assay corresponded very well to the results from the growth inhibition experiments with 
whole Arabidopsis seedlings. As before, compounds 1, 15 and 21 showed the strongest 
effects. To confirm these findings, these three compounds were then tested at varying 
concentrations (Fig. 35). These results indicate that the compounds have a similar dose 
dependent effect on proliferation in cell culture as previously shown in the whole plant growth 
inhibition studies. Of note, the compounds displayed a higher activity in cell culture probably 
due to the lack of typical plant cell walls which act normally as an additional physical 
diffusion barrier. Correspondingly, a significant growth retarding effect was already observed 
at a concentration of 3 µM for compound 1, 15 and 21.
Figure 35: Measurement of cell proliferation in presence of compound 1, 15 and 21. Arabidopsis cell culture 
(Col-0) were incubated with various concentrations of 1, 15 and 21 for 72 h and the increase in OD was 
determined by measuring the ratio between the OD after 72 hours and at the time point 0. Error bars indicate the 
standard deviation of at least three independent experiments.
4.1.5.3  Evaluation of Rotihibin A and derivatives in a cyclin B-reporter plant assays 
A chemical genetic screen based on the β-glucuronidase (GUS) reporter gene system was 
subsequently performed to identify transcriptional events that were affected by 
Rotihibin A (1) treatment.
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To this end, transgenic plant lines for measuring the ‘promoter 
activity’ via the insertion of a DNA construct consisting of the DNA sequence of the GUS
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enzyme fused behind the promoter sequence of different genes were used. Such plants 
therefore allow determining the promoter activity state via GUS staining in living plants. The 
expressed enzyme GUS produces an insoluble, blue dye after addition of an artificial colorless 
substrate X-Gal (Fig. 36).
Figure 36: Schematic representation of the GUS reporter gene system.
Along these lines, the reporter activities of genes that are known to play roles in plant 
pathogen defense were analyzed as Rotihibin A (1) is biosynthesized by a bacterial species. 
Furthermore, genes involved in plant hormone responses were investigated. As plant 
hormones are critical key players in plant growth and development and as Rotihibin A (1) was 
found to affect plant growth, it was reasonable to assume that Rotihibin A (1) may modulate
plant hormone function. In addition, the reporter activity of cyclin B as a general mitotic 
marker was investigated. This screen revealed that Rotihibin A (1) was affecting the mitotic 
cycle of the plants (Table 4).
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Table 4: Gene constructs used to characterize Rotihibin A (1)’s mode of action. Rotihibin A (1, 30 µM) was 
added to the corresponding transgenic ROI::GUS Arabidopsis seedlings followed by GUS staining (ROI: Gene 
reporter of interest, X = no change of reporter activity upon treatment with 1 (30 µM). = reduction of reporter 
activity upon treatment with 1 (30 µM).
Impact of Rotihibin A on diverse gene reporter
ROI::GUS role 1 (30 µM)
WRKY29::GUS immune response
X
VSP1::GUS plant defense X
DR5::GUS auxin depended promoter X
DC3::GUS ABA and mannitol depended promoter X
Cyclin B::GUS mitotic protein
The acquisition of water and nutrients by plant roots is strongly dependent on root branching. 
In fact, the proper development of lateral roots plays a central role for the plants to guarantee 
steady acesss to new soil resources. Lateral roots originate from a subset of xylem pole 
pericycle cells that undergo asymmetric cell division. These are formed nearby, nevertheless 
distantly from the primary root tip and starts from a small number of pericycle founder cells 
(meristemic cells) that undergo cell-divisions, giving rise to a single layered primordium.
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Subsequent cell-divisions yield a lateral primoradium which then grows through the outer cell 
layers and finally emerges from the primary root to form a lateral root.
Generally, tissues within a plant that are able to promote growth by mitosis are called 
meristems. Plants are equipped with meristematic tissue in several locations. For example, 
roots and shoots have meristematic tissue at their tips called apical meristems that are in 
charge of the elongation of both organs. Meristematic cells are entirely developed and 
completely functional at maturity, but unlike other cells in the plant, they stay totipotent. 
Thus, meristematic cells can be induced to develop into any plant tissue at any developmental 
stage of the plant.
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Therefore, meristematic plant cells can be considered as analogues of 
mammalian totipotent stem cells from early embryonic stages. Plants grow larger either by
cell division or by cell elongation. Primary plant growth is triggered by meristematic tissue 
because it is the primary site of cell proliferation, namely mitosis, in the plant. Meristematic
tissue is however not autarkic and its fate is regulated by several plant hormones. For 
instance, giberellins provoke cell division in the shoot meristem, thus stimulating plant 
growth.
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Cytokinins and auxins are also essential growth regulators.
28
Auxin promotes
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growth by provoking cell elongation, while cytokinins are thought to induce both cell division 
and elongation.
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As all new cells of a plant are formed in the meristem, this tissue plays an important
role in general plant growth. It was therefore not surprising that the reporter activity of 
cyclin B could only be observed in the meristematic areas, since this is the only place in the 
plant where mitosis takes place (Fig. 37).Consequently, DMSO treatment of the cycB::GUS 
reporter plant line resulted in a blue stain in the area where the meristemic cells are located, 
namely the root meristem, the shoot meristem and in the lateral primordia which represents 
the usual reporter activity of cyclin B in mitotic plant cells. In presence of 30 µM Rotihibin A 
(1), this signal was strongly reduced (Fig. 37). This pinpoints that cyclin B levels are also 
strongly reduced in these living plants which are usually required to complete the mitotic 
cycle. Consequently, the meristemic cells were not able to fulfill cell division anymore which 
would explain the observed dwarfed phenotype after incubation with Rotihibin A (1). 
Figure 37: Histochemical GUS staining of 10 days old cycB::GUS Arabidopsis seedlings after 24 h treatment 
with or without 1. Blue staining reflects reporter activity of cyclin B and thus also the approximate expression 
level. The images show representative distribution patterns of GUS staining in the primary root tip, the shoot and 
in the lateral primordia. Scale bar: 200 µm.
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These findings lead to the conclusion that primary plant growth which is caused by mitotic 
cell proliferation in the meristemic tissue of the Arabidopsis seedlings is inhibited by 
Rotihibin A (1). Subsequently, the same set of experiments was also performed with the 
Rotihibin derivatives and a strong correlation between a dwarfed phenotype and the cyclin B 
reporter activity was observed. Along these lines, derivatives that showed no effect on plant 
growth also did not show any reduction in cyclin B reporter activity, while active compounds 
displayed this phenotype.
As a control to prove that the transgenic cycB::GUS plants still respond with the same 
phenotypic effect towards Rotihibin A (1) as wild-type plants (cf. Fig. 31-33), the transgenic 
plants were likewise treated with various concentrations of 1 (Fig. 38).
Figure 38: (A): Cotyledon size of transgenic Arabidopsis seedlings [10 DAG] in presence of 1 (100% ≡ 6.88 
mm
2
). (B): Primary root length of transgenic Arabidopsis seedlings in presence of 1 (100% ≡ 22.30 mm). (C) 
Lateral primordia density of transgenic Arabidopsis seedlings in presence of 1 (100%≡ 0.28 No./cm). Error bars 
indicate the standard deviation of at least three independent experiments.
As depicted in Figure 38, Rotihibin A (1) had a comparable impact on the cotyledon size, the 
primary root length and the lateral primordia density in transgenic cycB::GUS plants like in 
the wild-type plants (cf. Fig. 31-33).
The total synthesis and derivatization of Rotihibin A (1) together with the subsequent 
biological evaluation revealed structural entities within the natural compound that strongly 
contribute to bioactivity and allowed therefore a first glance at structure-activity relationships
(SAR). The upcoming challenge will now be to design, according to these SAR-insights, a 
functional and bioactive natural product derived probe. To this end, all necessary groups, 
which account for a probe (c.f. Chapter 2.4.2), have to be integrated into the chemical 
structure of Rothibin A (1) without compromising the bioactivity. The present study gave the 
4. RESULTS AND DISCUSSION 66
first hints at which positions an incorporation of, for example, photo-reactive groups might be 
possible and at which positions chemical modifications are not tolerated regarding bioactivity. 
Finally, a bioactive Rotihibin A-derived probe, together with the synthesized Rothibin A (1) 
would be a meaningful tool to further study the mode-of-action of Rothibin A (1) and to 
promote the understanding of the well-orchestrated physiology underlying plant growth by 
the chance of revealing unknown networking cellular proteins.
4.2 Studies towards plant growth regulators Brevicompanine A, 
B & C 
During a screening campaign to discover novel plant growth regulators from fungal sources, 
Kimura and Kusano isolated three diketopiperazines Brevicompanine A (25), B (26) and C
(27) from a culture filtrate of Penicillium brevicompactum and found that they feature plant 
growth-regulating properties.
103,104
Compounds 25 and 26 were thereby elucidated to display
inhibitory activities upon the hypocotyl elongation of lettuce seedlings at a concentration of 
100 mg/L. In contrast, 25, 26 and 27 accelerated the root growth of lettuce seedlings in 
proportion to its concentration from 10 mg·l
-1
to 300 mg·l
-1
(26) and from 1 mg·l
-1
to 100 
mg·l
-1
(25, 27). Interestingly, it was also reported that compounds 25 and 26 showed no 
inhibitory effects on the root and stem elongation of rice seedlings up to 300 mg l
-1
.
R =
BrevA BrevB BrevC
25 26 27
Figure 39: (A) Structures of Brevicompanine A (25), B (26) & C (27); (B) Atomic numbering of prenyl and 
indoline moieties.
Brevicompanine A (25), B (26) and C (27) can be regarded as a diketopiperazine product of a 
hexahydropyrrolo[2,3-b]indole (HPI) moiety derived from L-tryptophan with either a D-
leucine, a D-allo-isoleucine or a D-valine residue (Fig. 39). L-Tryptophan from primary
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metabolism thereby serves as the biogenetic precursor for generation of the HPI-skeleton.
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In Brevicompanines, this HPI moiety is substituted with an inverted prenyl (α,α-
dimethylallyl) group at the C3 position which is a common structural element in various 
natural compounds like Amauromine
132
, Fructigenines
133
and Flustramines
134
. Besides L-
tryptophan, most of these substances contain a second amino acid and form cyclic dipeptides 
with a diketopiperazine structure or a derivative thereof, like it is the case for 
brevicompanines. Prenylated indole alkaloids are widely distributed in terrestrial and marine 
organisms.
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Most of these alkaloids feature a wide range of biological and pharmacological 
activities. 
The synthesis of Brevicompanine A (25) and B (26) and its allo-derivatives (these are 
derivatives that feature a L-amino acid configuration instead of the natural D configuration) 
has already been published.
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A total synthesis of Brevicompanine C (27) however has so far 
not been reported. More importantly, the biological activity of brevicompanines is still 
insufficiently evaluated; in particular, no direct target proteins of these compounds have yet 
been elucidated. The establishment of a total synthesis route to Brevicompanines could 
thereby open the possibility to generate in a second step also analogues that might allow to 
deduce structure-activity relationships (SAR) and might represent starting points for 
subsequent target identification. 
Consequently, a total chemical synthesis of Brevicompanine A (25), B (26) and C (27) 
and its allo-derivatives was performed, following essentially the route of Kitahara and 
coworkers.
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This allowed gaining access to sufficient quantities for further studying in vitro 
and in vivo activities of these compounds.
Figure 40: Retrosynthesis for generation of Brevicompanines and derivatives thereof. PG = protection group. 
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The retrosynthesis of Brevicompanines started with the disconnection of the two amide bonds 
of the diketopiperazine entity which leads to the reverse prenylated hexahydropyrrolo[2,3-
b]indole (HPI)-skeleton together with the corresponding amino acid (Fig. 40). The HPI-
moiety was generated starting from L-tryptophan methyl ester via heteroatom-mediated 
intramolecular selenocyclization, followed by selenoxide elimination and alkylation of a 
reverse prenyl nucleophile as discussed in the subsequent paragraphs.
Scheme 7: a) Boc2O, NaOH, NBu4HSO4, DCM, 0°C  rt, 16 h., 83%. b) N-(phenylseleno)phtalimide, p-TSA, 
Na2SO4 DCM, rt, 8 h, 47% (ratio of diastereomers). c) MeOTf, prenyl tributylstannane, 2,6-di-tert-butylpyridine, 
ACN, -78°C  reflux, 20 h, 96% (ratio of diastereomers). d) NaOH, THF, MeOH, reflux, 16 h, 97%. 
e) EDC*HCl, HOBt, DIPEA, aa methyl ester, DCM, rt, 12 h, 35- 93%. f) i: TMSI, ACN, 0°C  rt, 4 h; ii: 
NH4OH, MeOH, rt, 2 h, 10-38%.
The synthesis started with L-tryptophan methyl ester, which was converted to the 
corresponding bis-(Boc) derivative 31 using Boc anhydride under phase transfer conditions
(Scheme 7). The reaction occurred smoothly and with excellent yields. The tricyclic 
architecture of the HPI moiety was subsequently build up by a two-step procedure developed 
by Danishefsky and coworkers using N-(phenylseleno)-phtalimide and p-TSA to give the 3-
seleno-modified pyrroloindoles 32a and 32b.
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Sodium sulfate was used in this 
selenocyclization to remove the crystal water from the usage of the hydrated form of p-TSA. 
The cyclization occurred under gentle conditions yielding 32a and 32b as a 9:1 ratio of 
inseparable diastereomers. The relative high degree of stereoselection in this intramolecular 
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selenocyclization might thereby be explained by the thermodynamic stability of the pre-exo
and pre-endo intermediates (Fig. 41). In this model, the cyclization of the pre-endo
intermediate might be hampered by steric effects of the PG
2
at the carboxyl group with the 
indole moiety; the ratio of 32a and 32b might therefore be a consequence of the different 
thermodynamic stabilities of the exo and endo products as well as the reversibility of the
cyclization of the pre-exo and pre-endo intermediates.
Figure 41: Mechanism of intramolecular selenocyclisation and the formulation of a hypothesis for explaining 
the favored formation of the exo-product. (Adapted and modified from Depew et al.
137
)
The next step in the synthesis was the selenoxide elimination using MeOTf for oxidizing the 
selenium species 32a,b and eliminating the phenyl selenide resulting in the formation of a 
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cationic species. This can be alkylated via allylic transposition with prenyl tributylstannane, 
yielding compound 33 (still as a mixture of diastereomers) in excellent yields (Scheme 7). 
Next, the hydrolysis of methyl ester 33 to the free carboxylic acid 34 was accomplished under 
basic conditions. This step then also enabled a separation of the diastereomeric mixture by 
repeated flash chromatography. Subsequent coupling of the corresponding amino acid methyl 
ester using standard solution coupling reagents yielded the fully protected linear precursor 35. 
The cleavage of the two Boc protecting groups of compounds 35 with TMSI in anhydrous
acetonitrile at 0 °C generated the diamine which was directly subjected to a reaction with 
methanolic ammonia. This resulted in hydrolysis of the methyl ester and a spontaneous 
formation of the diketopiperazines 25-30. Following this route, Brevicompanine A (25), B 
(26) and C (27) as well as the isomeric compounds allo-Brevicompanine A (28), B (29) and C 
(30) were synthesized. All analytical data of synthetic Brevicompanines thereby agreed with 
those published for the natural compounds.
103; 104
For Brevicompanine C and its allo-
derivative (27 & 30), this was the first total synthesis reported so far.
For identifying the cellular target of these compounds, a probe was designed for 
performing pull-down experiments. The probe should host several important functionalities 
for such an approach. First, it should present a recognition site consisting of the natural 
product core-structure (i.e. the HPI-diketopiperazine residue), responsible for binding to 
potent target proteins. Second, the probe should contain a moiety for reporter attachment. This 
is essential to visualize target proteins and to go on with affinity-purification. To this end, an 
alkyne-moiety to attach a suitable reporter via bioorthogonal Click-chemistry was chosen. 
Therefore, two different probes have been developed: In the first one (37), only an alkyne 
residue was introduced into the final product via diketopiperazine ring formation with a 
propargyl glycine residue (Scheme 8).
Scheme 8: Synthesis of compound 37. a) EDC*HCl, HOBt, DIPEA, L-propargyl glycine methylester, DCM, rt, 
12 h, 41%. b) i: TMSI, ACN, 0°Crt, 4 h; ii: NH4OH, MeOH, rt, 2 h, 15%.
The probe 37 was successfully synthesized according to Scheme 8. As Brevicompanines 
however feature no ‘obvious’ electrophilic functionalities which might react in a covalent 
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manner with nucleophilic groups on target proteins, a second probe was designed that also 
featured a benzophenone residue for photo-cross-linking. The benzophenone residue 
photolyzes upon exposure to UV-light to give highly reactive triplet-state ketone 
intermediates (Fig. 9). The energized electron of an activated benzophenone can then insert 
into a hydrogen-carbon bonds and other reactive functionalities to give covalent linkages with 
target proteins. As a covalent linkage is much more applicable for pull-down experiments, a 
photo-reactive group was installed as depicted in Scheme 9. 
Scheme 9: Synthesis of photoreactive probe 44. a) Alloc-Cl, NaHCO3, H2O/dioxane, 0°Crt, 16 h, 99%. b) 
SOCl2, MeOH, 0°Creflux, 5 h, 95%. c) 39a, EDC*HCl, HOBt, DIPEA, DCM, rt, 16 h, 72% d) i) DEA, CAN, 
rt, 2 h. ii) 3-benzoylbenzoic acid, EDC*HCl, HOBt, DIPEA, DCM, rt, 4 h, 65%. e) Pd(PPh3)4, dimedone, THF, 
rt, 1.5 h, 44%. f) 34, PyBOP, HOBt, DIPEA, DCM, rt, 1.5 h, 26% g) i) TMSOTf, DCM, 0°C, 1.5 h. ii) LiOH, 
MeOH, THF, H2O, rt, 3 h.. iii) PyBOP, HOBt, DIPEA, DCM, rt, 16 h, 20%.
The synthesis of the photoreactive probe 44 started with D-Lys(Boc)-OH for maintaining the 
stereochemistry found in the natural products which all have D-amino acids within the 
diketopiperazine heterocycle (Fig. 38). Starting from commercially available D-Lys(Boc)-OH, 
the free amino group was first protected with Alloc (38). The C-terminus was subsequently
protected as a methyl ester using thionyl chloride in methanol which directly also cleaved the 
Boc protecting group, resulting in amine 39 in 95% yield over both steps. Next, the free amine 
39 was coupled to Fmoc-protected L-propargyl glycine using standard coupling reagents to 
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introduce the alkyne moiety for reporter attachment. This gave the desired dipeptide 40 in 
72% yield. The Fmoc-group was cleaved and coupling of 3-benzoylbenzoic acid was 
conducted to insert the photo-reactive group into the molecule resulting in compound 41 in 
65% yield. Palladium(0)-mediated deprotection of the Alloc-group (42) and coupling to 
carboxylic acid 34 provided 43. 43 was then treated with TMSOTf to cleave the Boc-
protecting groups and to give the corresponding free diamine. Subsequently, the methyl ester 
was hydrolyzed using lithium hydroxide followed by diketopiperazine formation performed 
with standard coupling conditions to yield 20% (over 3 steps) of the photoreactive probe 44.
4.2.1 Biological evaluation of Brevicompanines and derivatives thereof
The biological activities of compounds 25-30, as well as of 37 and 44 were examined in 
collaboration with the Kombrink group (MPI Cologne) using a bioassay with Arabidopsis
seedlings. As a readout, the effect of the Brevicompanines on root length and lateral root 
density was examined as Brevicompanines were reported to act as plant growth regulators.
Surprisingly, no enhancement of root growth in Arabidopsis could be observed as published 
for lettuce seedlings. Instead, each of the compounds showed inhibitory effects on the primary 
root growth of Arabidopsis seedlings in response to increasing concentrations (Fig. 42). 
Interestingly, the natural products 25, 26 and 27 showed a stronger effect than their allo-
isomers 28-30. This may indicate a stereospecific structure-activity-relationship (SAR) and 
suggests that the D-amino acids within the diketopiperazine moiety are favorable for this 
biological activity. The best inhibitory activity was observed for Brevicompanine B (26). 
Brevicompanine A (25) showed only slightly weaker bioactivities. Of note, both compounds 
possess a D-conformation within the diketopiperazine residue and both compounds feature the 
most hydrophobic amino acid side-chain in the diketopiperazine heterocycle. Subsequently,
the inhibitory activities of the synthesized probes 37 and 44 were determined. The inhibition 
of the root growth by 37 and 44 was not as good as the inhibition triggered by 25-30. 
Although the photoreactive probe 44 had the required D-stereochemistry within its 
diketopiperazine moiety, it showed almost no activity. The reduced inhibition of root growth 
might result from the bulky residues (benzophenone etc.) that might impart steric hindrance 
on the corresponding binding event(s). Probe 37 with its L-stereochemistry within the 
diketopiperazine possessed a less hydrophobic side chain (L-propargyl glycine) residue than 
for example allo-Brevicompanine B (29) which might also be required to retain activity. 
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Nevertheless both probes, 37 and 44, displayed inhibitory activity towards the lateral root 
density at 100 µM (Fig. 43). However, both probes also indicated an inhibition of the primary 
root growth at a concentration of 300 µM (data not shown).
Figure 42: Primary Root Length of Arabidopsis (Col-0) seedlings [DAG10] in the presence of varying 
concentrations of 25-30, 37 and 44 (100% ≡ 23.8 mm). Error bars indicate the standard deviation of at least three 
independent experiments.
In addition, the lateral root density (LRD) of Arabidopsis seedlings was examined. The LRD 
also decreased upon increasing concentrations of compounds 25-30 (Fig. 43). However, a 
correlation between stereochemistry of the diketopiperazine moiety and alteration of LRD 
could not be deduced. 
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Figure 43: Lateral root density of Arabidopsis (Col-0) seedlings [DAG10] in the presence of varying 
concentrations of 25-30, 37 and 44 (100% ≡ 1.77 No/cm). Error bars indicate the standard deviation of at least 
three independent experiments.
Altogether, these growth inhibition studies with the synthesized Brevicompanines and 
derivatives thereof (25-30) revealed inhibitory effects on the primary root growth of
Arabidopsis seedlings and a correlation between the stereochemistry of the diketopiperazine 
moiety and inhibition efficiency. A growth enhancing effect as described for lettuce seedlings 
could not be observed. These findings may conclude that the target protein(s) of 25, 26 and 27
on lettuce seedlings should be different from Arabidopsis seedlings.
However, since the acquisition of water and nutrients by plant roots strongly depended 
on root branching, the inhibition of the latter might be of further interest to elucidate the 
several processes of root expansion and to reveal more networking cellular proteins 
respectively. Therefore, the two natural product-based probes 37 and 44 were designed for 
identifying the corresponding target protein(s).
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4.2.2 ABPP experiments for cellular target elucidation
For target elucidation of Brevicompanines, Arabidopsis leaf extracts were incubated with 
probe 37 and 44, respectively. In a first experiment, an Arabidopsis lysate was preincubated 
with various concentrations of probe 37 and then with the corresponding “click-reagents” to 
attach a fluorescent reporter tag (Rhodamine) after labelling. Subsequent SDS gel analysis of 
such treated proteome should then reveal potential targets. Figure 44A depicts that no 
covalent labeling was observed using probe 37. This issue might indicate that 
Brevicompanines – as expected from their molecular structure- bind to their targets in a non-
covalent fashion.
Figure 44: (A) Labeling of Arabidopsis leaf extracts with probe 37. (B) Labeling of Arabidopsis leaf extracts 
with probe 44. (* = signal of free rhodamine-azide; ** = this labeled band is most likely to be the abundant 
protein RuBisCo)
In a second experiment, Arabidopsis leaf extracts were incubated with varying concentrations
of probe 44, and then irradiated with UV-light (360 nm) to initiate photo-crosslinking with 
target proteins. Afterwards the samples were treated with “click reagents” to attach again the 
fluorescent reporter tag. The outcome of this treatment is depicted in Figure 30B. A distinct 
band (**, Fig. 44B) was labeled by probe 44 at a concentration of 10 µM. The size of the 
labeled protein is about 50 kDa which however most probably is labeling of the abundant 
protein RuBisCo and thus a non-specific cross-link.
138
Remarkably, increasing concentrations
of 44 led to rather unspecific photo-crosslinking within the Arabidopsis leaf proteome 
(Fig. 44B). At a concentration of 100 µM the signal was unquestionably oversaturated. 
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Altogether, the current target identification studies are inconclusive. It is not clear if no target 
could be found due to technical or due to inherent problems with the probes. Further 
investigations that may help to shed light on this could be competition experiments with the 
natural products and 44 to confirm whether the labeled protein at 50 kDa is as expected non-
specific or represents specific labeling. Additional pull-down experiments using biotinylated
reporter tags and streptavidin enrichment could also be helpful for paving the path to the 
cellular targets of Brevicompanines. Finally, also alternative photo-affinity probes that display 
a stronger bioactivity might be required for target identification. 
However, due to the overall rather weak bioactivities of Brevicompanines and the time 
limitations from the PhD, such experiments were not performed within the frame of this 
thesis.
4.3 Synthesis of acyl-ATP probes for profiling of ATP binding 
proteins in A. thaliana
Adenosine triphosphate (ATP) is the biochemical fuel of all living organisms. The phosphor-
anhydride linkages in an ATP molecule are responsible for the high energy content of this 
molecule. Hydrolysis of these bonds releases this chemical energy that can then be used to 
drive metabolic reactions. In all living organisms, numerous proteins that are able to bind and 
hydrolyse ATP are found. An important and very large class of ATP-binding proteins are 
protein kinases which transfer the γ-phosphate from ATP to substrates. Nearly all signalling 
pathways rely on protein kinase cascades which precisely regulate cellular processes as for 
example cell division and differentiation. In the genome of the model plant Arabidopsis 
thaliana, over 1000 protein kinases and hundreds of other ATP binding proteins are encoded.
5
Due to their diverse and important roles, kinases have been intensively studied in plant 
science.
139; 140
The study of the ATP-binding proteome is an elaborate task considering the remaining 
hundreds of uncharacterized kinases in plants. Therefore, new chemical biological approaches 
are necessary to study kinases and other ATP binding proteins in plants. For visualizing ATP-
dependent enzymes, a directed activity-based probe named BHAcATP (5) has recently been
introduced (c.f. Table 5).
105
This probe represents an ATP-derivative which is modified with a 
reactive acyl phosphate group at the γ-phosphate followed by a reporter-tag. The acyl 
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phosphate probes target ATP binding sites and covalently label conserved lysine residues 
located in the ATP binding pocket. Such conserved lysine residues have been found for a 
huge number of kinases in their ATP binding site (Fig. 45B) and during ATP binding, these 
lysine residues are in very close proximity to the γ-phosphate (Fig. 45C).141 The acyl 
phosphate might therefore serve as an electrophilic warhead because a mixed carboxylic 
phosphoric anhydride residue is chemically rather reactive. Consequently, the electrophilic 
acyl phosphate within the probes can be attacked by the ε-amino group of a lysine, resulting 
in an irreversible acylation of the lysine with the reporter-tag accompanied by a release of 
ATP (Fig. 45A).
Figure 45: A) Mechanism of labeling with acyl phosphate probes. Probes consist of ATP that is modified into
an acyl phosphate warhead, an alkyl linker and a reporter tag. The ATP entity is binding to the ATP-binding 
pocket of a protein, the nucleophilic ε-NH2 from nearby lysine is attacking the acyl phosphate resulting in a 
covalent binding of the tag to the protein. B) Sequence logo representation (the size of each letter at a given 
position corresponds to the proportion of sequences, expressed in bits, containing this residue). Diagram shows 
the region of nine residues around the conserved lysine in the ATP binding loop based on an alignment of all 
protein kinases. C) Crystal structure of Protein Kinase A (PKA) in complex with ATP. Catalytic lysine (Lys72) 
is shown in magenta. The ε-NH2 is about 6.4 Å away from the γ-phosphate of ATP. (This figure was made using 
Protein Data Bank coordinates for Protein Kinase A (4DH1).142)
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For a global analysis of ATP-dependent enzymes within the Arabidopsis proteome, a set of 
acyl phosphate probes on the basis of ATP were therefore synthesized (Table 5).105
Scheme 10: Cation exchange of disodium ATP. a) DEAE Sephadex A-25, NHEt3CO3
To this end, the protocol of Patricelli and coworkers was essentially followed.105 The 
synthesis of the corresponding probes starts with a cation exchange of disodium ATP to 
enhance the ATP solubility in organic solvents. To this end, the commercially available 
disodium salt of ATP was converted to the triethyl ammonium salt 45 by passing it through an 
ion-exchange column packed with DEAE-Sephadex A-25. The ATP disodium salt was 
applied to this column and eluted with 0.5 M NH(Et)3CO3. The fractions containing ATP-
NH(Et)3
+ were pooled and lyophilized to form a white solid (Scheme 10).
As a first ATP probe derivative, a biotin-tagged derivative was synthesized. To this 
end, a linker was attached to biotin, resulting in 48 after coupling and methyl ester hydrolysis
(Scheme 11). To minimize the steric influence of biotin as a reporter tag, 6-aminohexanoic 
acid was introduced as an additional spacer.
Scheme 11: Synthesis of biotinyl-linker 48. a) 46, HBTU, HOBt, TEA, DMF, rt, 0.5 h, 85%. b) LiOH, H2O, 
MeOH, 0°Crt, 1 h, 99%.
48 was then coupled with previously prepared ATP compound 45, thereby yielding 
compound 49 (Scheme 12).
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Scheme 12: Synthesis of BHAcATP (49). a) TEA, IBCF, 45, dioxane/DMF/DMSO, 0°Crt, 20 h, 6%.
The crude acyl phosphate 49 was then purified manualy by RP-C18 silica gel using water as 
eluent. The manual purification became necessary as HPLC purification of 49 led to 
decomposition of the desired product.
By a simple exchange of the last acylation step (Scheme 12), four additional acyl 
phosphate probes (49-52) were successfully synthesized. Altogether, three different types of
reporter tags were introduced into the ATP probes: a biotin-tagged derivative (49), two
fluorophore-tagged derivatives (51, 52) and an alkyne tagged version (50) have been 
developed successfully by adapting the synthetic route of Patricelli (Table 5).105
Table 5: Chemical structures of synthesized acyl phosphate probes.
Chemical structure Cpd (type of tag)
49 (biotin-tag)
50 (click-tag)
51 (fluorescence-tag)
52 (fluorescence-tag)
With the bodipy-tagged probes 51 & 52, a direct visualization after labeling is possible 
whereas the biotin-tagged version 49 needs to be blotted and the alkyne-tagged probe 50 is
only effective when a two-step ABPP experiment is executed. In a very first experiment, the 
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reactivity of the acyl phosphate towards the ε-amine of lysine was evaluated. Therefore, a 
0.2 mM solution of probe 49 was incubated with salt-free lysine (1 mM) in water. After one 
hour, samples were taken and subjected to the LC-MS. MS and MS/MS spectra of the 
precursor ion were recorded (Fig. 46). This revealed that after one hour (which represents 
approximately the incubation time used in biological experiments) most of the probe 49 was 
converted to the lysine acylation product. This proves the general reactivity of acyl 
phosphates towards lysine side chain residues. It however also raises the question if not any 
lysine residue located at the surface of proteins might be reactive enough to react with acyl 
phosphate probes. 
Figure 46: Analysis of acylation of L-lysine with 49. (A) Positive ESI-MS spectrum of the acylation product 
after LC. (B) MS/MS spectrum of the precursor ion (486 m/z) resulted in three different fragmentations.
In collaboration with the van der Hoorn group (MPI Cologne), the labeling pattern of each 
probe was therefore evaluated in biological ABPP experiments. In Figure 47 is shown the 
typical labeling profiles of the acyl phosphate probes 49-52. Coomasie brilliant blue (CBB) 
staining indicates the equal loading. In each experiment, Arabidopsis leaf extracts were 
labeled with probes 49-52, respectively. In case of probe 49, the biotinylated proteins were 
detected on protein blots using streptavidin HRP. For probe 50, a two-step ABPP experiment 
was performed and the probe-labeled proteome was incubated in a second step with the 
“click-reagents” (Cu(I), TBTA, TCEP) and a trifunctional reporter tag (Tri-N3) including a 
biotin and an additional rhodamine as reporter tags (which makes a bifunctional detection 
possible - either Strep-HRP blot or direct in-gel fluoresecence scanning, Fig 47B,C). The 
labeling profile of the bodipy-tagged probes 51 and 52 could be easily detected by direct in-
gel fluorescence scanning. 
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Figure 47A shows a characteristic labeling profile of 49 in Arabidopsis leaf extracts. It can be 
seen that a wide range of proteins are adressed by the biotinyl-tagged acyl phosphate 
probe 49, as expected from the fact that the ATP-binding cleft within ATP-binding proteins is 
highly conserved. Figure 47B shows the labeling profile of the alkyne-tagged probe 50
detected by Western-blot and Figure 47C shows the same labeling profile detected by in-gel 
fluorescence scanning. Again, a widespread labeling was observed, although not as strong as 
for the biotinyl-tagged probe 49. A comparison of these labeling patterns with those of the 
two bodipy-tagged probes which only differed in the length of their linker region, showed 
interesting results (Fig. 47C, D): Only the probe with the shorter alkyl-chain 51 produced a 
comparable labeling pattern with the probe 49 (biotin) and 50 (alkyne). In contrast, probe 52
did not display labeling which cannot be explained easily and would require further 
investigations. 
Figure 47: Labeling patterns produced from acyl phosphate probes 49, 50, 51 and 52 on Arabidopsis leaf 
extracts. (A) Labeling profile of 49 (MCCA = 3-methylcrotonyl-CoA carboxylase, RBCL = ribulose-1,5-
bisphophate carboxylase oxygenase, BCCP = biotin carboxyl carrier protein) (B) Labeling profile of probe 50
after “click-reaction” using Strep-HRP blot for detection. (C) Labeling profile of probe 50 after “click-reaction” 
using in-gel fluorescence scanning for detection. (D) Labeling profile of probe 51 and 52 using in-gel 
fluorescence scanning for detection. (Labeling experiments performed by Joji Villamor, MPI Cologne)
Next, different labeling conditions were tested with probe 49 (Fig. 48). The labeling pattern 
of 49 towards an increasing concentration demonstrated that probe labeling is optimal using 
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probe concentrations below 60 µM. Higher probe concentrations instead led to massive 
labeling that hampers any assignment of signals (Fig. 48A). 
Figure 48: Labeling pattern of probe 49 depends on conditions. (A) Labeling patterns of probe 49 in relation to 
probe concentration. (B) Chemical structures of probe 49, ATP (Adenosine-5'-triphosphate), ADP (Adenosine-
5’-diphosphate), AMP (Adenosine-5’-monophosphate) and NAD
+
(Nicotinamide adenine dinucleotide). (C) pH-
dependency of labeling with probe 49. (D) Probe (49)-labeling was competed with ATP and ADP, but not with 
AMP and NAD. (Adapted and modified from Villamor et al.
143
)
In subsequent experiments, a probe concentration of 5 µM was used. First, the pH-
dependency regarding probe-labeling was investigated. To this end, the Arabidopsis leaf 
extracts were labeled with 49 at various pH levels (Fig. 48C). This revealed that labeling with 
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49 is strongly pH dependent. At acidic pH, only weak or even no labeling was observed,
while intense labeling occurs at neutral to basic pH (Fig. 48C).
In a second competitive ABPP experiment, a suppression of labeling with probe 49 by 
various nucleotides was investigated (Fig. 48B, D). This experiment series disclosed that a 
pre-incubation of ATP suppressed labeling of 49 very efficiently. Interestingly, also ADP 
could outcompete probe-labeling, whereas AMP and NAD
+
could not. This evidenced that 
ATP-binding proteins were susceptible for labeling with probe 49 and that the ATP-binding 
pocket has most likely been addressed. This demonstrated that the labeling event was
selective.
Finally, probe 49 was used in pull-down experiments in Arabidopsis leaf extracts 
using streptavidin beads to enrich probe-labeled proteins followed by gel-electrophoresis, 
trypsin digest and LCMS/MS analysis to identify the probe-labeled proteins. From this 
procedure, in total 112 proteins could be identified from Arabidopsis leaf extracts incubated 
with probe 49. 13 of these proteins were also detectable in the no-probe-control as 
background signals. Some of them were endogenously biotinylated proteins such as MCCA 
(3-methylcrotonyl-CoA carboxylase) at 80 kDa or BCCP (biotin carboxyl carrier protein) at 
34 kDa (Fig. 47A). All 112 detectable proteins were selected by spectral counts which 
revealed that the significant signal in the region of 55 kDa is attributed to the labeling of a 
subunit of the chloroplastic ATPase (ATPB) and the large subunit of ribulose-1,5-bisphophate 
carboxylase oxygenase (RBCL) (Fig. 47A). The majority of all detectable proteins were ATP-
binding proteins like RBCL. It emerged that only 21 of the total 112 labeled proteins could be 
assigned to protein kinases, including receptor-like kinases (RLKs), MAP kinases (MPKs) 
and calcium dependent kinases (CPKs). Since there are more than 1000 protein kinases 
encoded by the Arabidopsis genome, this represents a rather tiny section that was labeled by 
probe 49.
5
This may be caused by several reasons. One reason could be that not all protein 
kinases were expressed in the analyzed tissue (here: leaf). However, the analysis of labeling 
sites using protein databases showed that the biotinylated probe 49 targets predominantly but 
not exclusively the ATP binding pockets of a broad range of protein kinases and other 
unrelated ATP binding proteins.
Overall, these results demonstrate that the probes 49-52 generally compile a powerful 
toolbox to study and identify ATP binding activities in native plant proteomes, which has not 
been done before. Future studies could involve, for example the identification of selective 
inhibitors of Arabidospis kinases or to study the activation of kinases upon external stimuli by 
using the probes 49-52.
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5. SUMMARY AND OUTLOOK
During this PhD project, syntheses of small molecule modulators for functional chemical 
biological investigations in plants were accomplished. Two different approaches were thereby 
followed:
In the first approach and main project of this thesis, chemical syntheses of bioactive 
plant growth-modulating natural products and their subsequent evaluation as potential 
chemical probes to decipher root growth biology were successfully performed. 
In this context, the first total synthesis of the natural product Rotihibin A (1) was 
successfully achieved (c.f. Chapter 4.1). This lipopeptidic natural product features a vast 
array of non-proteinogenic amino acids and the natural product 1 was described in literature 
as a potent root-growth inhibitor. The developed first total synthesis of Rotihibin A (1) was 
based on a solid phase synthesis after previous amino acid building block generation and 
allowed to confirm the previous structural assignment. After confirmation of the reported 
bioactivity via bioassays using living plants, a whole set of Rotihibin A derivatives (15-24) 
for structure-activity relationship studies was synthesized by the developed synthetic route. In 
these studies, several structural features with a critical role for bioactivity could be revealed. 
Moreover, assays with different Arabidopsis reporter lines and cell-based assays
demonstrated that Rotihibin A (1) impairs root growth via inhibiton of cell mitosis. These 
studies therefore open the possibility to generate chemical probes for protein target 
identification in the future. 
In a second project, a focused library of derivatives of the Brevicompanine natural 
product family was successfully generated (compounds 25-30). The Brevicompanines belong 
to a natural product class that are characterized by a hexahydropyrroloindole (HPI) moiety, 
derived from L-tryptophan, which undergoes a diketopiperazine formation with a second 
amino acid residue. 
The chemical synthesis of these compounds was succeffully achieved via a 
heteroatom-mediated intramolecular selenocyclization followed by an allylic transposition 
and finally the formation of the diketopiperazine (c.f. Chapter 4.2). The biological evaluation 
of this compound series was executed in cooperation with the Kombrink group (MPI 
Cologne). In these studies, the synthesized compounds showed root growth inhibition 
properties reminiscent of cytokines. The best inhibitory activity showed compound 26. The 
corresponding structure-activity-relationship studies furthermore revealed that growth 
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inhibition required a D-configured amino acid within the diketopiperazine heterocycle. The 
determined structure-activity relationships then allowed the generation of a series of first 
photoaffinity- and alkyne-tagged Brevicompanine derivatives 37 and 44 usable for target 
identification studies. Although the subsequent target identification studies did not yet result 
in the elucidation of a target, they nevertheless demonstrated the general feasibility of such an 
approach. In future studies, an optimization of pull-down procedures as well as the generation 
of structurally alternative natural product-based probes can be envisioned to finally elucidate 
the cellular target.
In the second approach, activity-based probes were synthesized to expand the scope of 
ABPP approaches in plants (c.f. Chapter 4.3). To this end, diverse acyl-phosphate probes 49-
52 with different reporter groups for profiling protein kinases and other ATP binding proteins 
in plants were successfully synthesized. These probes entail an ATP-derivative which is 
modified with a reactive acyl phosphate group at the γ-phosphate followed by a reporter-tag.
This type of probes was shown to act by binding to the P-loop of ATP-binding proteins. At 
this binding site, the acyl-phosphate probes are nucleophilically attacked by a conserved 
lysine residue, resulting in a transfer of the reporter group onto the lysine residue and thus
irreversible ATPase inhibition and covalent labeling of the enzyme. The synthesized acyl 
phosphate probes were utilized to launch a new approach to explore the ATP-binding 
proteome of the model plant Arabidopsis thaliana. The biological evaluation of all probes 
were performed in cooperation with the van der Hoorn group (MPI Cologne). However, the 
labeling pattern of all acyl phosphate probes showed a comparable broad-range labeling, since 
all ATP-binding proteins should be susceptible to these probes. By using the biotinylated acyl 
phosphate probe 49 in ABPP and pull-down approaches, the first in-depth analysis of targets 
in a plant proteome was possible. The labeled proteins include a few well-characterized ATP-
binding proteins, and many ATP-binding proteins that have not been studied so far. A total of 
112 proteins, of which 21 were protein kinases, were identified in the labeling experiments
while only 13 of these proteins were also identified in the no-probe-control. The analysis of 
labeling sites using the protein database showed that the biotinylated probe 49 targets
predominantly but not exclusively the ATP binding pockets of a broad range of protein 
kinases and other unrelated ATP binding proteins. These studies therefore demonstrated that 
the acyl-phosphate probes 49-52 generally compile a powerful toolbox to study and identify 
ATP binding activities in native plant proteomes. .
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6. ZUSAMMENFASSUNG UND AUSBLICK
Im Rahmen dieser Dissertation wurden chemische Synthesen von niedermolekularen 
Modulatoren zur Durchführung von chemisch-biologischen Ansätzen in Pflanzen entwickelt. 
Dazu wurden zwei verschiedene Strategien verfolgt.
Bei dem ersten Ansatz und Hauptprojekt dieser Dissertation wurden chemische 
Synthesen von bioaktiven Pflanzenwachstums-modulierenden Naturstoffen und deren 
nachfolgende biologische und biochemische Evaluierung erfolgreich durchgeführt.
In diesem Zusammenhang wurde eine erste erfolgreiche Totalsynthese des 
Naturstoffes Rotihibin A (1) realisiert (vgl. Kapitel 4.1). Dieser lipopeptidische Naturstoff 
besteht aus einer Vielzahl von nicht-proteinogenen Aminosäuren und wurde in der Literatur 
als potenter Hemmstoff für das Wurzelwachstum bei Pflanzen beschrieben. Die Totalsynthese 
wurde nach vorangegangener Bausteinsynthesen an der festen Phase mittels Fmoc-Strategie 
erfolgreich abgeschlossen. Dabei wurde auch gleichzeitig die vorher nur mittels 
Spektroskopie bestimmte Struktur und Stereochemie des isolierten Naturstoffes bestätigt. 
Nachdem die beschriebene Bioaktivität in Bioassays reproduziert werden konnte, wurde eine 
kleine Substanzbibliothek von Rotihibin A-Derivaten (15-24) für Struktur-
Wirkungsuntersuchungen unter Verwendung der vorher etablierten Synthese generiert. In 
diesen Untersuchungen konnten mehrere strukturelle Eigenschaften des Naturstoffes
identifiziert werden, die essentiell für den Erhalt der Bioaktivität sind. Des Weiteren konnte 
unter Heranziehung verschiedener transgener Arabidopsis Reporter-Linien und zellbasierter 
Assays gezeigt werden, dass Rotihibin A (1) die Hemmung des Wurzelwachstums über eine 
Inhibition des mitotischen Zellzyklus erreicht. Zukünftige Arbeiten können nun die aus diesen 
Studien gewonnenen Struktur-Wirkungsbeziehungen ausnutzen, um entsprechende bioaktive 
Naturstoff-basierte Sonden zur Aufklärung der molekularen Zielproteine von Rotihibin A (1) 
zu generieren. 
Ergänzend hierzu wurde des Weiteren eine Synthese einer fokussierten Bibliothek von 
Derivaten (25-30) der Brevicompanin-Naturstoffklasse (vgl. Kapitel 4.2) durchgeführt. Diese 
Naturstoffklasse zeichnet sich strukturell durch ein an der C3-Position revers-prenyliertes 
Hexahydropyrrolo[2,3-b]indol (HPI)- Grundgerüst aus, welches aus einem L-Tryptophan 
abgeleitet werden kann. Die HPI-Aminosäure bildet dann mit einer weiteren Aminosäure ein 
Diketopiperazinderivat. Die erfolgreiche chemische Synthese dieser Verbindungen gelang 
mittels einer Heteroatom-vermittelten, intramolekularen Selenocyclisierung, gefolgt von einer 
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reversen Prenylierung und schließlich der Bildung des gemischten Diketopiperazins. Die 
biologische Evaluierung dieser so erstellten Verbindungsbibliothek (25-30) wurde in 
Kooperation mit der Arbeitsgruppe von Erich Kombrink (MPI Köln) realisiert. Dabei zeigten 
diese Verbindungen Wurzelwachstums-hemmende Eigenschaften, wobei Verbindung 26 die 
stärkste inhibitorische Aktivität zeigte. In diesen Studien konnte des Weiteren gezeigt werden, 
dass eine Aminosäure mit D-Konfiguration innerhalb des Diketopiperazin-Heterozyklus sich 
günstig auf die biologische Aktivität auswirkte. Die so gewonnen Struktur-
Wirkungsbeziehungen konnten direkt in der Generierung von Photoaffinitäts- und Alkin 
modifizierten Brevicompanin-Derivaten (37, 44) für die Zielproteinidentifizierung umgesetzt 
werden. Leider gelang bisher jedoch noch keine Aufklärung des molekularen Targets. 
Zukünftige Arbeiten müssten diesbezüglich eine Optimierung der Pull-down Strategien 
anstreben oder die Synthese von Brevicompanin-Sonden mit besseren Bioaktivtäten 
beinhalten, um abschließend die zellulären Zielproteine der Brevicompanin-Naturstoffklasse 
aufzuklären. 
In einem zweiten aktivitäts-basierten Ansatz wurden neuartige molekulare Sonden für 
die aktivitäts-basierte Proteinprofilierung in Pflanzen synthetisiert (vgl. Kapitel 4.3). Dazu 
wurden verschiedene Acyl-Phosphat-Sonden (49-52) generiert, um Kinasen und andere ATP-
bindene Proteine in Arabidopsis thaliana zu studieren. Diese Sonden basierten auf ATP, 
welches am γ-Phosphat mit einem reaktiven Acyl-Phosphatrest und mit verschiedenen 
Reportereinheiten versehen wurden. Für diese Art von Sonden wurde bereits gezeigt, dass sie 
an die P-Schleife (die Phosphat-bindene Schleife) von ATP-bindenen Proteinen binden. An 
dieser Phosphat-bindenen Kavität befindet sich in vielen ATP-bindenen Proteinen ein 
konserviertes Lysin. Dieses Lysin greift nukleophil das Acyl-Phosphat der Sonden an, 
wodurch die Reportereinheit kovalent auf den Lysinrest übertragen wird. Dadurch werden 
diese Enzyme kovalent markiert und die ATPase-Aktivität der jeweiligen Enzyme 
gleichzeitig inhibiert. Diese neu synthetisierten Acyl-Phosphat-Sonden wurden dann dazu 
benutzt, einen neuen chemisch-biologischen Ansatz zu entwickeln, um das ATP-bindene 
Proteom der Modellpflanze Arabidopsis thaliana zu untersuchen. Die biologische 
Evaluierung dieser Sonden wurde von der Arbeitsgruppe um R. van der Hoorn (MPI Köln) 
durchgeführt. Die Markierungsmuster aller synthetisierten Sonden (49-52) zeigten, dass eine 
Vielzahl von Enzymen für Sonden dieser Art zugänglich war. Diese Tatsache entsprach den 
Erwartungen, dass prinzipiell alle ATP-bindenen Proteine durch diese Art von Sonden 
adressierbar sind. Durch die Verwendung der biotinylierten Acyl-Phosphatsonde 49 in ABPP 
und pull-down Experimenten konnte eine erste eingehende Analyse der für die Sonde 
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zugänglichen ATP-bindenen Proteine in Pflanzenproteomen berichtet werden. Die markierten 
Proteine beinhalteten einige gut charakterisierte ATP-bindene Proteine und viele weitere 
ATP-bindende Proteine, die bis jetzt noch für keine Studien zugänglich waren. Insgesamt 
wurden in diesem chemisch-biologischen Ansatz 112 Proteine, davon 21 Proteinkinasen, als 
Zielproteine der Acyl-Phosphatsonde 49 in Pflanzen identifiziert. Die Analyse der genauen 
Bindungsstelle der Sonde 49 ergab, dass hauptsächlich die ATP-Bindungstaschen (P-Schleife) 
modifiziert wurden. In diesen Studien stellten sich solche Acyl-Phosphat-Sonden daher als 
besonders hilfsreiches chemisches Werkzeug für das Studium des ATP-bindenen Proteoms in 
Pflanzen dar.
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7. EXPERIMENTAL PART
7.1 General methods and instruments
Chemicals
All chemicals were purchased from Alfa Aesar, Acros, ABCR, Senn Chemicals, Bachem, 
Carl Roth, Fluka, TCI chemicals, Merck, Novabiochem, Riedel de Haen, Iris, Roth, 
Invitrogen, or Sigma-Aldrich and were used without any further purification. Anhydrous 
solvents in the highest available quality were purchased from the same suppliers.
Thin layer chromatography (TLC)
TLC was performed on Merck aluminum pre-coated silica gel plates (20 × 20 cm, 60F254).
Spots were detected using UV irradiation at 254 nm or by soaking the TLC plates with 
developing solution A or B. Subsequently, the TLC plates were heated to visualize the 
respective spots. Eluents and Rf values are given in the particular experimental description. 
Reversed-phase TLC was carried out on Merck aluminum pre-coated silica gel plates (60 RP-
18 F254S) utilizing UV irradiation at 254 nm or the following developing reagents to visualize 
the spots. 
Developing solution A: 20 g of phosphomolybdic acid hydrate in 80 mL ethanol 
Developing solution B: 1.5 g KMnO4, 10 g K2CO3 and 1.25 mL of 10% aq. NaOH in 200 mL 
water
Silica gel flash liquid chromatography  
Column chromatography purifications were performed with silica gel from Acros (particle 
size 35-70 μm). Reversed-phase chromatography was performed with LiChroprep RP-18 (40-
63 µm) from Merck. 
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Reactions under inert atmosphere using balloon technique
In order to run air or moisture sensitive reactions, all glassware was thoroughly dried in an 
oven at 100 °C for 12 h. Next, the flasks were evacuated from air in the vacuum and flushed 
by argon gas. This was carried out using a two-way vacuum line or by an argon-filled balloon. 
An argon filled balloon that was connected to the flask via a septum was also used to provide 
the necessary pressure compensation for reactions under inert atmosphere.
Reversed-phase liquid chromatography - electrospray ionization mass spectrometry 
(LC-MS) 
LC-MS analyses were performed on a LC-MS system from Thermo Scientific with an Eclipse 
XDB-C18 (5 μm) column from Agilent (peak detection at 210 nm) and a Thermo Scientific 
LCQ Fleet
TM
ESI-Spectrometer. For positive mode measurements, a linear gradient of solvent 
B (0.1% formic acid in acetonitrile) in solvent A (0.1% formic acid in water) was used at 
1 mL/min flow rate. For negative mode measurements, a linear gradient of solvent C (5 mM 
NH4OAc in acetonitrile) in solvent D (5 mM NH4OAc in H2O) at 1 mL/min flow rate was 
employed. 
Gradient for positive mode: 0 min / 10% B → 1 min / 10% B → 10 min / 100% B → 12 min / 
100% B → 15 min / 10% B
Gradient for negative mode: 0 min / 10% C → 1 min / 10% C → 10 min / 100% C → 12 min 
/ 100% C → 15 min / 10% C
Preparative reversed-phase high performance liquid chromatography (prep HPLC)   
Purification of the compounds was carried out on a Shimadzu HPLC system (Prominence 
UFLC) with a RP-C18-column from Phenomenex (Phenomenex Luna® 5 µm C18(2), 100 x 
21.20 mm)) and peak detection at 210 and 254 nm. Linear gradients of solvent B (0.1% TFA 
in acetonitrile) in solvent A (0.1% TFA in water) were applied at a 25 mL/min flow rate.
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Freeze drying
Freeze-drying or lyophilisation was conducted with a Freeze Dryer ALPHA 2-4 LD plus 
(CHRIST). To this end, an aqueous solution of the substance was frozen separately in round-
bottom flasks using liquid nitrogen. As the time required for the drying process is affected by 
the thickness of the ice layer, the samples were frozen under rotation which leads to the 
formation of a thin uniform ice layer inside the glass vessel. Thus frozen samples were 
submitted to the freeze dryer. The samples were usually completely lyophilized after 24 h.
Nuclear magnetic resonance spectroscopy (NMR)   
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Avance II 400 system 
(400 MHz for 
1
H- and 100 MHz for 
13
C-NMR) or a Bruker Avance II 700 MHz system 
(700 MHz for 
1
H and 176 MHz for 
13
C-NMR). 
1
H NMR spectra are reported in the following 
manner: chemical shifts (δ) in ppm calculated with reference to the residual signals of 
undeuterated solvent, multiplicity (s, singlet; d, doublet; t, triplet; dd, doublet of doublet; dt, 
doublet of triplet; m, multiplet; b, broad signal), coupling constants (J) in Hertz (Hz), and 
number of protons (H).  
Optical rotation 
Optical rotations were measured with a Polartronic universal polarimeter from Schmidt + 
Haensch. The concentrations (given in g/100 ml) and the solvent used are given with the 
respective experimental data. The wavelength of the light is 589 nm (the sodium D line). 
[]
 =

 	 

[1]
l = length of the cuvette in decimeter
C = concentration (g/100 ml)
λ = wavelength (typically: 589 nm)
T = temperature (typically: 20 °C)
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7.2 Synthesis of Rotihibin A and derivatives
7.2.1 Syntheses of building blocks
(Z)-methyl dec-2-enoate (7):
To a solution of methyl P,P-bis(2,2,2-trifluoroethyl)phosphonoacetate (1.272 g, 4 mmol) in 
anhydrous THF (16 ml) was added cautiously a solution of NaH (60% dispersion in mineral 
oil, 224 mg, 5.6 mmol) in dry THF (4 ml) at -78 °C under argon atmosphere. This mixture 
was stirred for 15 min. at -78 °C, then octanal (512 mg, 4 mmol) dissolved in anhydrous THF 
(4 ml) was added. This mixture was stirred for 1 h at -78 °C. After TLC indicated completion 
of the reaction, saturated aqueous NH4Cl solution (20 ml) was added and the quenched 
reaction mixture was warmed to rt. The product was twice extracted into diethyl ether. The 
organic layers were combined, dried over Na2SO4, filtered and evaporated. The resulting 
residue was purified by flash chromatography (SiO2, CH/DEE 50:1). 
Yield: 611 mg (3.6 mmol, 90%) as colorless oil, ee % E/Z 1:9 (by TLC)
TLC (CH/DEE = 20:1): Rf = 0.43
1
H NMR (400 MHz, CDCl3): δ = 6.23 (dt, J = 11.5, 7.5 Hz, 1H), 5.76 (dt, J = 11.5, 1.7 Hz, 
1H), 3.71 (s, 3H), 2.64 (qd, J = 7.5, 1.7 Hz, 2H), 1.30 (dd, J = 12.1, 6.8 Hz, 10H), 0.91 – 0.87 
(m, 3H)
13
C NMR (101 MHz, CDCl3): δ = 167.06, 151.19, 119.28, 51.10, 31.93, 29.41, 29.24, 29.18, 
22.77, 14.22
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(Z)-dec-2-enoic acid (2):
To a solution of 7 (132 mg, 0.72 mmol) in THF/MeOH (3:1, 8 ml) was added 1 M LiOH 
(2 ml, 2 mmol) at 0 °C. After this, the solution was allowed to warm to rt and was then heated 
up to 50 °C and stirred at this temperature for 5 h. The reaction was monitored by TLC 
(DEE/CH 1:20). The reaction mixture was diluted with 1 M HCl (10 ml) and extracted three 
times with DCM. The combined organic layers were dried (Na2SO4), filtered and 
concentrated under reduced pressure giving the title compound which was used in following 
steps without further purification.
Yield: 120 mg (0.71 mmol, 98%) as a colorless oil
1
H NMR (400 MHz, CDCl3): δ = 6.35 (dt, J = 11.5, 7.6 Hz, 1H), 5.83 – 5.75 (m, 1H), 2.66 
(qd, J = 7.5, 1.7 Hz, 2H), 1.39 – 1.18 (m, 10H), 0.88 (t, J = 6.9 Hz, 3H)
13
C NMR (101 MHz, CDCl3): δ =  171.34, 153.73, 118.95, 31.91, 29.37, 29.22, 29.10, 27.08, 
22.78, 14.22
LC-MS (ESI): tR = 9.28 min, calcd. for C10H17O2
-
[M-H]
-
: 169.12, found 169.54
Fmoc-D-Cit-OH (3):
H-D-Cit-OH (500 mg, 2.85 mmol) was dissolved in water (10 ml) and NaHCO3 (479 mg, 
5.7 mmol) was added under stirring. The resulting solution was cooled to 0 °C and Fmoc-OSu 
(1.44 g, 4.28 mmol) was slowly added as a solution in dioxane (10 ml). The resulting solution 
was stirred at 0 °C for 1 h and allowed to warm to rt while stirring overnight. Subsequently, 
water (10 ml) was added and the aqueous layer was extracted twice with EtOAc. The organic 
layer was re-extracted twice with sat. NaHCO3. The combined aqueous layers were acidified 
to a pH of 1 by addition of 1 N HCl and then extracted three times with EtOAc. The 
combined organic layers were dried (Na2SO4) and concentrated. The obtained residue was 
purified by flash chromatography (SiO2, DCM/MeOH 9:1) which led to the desired product.
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Yield: 0.953 g (2.4 mmol, 85%) as a colorless solid
TLC (DCM/MeOH = 9:1): Rf = 0.2
1
H NMR (400 MHz, CDCl3): δ = 7.72 (d, J = 7.5 Hz, 2H), 7.61 – 7.51 (m, 2H), 7.35 (t, J = 
7.4 Hz, 2H), 7.26 (td, J = 7.5, 1.1 Hz, 2H), 4.41 – 4.28 (m, 2H), 4.19 (dt, J = 13.8, 6.0 Hz, 
2H), 3.09 (t, J = 6.7 Hz, 2H), 1.84 (td, J = 13.4, 7.9 Hz, 1H), 1.75 – 1.59 (m, 1H), 1.60 – 1.44 
(m, 2H) 
13
C NMR (101 MHz, CDCl3): δ = 174.31, 160.31, 156.67, 143.78, 143.63, 141.19, 127.62, 
126.98, 124.95, 119.83, 66.85, 57.55, 53.49, 47.03, 39.34, 29.29, 25.84
LC-MS (ESI): tR = 7.70 min, calcd. for C21H24N3O5
+
[M+H]
+
: 398.17, found 398.00
Boc-L-allo-Thr-OH (4):
L-allo-Thr-OH (1 g, 8.38 mmol) was dissolved in 10% aqueous Na2CO3 (20 ml) and cooled to 
0 °C in an ice-bath. A solution of Boc2O in dioxane (20 ml) was added dropwise. The reaction 
mixture was allowed to warm to rt and stirred 16 h at ambient temperature. After that, all 
volatiles were removed using reduced pressure and the residue was taken up in EtOAc/1 N 
HCl (1:1, 50 ml). The organic layer was separated, dried over Na2SO4, filtered and 
concentrated. 
Yield: 1.7 g (7.8 mmol, 93%) as a colorless glasslike solid
1
H NMR (400 MHz, CDCl3): δ = 5.70 (s, 1H), 4.27 (d, J = 47.8 Hz, 1H), 4.16 (s, 1H), 1.43 (s, 
9H), 1.32 – 1.22 (m, 3H)
13
C NMR (101 MHz, CDCl3): δ = 174.00, 156.62, 85.35, 80.89, 69.33, 28.40, 27.54, 18.96
LC-MS (ESI): tR = 2.76 min, calcd. for C9H16NO5
-
[M-H]
-
: 218.10, found 218.48
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L-threo-β-hydroxyaspartic acid (8):
Enantioresolution of D,L-threo-β-hydroxyaspartic acid: Enantioresolution of D,L-tHyAsp was 
performed following the described method of Bionda and coworkers.
117
A racemic mixture of 
D,L-tHyAsp (purchased from TCI Deutschland GmbH) (2 g, 13.68 mmol) was dissolved in 
water (16 ml) by smooth heating (~40 °C). L-lysine in a salt-free form (1.96 g, 13.68 mmol) 
was subsequently added to this solution. After dissolution of all compounds, MeOH (13 ml) 
was added in small portions. The resulting mixture was slowly cooled to rt and then cooled to 
4°C and kept overnight to crystallize. Precipitated crystals were filtered off, washed with a 
small amount of cold MeOH and recrystallized from water (10.6 ml) by addition of MeOH 
(8.6 ml). Crystals consisting of [L-Lys*L-tHyAsp] were collected by filtration and dried under 
reduced pressure. Subsequently, the ion-exchanger resin DOWEX 1x4-50 was loaded into a 
column and converted to the OH
-
-form by washing with 5 to 10 volumes of 1 M NaOH. The 
resin was thereby washed slowly to ensure that the whole washing procedure last at least 1 h. 
Next, the resin was washed with H2O(dest.) until the pH of the eluent was neutral. Then, the 
resin was flushed with 1 N AcOH which converted the resin to its acetate form. The excess of 
acetic acid was rinsed off by applying H2O(dest.) again until the pH was neutral. The previously 
obtained crystals were dissolved in water (2 ml) and applied on the ion-exchanger. Once L-
Lys was eluted from the column by using 0.5 M AcOH as the eluent, the eluent was changed 
to 2 M AcOH to elute enantiomerically pure L-tHyAsp. Fractions containing L-tHyAsp were 
combined and evaporated yielding the title compound, which was used in the next steps 
without any further purification.
Yield: 0.64 g (4.3 mmol, 63 %) as a colorless solid
1
H NMR (400 MHz, DMSO): δ = 4.08 (d, J = 8 Hz, 1H), 3.82 (d, J = 8 Hz, 1H)
13
C NMR (101 MHz, DMSO): δ = 172.74, 168.57, 66.74, 54.02
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Boc-L-threo-β-HyAsp(OMe)-OH (9):
8 (135 mg, 0.73 mmol) was dissolved in a solution of concentrated HCl (120 µl) in MeOH 
(3 ml) at 0 °C. The reaction mixture was refluxed for 3 h, allowed to cool to rt and 
concentrated using reduced pressure. The crude product was dried under high vacuum and 
used without further purification in the following reaction. The free amine was dissolved in an 
aqueous solution of 10% Na2CO3 (3 ml) at 0 °C. Next, a solution of Boc2O (0.488 g, 
2.19 mmol) in dioxane (3 ml) was added dropwise and the resulting mixture was stirred at rt 
overnight. After removing all volatiles using a rotary evaporator, the residue was dissolved in 
EtOAc and washed with 1 N HCl. The organic layer was separated, dried (Na2SO4) and 
concentrated to dryness. The crude product was purified using flash chromatography (SiO2, 
DCM/MeOH: 5:1) thereby yielding the title compound.
Yield: 194 mg (0.72 mmol, 98%) as colorless oil
TLC (DCM/MeOH = 5:1): Rf = 0.33 (smeary)
[α]
22
D:  +18 (c 1.00, MeOH)
1
H NMR (400 MHz, MeOD): δ = 4.73 (d, J = 1.9 Hz, 1H), 4.56 (d, J = 22.0 Hz, 1H), 3.75 (d, 
J = 11.5 Hz, 3H), 1.43 (s, 9H)
13
C NMR (101 MHz, MeOD): δ = 173.85, 157.58, 80.82, 72.51, 58.30, 52.88, 28.59
LC-MS (ESI): tR = 5.16 min, calcd. for C10H17NNaO7
+
[M+Na]
+
: 286.09, found 286.63
Boc-L-threo-β-HyAsn-OH (10):
9 (250 mg, 0.95 mmol) was transferred to a 50 ml round bottom flask and dissolved in 7 M 
NH3 in MeOH (20 ml). The flask was sealed properly using a septum and the solution was 
stirred for 4 days at rt until reaction was completed according to LC/MS analysis. The 
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reaction mixture was concentrated to dryness and used in the following steps without further 
purification.
Yield: 230 mg (0.93 mmol, 98%) as colorless oil
TLC (DCM/MeOH = 5:1): Rf = 0.3 (smeary)
[α]
22
D:  -9 (c 1.00, MeOH)
1
H NMR (400 MHz, MeOD): δ = 4.67 (s, 1H), 4.52 (s, 1H), 1.43 (s, 9H)
13
C NMR (101 MHz, MeOD): δ = 178.06, 157.84, 80.71, 73.47, 66.82, 28.81
LC-MS (ESI): tR = 3.92 min, calcd. for C9H16N2NaO6
+
[M+Na]
+
: 271.09, found 271.90
Boc-L-threo-β-HyAsn-OBn (11):
A solution of 10 (468 mg, 1.89 mmol) in DMF (10 ml) was cooled to 0 °C. Subsequently, the 
solution was treated with NaHCO3 (317 mg, 3.77 mmol) and benzyl bromide (894 µl, 
5.22 mmol). The resulting reaction mixture was stirred for 2 h at 0 °C and then for 24 h at rt. 
H2O (50 ml) was added to quench the reaction. The obtained aqueous mixture was extracted 
three times with EtOAc. The organic layers were separated, combined and washed three times 
with H2O. The organic layer was dried (Na2SO4), filtered and concentrated. Finally, the crude 
product was purified using flash chromatography (SiO2, DCM/MeOH: 30:1) yielding the title 
compound.
Yield: 418 mg (1.24 mmol, 66%) as a colorless solid
TLC (DCM/MeOH = 9:1): Rf = 0.5
[α]
22
D:  -18 (c 1.00, MeOH)
1
H NMR (400 MHz, MeOD): δ = 7.45 – 7.27 (m, 5H), 5.21 (s, 2H), 4.71 (d, J = 1.9 Hz, 1H), 
4.57 (t, J = 10.1 Hz, 1H), 1.38 (s, 9H)
13
C NMR (101 MHz, MeOD): δ = 176.53, 172.03, 158.10, 137.12, 129.54, 129.26, 129.11, 
80.93, 72.76, 68.25, 58.16, 28.62
LC-MS (ESI): tR = 6.70 min, calcd. for C16H22N2NaO6
+
[M+Na]
+
: 361.14, found 361.85
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Fmoc-L-threo-β-HyAsn-OBn (12):
11 (400 mg, 1.18 mmol) was dissolved in 4 N HCl in dioxane (10 ml) and stirred for 2 h at rt. 
Next, all volatiles were removed using rotary evaporation. The obtained residue was dried 
under high vacuum for at least 2 h. The resulting solid was dissolved in H2O (9 ml), NaHCO3
(200 mg, 2.38 mmol) was added and the solution was cooled to 0 °C. To this solution was 
added Fmoc-OSu (616 mg, 1.82 mmol) as a solution in ice-cold dioxane (9 ml). The reaction 
mixture was stirred overnight at rt. Afterwards, the solution was diluted by addition of EtOAc 
(70 ml) and saturated aqueous NaHCO3 (50 ml). The aqueous layer was separated and 
extracted three times with EtOAc. The organic layers were combined, dried (Na2SO4), filtered 
and concentrated. The resulting residue was dissolved in a minimum of 20% MeOH in CHCl3
and the title compound precipitated by addition of cyclohexane.
Yield: 544 mg (1.18 mmol, >98%) as a white solid
TLC (DCM/MeOH = 19:1): Rf = 0.3 
[α]
22
D:  -16 (c 0.80, CHCl3)
1
H NMR (400 MHz, MeOD): δ = δ 7.80 (d, J = 7.7 Hz, 2H), 7.65 (d, J = 7.5 Hz, 2H), 7.40 –
7.26 (m, 9H), 5.26 – 5.17 (m, 2H), 4.66 – 4.62 (m, 1H), 4.36 (dd, J = 10.0, 6.7 Hz, 1H), 4.22 
(m, 2H)
13
C NMR (101 MHz, MeOD): δ = 176.46, 171.75, 158.82, 145.27, 142.52, 137.10, 129.55, 
129.26, 129.09, 128.78, 128.21, 126.36, 126.28, 120.89, 72.81, 68.33, 58.62
LC-MS (ESI): tR = 8.33 min, calcd. for C26H25N2O6
+
[M+H]
+
: 461.17, found 461.53
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Fmoc-L-threo-β-HyAsn(Trt)-OBn (13):
12 (544 mg, 1.18 mmol) and triphenylmethanol (3.07 g, 11.8 mmol) were suspended in acetic 
acid (10 ml) and heated to 50 °C. To this mixture, a catalytic amount of conc. H2SO4 (41 µl, 
0.706 mmol) was added. The resulting muddy mixture was stirred at 50 °C for 2.5 h. After 
cooling to rt, the reaction mixture was diluted by addition of EtOAc (70 ml) and washed with 
a saturated, aqueous NaHCO3 solution (100 ml). The organic layer was separated and the 
aqueous layer was extracted once more with EtOAc. The organic layers were combined, dried 
(Na2SO4), filtered and concentrated using rotary evaporation. The crude product was purified 
by flash chromatography (SiO2, CH/EA: 5:1) yielding the desired product.
Yield: 608 mg (0.87 mmol, 74%) as a white solid
TLC (CH/EA = 2:1): Rf = 0.3 
[α]
22
D:  -12 (c 0.93, CHCl3)
1
H NMR (400 MHz, MeOD): δ = 7.82 – 7.72 (m, 2H), 7.75 – 7.58 (m, 2H), 7.41 – 7.13 (m, 
24H), 5.21 (s, 2H), 4.82 (d, J = 2.1 Hz, 1H), 4.68 – 4.62 (m, 1H), 4.52 (dd, J = 13.2, 9.7 Hz, 
1H), 4.17 (m, 2H)
13
C NMR (101 MHz, MeOD): δ = 172.19, 171.77, 158.93, 145.75, 145.32, 145.04, 142.56, 
142.47, 137.09, 129.87, 129.54, 129.29, 129.23, 129.01, 128.91, 128.80, 128.74, 128.24, 
128.12, 126.53, 126.22, 120.89, 73.42, 71.53, 68.59, 68.32, 58.63, 48.25
LC-MS (ESI): tR = 11.28 min, calcd. for C45H38N2NaO6
+
[M+Na]
+
: 725.26, found 726.26
Fmoc-L-threo-β-HyAsn-OH (5):
13 (608 mg, 0.87 mmol) was dissolved in ethanol (10 ml). 10 wt. % Pd/C (60.8 mg, 
0.57 mmol) was carefully added to the solution. The atmosphere within the flask was 
exchanged to 1 atm H2 and stirred for 1 h. The catalyst was removed by filtration through a 
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pad of Celite and the filter cake was rinsed with ethanol. The filtrate was evaporated to 
dryness under reduced pressure and the residue was purified by flash chromatography (SiO2, 
CHCl3CHCl3/MeOH 1:1) which delivered the desired product. 
Yield: 401 mg (0.66 mmol, 76%) as a colorless glasslike solid
TLC (DCM/MeOH = 1:1): Rf = 0.3 (smeary)
[α]
22
D:  -16 (c 1.00, CHCl3/MeOH 1:1)
1
H NMR (400 MHz, DMSO): δ = 8.40 (s, 1H), 7.89 (dd, J = 7.5, 2.7 Hz, 2H), 7.81 (d, J = 7.5 
Hz, 1H), 7.77 (d, J = 7.5 Hz, 1H), 7.40 (dd, J = 7.4, 3.5 Hz, 2H), 7.25 – 7.13 (m, 18H), 4.47 
(d, J = 2.1 Hz, 1H), 4.44 – 4.29 (m, 2H), 4.19 (t, J = 6.6 Hz, 2H)
13
C NMR (101 MHz, DMSO): δ = 173.83, 170.19, 156.29, 144.59, 143.75, 140.66, 128.40, 
127.58, 127.06, 126.61, 125.56, 125.43, 120.03, 72.25, 69.16, 66.01, 57.19, 46.62
LC-MS (ESI): tR = 10.19 min, calcd. for C38H32N2NaO6
+
[M+H]
+
: 635.22, found 635.59
Fmoc-L-Asn(Trt)-ol (6):
Fmoc-L-Asn(Trt)-OH (2.98 g, 5 mmol) was dissolved in THF (5 ml) and cooled to -10 °C. To 
this solution were added successively N-methyl morpholine (0.604 ml, 5.5 mmol) and 
isobutyl chloroformate (0.72 ml, 5.5 mmol). After 5 min., a solution of NaBH4 (0.24 g, 
6.3 mmol) in H2O (6.3 ml) was added at once (strong gas evolution was observed). The 
mixture was stirred for 0.5 h and then quenched by addition of a saturated aqueous NaHCO3
solution (20 ml). The product was extracted twice with EtOAc (2x 40 ml). The organic layers 
were combined and washed extensively with 1 M KHSO4 and brine, dried over Na2SO4, 
filtered and concentrated under reduced pressure which delivered the title compound.
Yield: 2.75 g (4.73 mmol, 94%) as a white solid
[α]
22
D:  +17 (c 1.00, DCM)
1
H NMR (400 MHz, MeOD): δ = 7.77 (d, J = 7.5 Hz, 2H), 7.61 (t, J = 6.9 Hz, 2H), 7.36 (t, J 
= 7.4 Hz, 2H), 7.23 (d, J = 17.9 Hz, 17H), 4.48 – 4.24 (m, 2H), 4.15 (dd, J = 13.1, 6.8 Hz, 
1H), 3.96 (d, J = 5.7 Hz, 1H), 3.46 (tt, J = 34.9, 17.4 Hz, 2H), 2.59 – 2.40 (m, 2H) 
13
C NMR (101 MHz, MeOD): δ = 170.84, 156.57, 144.28, 143.93, 141.43, 128.72, 128.16, 
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127.86, 127.34, 127.23, 125.20, 120.12, 71.01, 67.02, 64.31, 50.12, 47.29, 39.45
LC-MS (ESI): tR = 10.26 min, calcd. for C38H34N2NaO4
+
[M+Na]
+
: 605.24, found 605.71
General methods for solid phase peptide synthesis (SPPS) using the Fmoc-
strategy
Method A: Fmoc-determination:
Loadings of Fmoc-protected peptide resins were quantitatively determined using a UV/Vis 
spectrophotometer. For Fmoc-determinations, a small sample of ~5 mg of dried resin was 
added to a 25 ml conical flask and the portion was weighted exactly. A freshly prepared 20% 
piperidine in DMF solution (5 ml) was added (in total 10 ml of the 20% piperidine/DMF was 
prepared, either for serial dilution of the sample and as a reference). The resulting suspension 
was shaken at rt on an orbital shaker for 20 min. The resin within the flask was allowed to 
settle down and the UV absorption of 1 ml (or a dilution thereof) of the cleavage solution was 
measured at λ = 301 nm. The measured value which was adjusted by dilution of the sample 
was always between 0.1 and 1 to ensure accurate results. The measurements were repeated at 
least three times. The loading of the resin was calculated using the following equation and 
used in subsequent steps to calculate resin amount and/or reagent equivalents.
 =
∙∙	

∙∙
[2]
c = resin load (mmol/g)
A301 = absorption value, λ = 301 nm
V = Volume of cleavage solution 
F = dilution factor (e.g. 3, 5…)
ε301 = extinction coefficient (7800 M
-1
cm
-1
)
d = thickness of cuvette 
m = weighed mass of the resin
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Method B: Amino acid coupling condition
All subsequent amino acid couplings were performed in a syringe reactor using the 
corresponding Fmoc-amino acids (4 eq.) and HOBt (4 eq.), HBTU (4 eq.) and DIPEA (4 eq.) 
(always 4 eq. if not specified in the experimental description). To this end, the respective 
Fmoc-Nα-amino acid, HOBT, HBTU and DIEA were dissolved in an adequate amount of 
DMF (~5 ml) and stirred for a few minutes in a separate flask to preactivate the amino acid. 
This solution was then added to a syringe reactor containing the resin and the suspension was 
shaken for 2 h at rt. Finally, the reaction solution was discarded and the resin was washed 
sequentially with 3 x DMF, 3 x DCM, 3 x MeOH, 3 x DCM and 3 x DMF.
Method C: Kaiser test
Amino acid coupling reactions were monitored by the Kaiser test to evaluate the efficiency of 
amide bond formation as the Kaiser test allows to determine the presence of primary amines 
on solid support. For the Kaiser test, the following solutions were used: 
Solution I: 5% Ninhidrin in ethanol
Solution II: 20% phenol in ethanol
Solution III: 0.4 ml of 0.001 M KCN(aq) in pyridine (20 ml)
A few resin beads were transferred into a small glass tube. 3 drops of solution I, 2 drops of 
solution II and 3 drops of solution III were sequentially added and the resulting suspension 
was mixed well and placed for 5 min in a pre-heated oven (100 °C). The formation of a blue 
solution indicated the presence of primary amines. To reduce the occurrence of false negative 
results, a positive control was always performed in parallel. 
Method D: Base induced cleavage of Fmoc protection group
A solution of 20% piperidine in DMF was added to the resin and this suspension was agitated 
for 15 min. The cleavage solution was discarded. This procedure was repeated once more. 
Afterwards the resin was extensively washed by an alternation of 3 x DMF, 3 x DCM, 3 x 
MeOH, 3 x DCM and 3x DMF.
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Method E: Pd catalyzed cleavage of the Alloc protecting group
The resin was washed extensively with DCM and subsequently dried overnight under high 
vacuum. The dried resin was transferred to a flame dried conical 25 ml flask under argon 
atmosphere. Anhydrous and degassed DCM (3 ml) was added to the resin and to this 
suspension degassed morpholine (24 eq.) was added dropwise followed by a degassed 
solution of Pd(PPh3)4 (0.25 eq.) in anhydrous DCM (2 ml). The resulting reaction suspension 
was shaken under an argon atmosphere and light exclusion on an orbital shaker for 90 min at 
rt. The reaction suspension was transferred into a syringe reactor and washed 3 x with DCM, 
3 x DMF, 3 x with a 0.02 M solution of Et2NCS2Na in NMP and 5 x with DMF.
Method F: Microcleavage for LC/MS analysis
After a critical synthetic step or if the Kaiser test (method C) showed incomplete couplings, a 
microcleavage was implemented to analyze a small amount of the intermediate product by 
LC/MS analysis. To this end, 1-2 mg of resin beads was transferred to a separate, small 
syringe reactor (2 ml). The cleavage cocktail (95% TFA, 2.5% TIS, 2.5% H2O, 500 µl) was 
added and the resulting suspension was shaken for 1 h at rt. The solution was transferred to a 
small 5 ml flask and all volatiles were removed under reduced pressure. The crude residue 
was dissolved in H2O/ACN (1:1, 500 µl), filtered, transferred to a LC/MS vial and injected in 
a LC-MS apparatus.
Method G: Final cleavage of side-chain protecting groups and cleavage of peptidyl alcohols 
from 2-chlorotrityl resin
The cleavage cocktail (95% TFA, 2.5% TIS, 2.5% H2O, 5 ml) was added to the peptide-
loaded resin. The resulting suspension was agitated for 2 h at rt, then filtered and transferred 
to a 50 ml falcon tube. This falcon tube was replenished with ice-cold diethyl ether to 
precipitate the crude peptidyl alcohols. The suspension was put into the freezer for 15 min, 
then the precipitate was isolated by centrifugation (2200 g, 15 min, 4°C), decanted and the 
obtained pellet washed with ice-cold diethyl ether (40 ml) and centrifuged once more. Finally, 
the crude pellet was dried under a continuous stream of N2-gas.
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Method H: Preparative HPLC purification of peptidyl alcohols 
A maximal amount of 50 mg crude product was dissolved in ACN/H2O + 0.1% TFA (1:4, 
5 ml). Linear gradients of solvent B (0.1% TFA in acetonitrile) in solvent A (0.1% TFA in 
water) were applied at a 25 ml/min flow rate and a peak detection at 210 nm. The binary 
gradient was adjusted according to the polarity of the product (elution time ~ 30-40 min). 
Fractions (each 18 ml) were collected corresponding to product peak. ACN was removed by 
rotary evaporation at reduced pressure. The aqueous solution was finally lyophilized. 
7.2.2 Solid phase synthesis of Rotihibin A
Coupling of 6 to 2-Chlorotrityl chloride resin (14):
2-Chlorotrityl resin (250 mg, c = 1.22 mmol/g) was transferred into a flame dried 
Rosenbaum-reactor under an argon atmosphere. Separately, 6 (532.5 mg, 0.915 mmol) was 
dissolved in anhydrous DCM (8 ml) and pyridine (147 µl, 1.83 mmol) was added. This 
solution was transferred to the Rosenbaum-reactor and the suspension was shaken on an 
orbital shaker for 16 h under an argon atmosphere. Methanol (4 ml) was added and the 
mixture was shaken for further 30 min to terminate the reaction and to quench the resin. The 
loaded resin was washed alternately with DCM (3x), DMF (3x) and again with DCM (3x) and 
then dried under high vacuum. The loading of the resin was quantified using method A. 
Loading: 0.3 mmol/g (25%) 
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Solid phase synthesis of Rotihibin A (1):
General procedure I: Solid phase synthesis using Fmoc-strategy
The resin 14 (250 mg, 0.075 mmol) was placed in a syringe reactor and the Fmoc-protecting
group was removed using method D. The coupling of 5 was performed according to method 
B. To this end, 2 eq. of 5 were used. The quantities of the reagents were as follows:
5: 92 mg, 0.15 mmol
HBTU: 56.8 mg, 0.15 mmol
HOBT: 20 mg, 0.15 mmol
DIPEA: 25 µl, 0.15 mmol
DMF: 5 ml
After this step, a microcleavage, performed according to method F, showed a complete 
turnover.
Deprotection of the Fmoc-protecting group was performed using method D. The coupling of 
Fmoc-Dab(Alloc)-OH was performed according to method B. The quantities of the reagents 
were as follows:
Fmoc-L-Dab(Alloc)-OH: 127.3 mg, 0.3 mmol
HBTU: 113.7 mg, 0.3 mmol
HOBT: 40 mg, 0.3 mmol
DIPEA: 50 µl, 0.3 mmol
DMF: 5 ml
Cleavage of the Alloc-protecting group of CTC-asparaginol(Trt)-hyAsn(Trt)-Dab(Alloc)-
Fmoc was carried out using method E. A Kaiser test, performed according to method C,
showed the presence of primary amines which ensured full Alloc-cleavage. 
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The subsequent coupling of 4 was performed according to method B. The quantities of the 
reagents were as follows:
4: 60.3 mg, 0.3 mmol
HBTU: 113.7 mg, 0.3 mmol
HOBT: 40 mg, 0.3 mmol
DIPEA: 50 µl, 0.3 mmol
DMF: 5 ml
Cleavage of the Fmoc-protection group of CTC-asparaginol(Trt)-hyAsn(Trt)-Dab(Boc-allo-
Thr)-Fmoc was carried out using method D. 
The coupling of Fmoc-L-Ser(OtBu)-OH was performed corresponding to method B. The 
quantities of the reagents were as follows:
Fmoc-L-Ser(OtBu)-OH: 115 mg, 0.3 mmol
HBTU: 113.7 mg, 0.3 mmol
HOBT: 40 mg, 0.3 mmol
DIPEA: 50 µl, 0.3 mmol
DMF: 5 ml
Cleavage of the Fmoc-protection group of CTC-asparaginol(Trt)-hyAsn(Trt)-Dab(Boc-allo-
Thr)-Ser(OtBu)-Fmoc was carried out using method D. 
The subsequent coupling of 3 was performed corresponding to method B. The quantities of 
the reagents were as follows:
3: 120 mg, 0.3 mmol
HBTU: 113.7 mg, 0.3 mmol
HOBT: 40 mg, 0.3 mmol
DIPEA: 50 µl, 0.3 mmol
DMF: 5 ml
Cleavage of the Fmoc-protection group of CTC-asparaginol(Trt)-hyAsn(Trt)-Dab(Boc-allo-
Thr)-Ser(OtBu)-Cit-Fmoc was carried out using method D. 
The coupling of 2 was performed corresponding to method B. The quantities of the reagents 
were as follows:
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2: 51.6 mg, 0.3 mmol
HBTU: 113.7 mg, 0.3 mmol
HOBT: 40 mg, 0.3 mmol
DIPEA: 50 µl, 0.3 mmol
DMF: 5 ml
The final cleavage of side-chain protecting groups and the cleavage from 2-chlorotrityl resin 
were carried out in one step according method G. The preparative purification was conducted 
via RP-HPLC corresponding to method H, which yielded the desired product.
Yield: 19.8 mg (0.0234 mmol, 31% overall yield) as a white solid
[α]
23
D:  +8 (c 0.50, DMSO)
1
H NMR (400 MHz, DMSO): δ = 8.37 (t, J = 5.4 Hz, 1H), 8.32 (d, J = 7.1 Hz, 1H), 8.07 (d, J 
=  7.2 Hz, 1H) 8.05 (d, J =  7.6 Hz, 1H), 7.99 (s br., 2H), 7.53 (d, J = 8.8 Hz, 1H), 7.39 (d, J = 
8.3 Hz, 1H), 7.34 (s, 1H), 7.25 (d, J = 2 Hz, 1H), 7.17 (d, J = 2 Hz, 1H), 6.83 (s, 1H), 5.96 (m, 
1H), 5.92 (m, 1H), 5.88 (d, J = 11.6 Hz, 1H), 5.82 (d, J = 5.9 Hz, 1H), 5.50 (d, J = 4.2 Hz, 
1H), 5.38 (s, 2H), 5.10 (t, J = 5.2 Hz, 1H), 4.67 (t, 5.6 Hz, 1H), 4.54 (dd, J = 2.4, 8.8 Hz, 1H), 
4.36 (m, 2H), 4.29 (dd, J = 2.4, 6 Hz, 1H), 4.26 (dd, J = 7.2, 14 Hz, 1H), 4.05 (m, 2H), 3.69 
(d, J = 4.6 Hz, 1H), 3.60 (m, 2H), 3.38 (m, 2H), 3.16 (m, 2H), 2.94 (m, 2H), 2.65 (m, 1H), 
2.54 (m, 1H), 2.38 (dd, J  = 6.4, 14.8 Hz, 1H), 2.23 (dd, J = 6.8, 14.8 Hz, 1H), 1.89 (m, 1H), 
1.73 (m, 1H), 1.61 (m, 1H), 1.49 (m, 1H), 1.35 (m, 4H), 1.24 (m, 8H), 1.06 (d, J = 6.5 Hz, 
3H), 0.85 (t, J = 6.9 Hz, 3H)
13
C NMR (101 MHz, DMSO): δ = 173.18, 172.76, 172.03, 170.87, 170.64, 168.75, 166.22, 
165.70, 158.80, 144.74, 122.52, 70.97, 64.78, 62.47, 61.65, 57.49, 55.50, 54.59, 52.00, 51.35, 
48.67, 36.47, 35.86, 31.20, 30.98, 29.65, 28.72, 28.51, 27.91, 26.62, 26.57, 22.04, 17.72, 
13.93
LC-MS (ESI): tR = 4.89 min, calcd. for C35H64N11O13
+
[M+H]
+
: 846.47, found 846.52
HR-MS (ESI): calcd. for C35H64N11O13
+
[M+H]
+
: 846.468, found 846.469
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7.2.3 Solid phase synthesis of Rotihibin A-derivatives
Solid phase synthesis of RotA-DB (15):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H which yielded 
the title compound.
Yield: 16.2 mg (0.019 mmol, 26% overall yield) as a white solid
1
H NMR (400 MHz, DMSO-d6): δ = 8.37 (t, J = 5.4 Hz, 1H), 8.28 (d, J = 7.2 Hz, 1H), 8.04 
(d, J = 7.6 Hz, 1H), 7.98 (m, 3H), 7.52 (d, J = 8.7 Hz, 1H), 7.37 (d, J = 8 Hz, 1H), 7.34 (s, 1H) 
7.25 (d, J = 2 Hz, 1H), 7.18 (d, J = 2 Hz, 1H), 6.86 (s, 1H), 5.92 (t, J = 5.9 Hz, 1H), 5.80 (d, J 
= 5.9 Hz, 1H), 5.49 (d, J = 4.2 Hz, 1H), 5.37 (s, 2H), 5.07 (t, J = 5.3 Hz, 1H), 4.67 (t, J = 5.4 
Hz, 1H), 4.53 (dd, J = 8.8, 2.3 Hz, 1H), 4.34 (m, 1H), 4.27 (m, 3H), 4.05 (m, 2H), 3.69 (s, 
1H), 3.60 (m, 2H), 3.37 (m, 2H), 3.19 (m, 2H), 2.94 (m, 2H), 2.36 (dd, J = 6.4, 14.8 Hz, 1H), 
2.23 (dd, J = 6.4, 14.8 Hz, 1H), 2.11 (m, 2H), 1.89 (m, 1H), 1.74 (m, 1H), 1.58 (m, 1H), 1.45 
(m, 3H), 1.26 (m, 12H), 1.06 (d, J = 6.5 Hz, 3H), 0.86 (t, J = 6.8 Hz, 3H)
LC-MS (ESI): tR = 5.02 min, calcd. for C35H66N11O13
+
[M+H]
+
: 848.48, found 849.09
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Solid phase synthesis of RotA-L-Cit (16):
The synthesis was carried out following the general procedure I and by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H, which yielded 
the title compound.
Yield: 21.0 mg (0.025 mmol, 33% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.35 (t, J = 5.4 Hz, 1H), 8.18 (d, J = 7.2 Hz, 1H), 8.04 (d, J 
=  7.6 Hz, 1H) 8.03 (d, J =  7.6 Hz, 1H), 7.99 (s br., 2H), 7.61 (d, J = 9.2 Hz, 1H), 7.45 (d, J = 
8.4 Hz, 1H), 7.34 (s, 1H), 7.25 (d, J = 2 Hz, 1H), 7.17 (d, J = 2 Hz, 1H), 6.87 (s, 1H), 5.94 (m, 
2H), 5.89 (m, 1H), 5.84 (m, 1H), 5.50 (d, J = 4.0 Hz, 1H), 5.39 (s, 2H), 5.04 (t, J = 5.2 Hz, 
1H), 4.68 (t, 5.6 Hz, 1H), 4.56 (dd, J = 2.4, 8.8 Hz, 1H), 4.35 (m, 2H), 4.29 (m, 2H), 4.05 (m, 
2H), 3.69 (m, 2H), 3.62 (m, 2H), 3.37 (m, 2H), 3.18 (m, 2H), 2.94 (m, 2H), 2.59 (m, 2H), 
2.38 (dd, J  = 6.4, 14.8 Hz, 1H), 2.23 (dd, J = 6.8, 14.8 Hz, 1H), 1.89 (m, 1H), 1.73 (m, 1H), 
1.64 (m, 1H), 1.49 (m, 1H), 1.35 (m, 4H), 1.24 (m, 8H), 1.06 (d, J = 6.5 Hz, 3H), 0.85 (t, J = 
6.9 Hz, 3H)
LC-MS (ESI): tR = 5.04 min, calcd. for C35H64N11O13
+
[M+H]
+
: 846.47, found 846.75
HR-MS (ESI): calcd. for C35H64N11O13
+
[M+H]
+
: 846.468, found 846.468
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Solid phase synthesis of RotA-hyAsn (17):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H, which yielded 
the title compound.
Yield: 24.6 mg (0.034 mmol, 45% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.35 (t, J = 5.2 Hz, 1H), 8.17 (d, J = 7.4 Hz, 1H), 8.11 (d, J 
= 7.6 Hz, 1H), 8.08 (d, J = 7.6 Hz, 1H), 7.99 (s br., 2H), 7.45 (d, J = 8.2 Hz, 1H), 7.19 (s, 1H), 
6.79 (s, 1H), 5.96 (m, 1H), 5.92 (m, 1H), 5.87 (d, J = 11.6 Hz, 1H), 5.49 (d, J = 4.2 Hz, 1H), 
5.37 (s, 2H), 5.11 (t, J = 5.2, 1H), 4.66 (s, 1H), 4.32 (m, 2H), 4.20 (m, 1H), 4.02 (m, 2H), 3.66 
(m, 2H), 3.57 (m, 1H), 3.21 (m, 1H), 3.10 (m, 1H), 2.95 (m, 2H), 2.65 (m, 1H), 2.54 (m, 1H), 
2.32 (dd, J  = 6.4, 14.8 Hz, 1H), 2.14 (dd, , J = 6.4, 14.8 Hz, 1H), 1.94 (m, 1H), 1.72 (m, 1H), 
1.61 (m, 1H), 1.50 (m, 1H), 1.36 (m, 4H), 1.24 (m, 8H), 1.06 (d, J = 6.5 Hz, 3H), 0.85 (t, J = 
6.4 Hz, 3H)
LC-MS (ESI): tR = 4.94 min, calcd. for C31H58N9O10
+
[M+H]
+
: 716.43, found 716.73
HR-MS (ESI): calcd. for C31H58N9O10
+
[M+H]
+
: 716.430, found 716.431
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Solid phase synthesis of RotA-L-Asn (18):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H, which yielded 
the title compound.
Yield: 3.64 mg (0.0043 mmol, 6% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.37 (t, J = 5.4 Hz, 1H), 8.22 (d, J = 5.6 Hz, 1H), 8.1 (m, 
2H), 7.98 (s br., 2H), 7.61 (m, 1H), 7.55 (m, 1H), 7.31 (s, 1H), 7.26 (s, 1H), 6.91 (s, 1H), 6.81 
(s, 1H), 5.96 (m, 2H), 5.89 (m, 1H), 5.49 (d, J = 3.2 Hz, 1H), 5.37 (s, 2H), 5.12 (t, J = 4.0 Hz, 
1H), 4.64 (t, 4.4 Hz, 1H), 4.45 (m, 1H), 4.33 (m, 2H), 4.22 (m,  1H), 4.02 (m, 2H), 3.69 (d, J 
= 2.8 Hz, 1H), 3.62 (m, 2H), 3.20 (m, 2H), 2.94 (m, 2H), 2.67 (m, 1H), 2.54 (m, 1H), 2.35 (m, 
1H), 2.19 (dd, J = 65.6, 12.0 Hz, 1H), 1.89 (m, 1H), 1.73 (m, 1H), 1.61 (m, 1H), 1.49 (m, 1H), 
1.42 (m, 4H), 1.24 (m, 8H), 1.06 (d, J = 5.2 Hz, 3H), 0.85 (t, J = 5.2 Hz, 3H)
LC-MS (ESI): tR = 6.00 min, calcd. for C35H64N11O12
+
[M+H]
+
: 830.47, found 830.40
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Solid phase synthesis of RotA-Rh (19):
1 (1.5 mg, 1.7 µmol) was dissolved in DMF (0.5 ml). To this solution, Rhodamine B 
isothiocyanate (5 mg, 9.3 µmol) and DIPEA (5 µl, 29 µmol) were added. The reaction 
mixture was stirred in the dark at ambient temperature for 4 h. All volatiles were removed 
under reduced pressure and the residue was purified via HPLC according to method H.
Yield: 1.2 mg (0.9 µmol, 53%) as a purple solid
LC-MS (ESI): tR = 6.18 min, calcd. for C64H93N14O16S
+
[M+H]
+
: 1345.66, found 1345.77
Solid phase synthesis of RotA-Ac (20):
1 (1.5 mg, 1.7 µmol) was dissolved in DMF (0.5 ml). To this solution, Ac2O (20 µl, 
0.2 mmol) was added. The reaction mixture was stirred at ambient temperature for 2 h. All
volatiles were removed under reduced pressure which yielded the title compound.
Yield: 1.5 mg (1.7 µmol, quant.) as a white solid
LC-MS (ESI): tR = 5.39 min, calcd. for C37H66N11O14
+
[M+H]
+
: 888.48, found 888.56
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Solid phase synthesis of RotA-Ala (21):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H, which yielded 
the title compound.
Yield: 7.1 mg (8.5 µmol, 11% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.36 (t, J = 5.6 Hz, 1H), 8.20 (d, J = 7.2 Hz, 1H), 8.16 (d, J 
=  7.2 Hz, 1H), 7.99 (m, 3H), 7.47 (d, J = 8.4 Hz, 1H), 7.43 (d, J = 8.8 Hz, 1H), 7.33 (s, 1H), 
7.27 (d, J = 1.6 Hz, 1H), 7.13 (d, J = 1.6 Hz, 1H), 6.85 (s, 1H), 5.94 (m, 2H), 5.89 (m, 2H), 
5.50 (d, J = 2.0 Hz, 1H), 5.38 (s, 2H), 4.66 (s, 1H), 4.53 (dd, J = 2.4, 8.8 Hz, 1H), 4.31 (m, 
2H), 4.28 (m, 2H), 4.05 (m, 2H), 3.69 (t, J = 4.4 Hz, 1H),  3.31 (m, 2H), 3.18 (m, 2H), 2.94 
(m, 2H), 2.63 (m, 1H), 2.53 (m, 1H), 2.36 (dd, J  = 6.4, 14.8 Hz, 1H), 2.23 (dd, J = 6.8, 14.8 
Hz, 1H), 1.89 (m, 1H), 1.72 (m, 1H), 1.59 (m, 1H), 1.49 (m, 1H), 1.33 (m, 4H), 1.25 (m, 8H), 
1.23 (s, 3H), 1.06 (d, J = 6.4 Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H)
LC-MS (ESI): tR = 4.92 min, calcd. for C35H64N11O12
+
[M+H]
+
: 830.47, found 830.56
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Solid phase synthesis of RotA-Ala-hyAsn (22):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H, which yielded 
the title compound.
Yield: 4.1 mg (5.8 µmol, 7.8% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.33 (t, J = 5.2 Hz, 1H), 8.26 (d, J = 7.2 Hz, 1H), 8.07 (d, J 
=  7.2 Hz, 1H), 8.02 (d, J =  8.0 Hz, 1H), 7.99 (s br., 2H), 7.46 (d, J = 8.0 Hz, 1H), 7.23 (s, 
1H), 6.81 (s, 1H), 5.93 (m, 3H), 5.49 (s, 1H), 5.37 (s, 2H), 4.25 (m, 3H), 4.01 (m, 2H), 3.69 (t, 
J = 3.6 Hz, 1H), 3.60 (m, 2H), 3.31 (m, 2H), 3.14 (m, 2H), 2.94 (m, 2H), 2.63 (m, 1H), 2.54 
(m, 1H), 2.29 (dd, J  = 6.4, 14.8 Hz, 1H), 2.18 (dd, J = 6.8, 14.8 Hz, 1H), 1.87 (m, 1H), 1.72 
(m, 1H), 1.59 (m, 1H), 1.49 (m, 1H), 1.33 (m, 4H), 1.25 (m, 8H), 1.23 (s, 3H), 1.05 (d, J = 6.4 
Hz, 3H), 0.85 (t, J = 6.8 Hz)
LC-MS (ESI): tR = 4.98 min, calcd. for C31H58N9O9
+
[M+H]
+
: 700.44, found 700.64
7. EXPERIMENTAL PART 115
Solid phase synthesis of RotA-Phe (23):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling-steps were 
accomplished using method D, B and E. The analysis of the intermediate products was 
performed in compliance with method C and F. The final cleavage from 2-chlorotrityl resin 
and the preparative purification were conducted according to method G and method H, which 
yielded the title compound.
Yield: 4.0 mg (4.8 µmol, 6.5% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.35 (t, J = 5.6 Hz, 1H), 8.23 (d, J = 7.2 Hz, 1H), 8.17 (d, J 
=  7.6 Hz, 1H) 8.06 (d, J =  8.4 Hz, 1H), 7.93 (s br., 2H), 7.62 (d, J = 8.8 Hz, 1H), 7.45 (d, J = 
8.4 Hz, 1H), 7.35 (s, 1H), 7.25 (m, 5H), 7.16 (m, 2H), 6.87 (s, 1H), 5.84 (m, 3H), 5.49 (d, J = 
4.4 Hz, 1H), 5.09 (t, J = 5.2 Hz, 1H), 4.67 (t, 5.6 Hz, 1H), 4.62 (m, 1H), 4.56 (dd, J = 2.4, 8.8 
Hz, 1H), 4.36 (dd, J = 5.6, 13.2 Hz, 1H), 4.30 (dd, J = 2.4, 6 Hz, 1H), 4.03 (m, 2H), 3.69 (m, 
2H), 3.62 (m, 1H), 3.37 (m, 1H), 3.28 (m, 1H), 3.20 (m, 2H), 3.07 (m, 1H), 2.74 (m, 1H), 
2.40 (m, 2H), 2.23 (dd, J = 6.8, 14.8 Hz, 1H), 1.89 (m, 1H), 1.73 (m, 1H), 1.23 (m, 10H), 1.05 
(d, J = 6.4 Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H)
LC-MS (ESI): tR = 5.78 min, calcd. for C38H62N9O12
+
[M+H]
+
: 836.45, found 836.58
7. EXPERIMENTAL PART 116
Solid phase synthesis of RotA-Phe-hyAsn (24):
The synthesis was carried out following the general procedure I by the use of the 
corresponding building blocks. All subsequent deprotection- and coupling steps were 
accomplished using method D, B and E. The analysis of intermediate products was performed 
in compliance with method C and F. The final cleavage from 2-chlorotrityl resin and the 
preparative purification were conducted according to method G and method H which yielded 
the title compound.
Yield: 5.0 mg (7.1 µmol, 9.5% overall yield) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.32 (t, J = 6.0 Hz, 1H), 8.13 (d, J = 7.6 Hz, 1H), 8.08 (d, J 
=  7.6 Hz, 1H) 8.07 (d, J =  8.4 Hz, 1H), 7.93 (s br., 2H), 7.66 (d, J = 8.4 Hz, 1H), 7.25 (m, 
5H), 7.17 (m, 1H), 6.81 (s, 1H), 5.88 (m, 1H), 5.77 (m, 1H), 5.47 (d, J = 4.4 Hz, 1H), 5.11 (t,
J = 5.2 Hz, 1H), 4.71 (t, 5.6 Hz, 1H), 4.62 (m, 1H), 4.33 (dd, 6.2, 13.2 Hz, 1H), 4.25 (dd, J = 
8, 14.0 Hz, 1H), 4.03 (m, 2H), 3.66 (m, 2H), 3.58 (m, 1H), 3.34 (m, 1H), 3.28 (m, 1H), 3.14 
(m, 3H), 2.75 (m, 1H), 2.40 (m, 2H), 2.17 (dd, J = 6.8, 14.8 Hz, 1H), 1.89 (m, 1H), 1.70 (m, 
1H), 1.23 (m, 10H), 1.05 (d, J = 6.4 Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H)
LC-MS (ESI): tR = 5.92 min, calcd. for C34H56N7O9
+
[M+H]
+
: 706.41, found 706.64
7. EXPERIMENTAL PART 117
7.3 Synthesis of Brevicompanines
Boc-Trp(Boc)-OMe (31):
Freshly grounded NaOH (4 g, 100 mmol) was added to a solution of L-tryptophan methyl 
ester hydrochloride (5 g, 19.63 mmol) and tetrabutylammonium hydrogen sulfate (666 mg, 
1.963 mmol) in DCM (200 ml). This mixture was stirred for 2 h at rt. Di-tert-butyl 
dicarbonate (13.52 ml, 58.90 mmol) was added and the mixture was stirred o.n. at rt. This 
mixture was filtered through a pad of celite and evaporated in vacuo. The residue was purified 
by flash chromatography (30% EA inCH) to afford the title compound. 
Yield: 6.82 g (16.3 mmol, 83%) as colorless oil
TLC (EA/CH = 1:2): Rf = 0.6
1
H NMR (400 MHz, CDCl3): δ = 8.11 (d, J = 7.2 Hz, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.39 (s, 
1H), 7.34 – 7.27 (m, 1H), 7.22 (t, J = 7.4 Hz, 1H), 5.12 (d, J = 7.6 Hz, 1H), 4.65 (dd, J = 12.8, 
5.5 Hz, 1H), 3.69 (s, 3H), 3.22 (ddd, J = 34.8, 14.7, 5.4 Hz, 2H), 1.66 (s, 9H), 1.44 (s,  9H)
13
C NMR (101 MHz, CDCl3): δ = 172.38, 155.15, 149.64, 146.83, 135.44, 130.64, 124.57, 
124.15, 122.61, 118.95, 115.32, 115.15, 85.21, 83.70, 79.98, 53.77, 52.38, 28.38, 28.27, 
27.48.
LC-MS (ESI): tR = 10.85 min, calcd. for C22H30N2NaO6
+
[M+Na]
+
, 441.20, found  440.92 
7. EXPERIMENTAL PART 118
(2S,3aR,8aR)-1,8-di-tert-butyl-2-methyl-3a-(phenylselanyl)-3,3a-dihydropyrrolo[2,3-
b]indole-1,2,8(2H,8aH)-tricarboxylate (32a/b):
To a suspension of 31 (923 mg, 2.2 mmol), N-phenylselenophthalimide (1 g, 3.3 mmol) and 
powdered Na2SO4 (3.13 g, 22 mmol) in DCM (5 ml) was added p-toluenesulfonic acid 
(41.8 mg, 0.22 mmol). The resulting mixture was stirred for 8 h, filtered through a pad of 
Celite, and the filtered solids rinsed with DCM. The filtrate was washed with 1 N NaOH (3 
times), and the combined aqueous layers re-extracted with DCM. The combined organic 
layers were dried over Na2SO4, filtered, concentrated and purified by gel chromatography
(silica gel, EA/CH 1:9) to yield the title compound as a 9:1 ratio of diastereomers. 
Yield: 587 mg (1.02 mmol, 47%) as an off-white solid
TLC (EA/CH = 1:2): Rf = 0.64
1
H NMR (400 MHz, CDCl3): δ = 7.32 (m, 4H), 7.23 – 7.14 (m, 4H), 7.02 (dd, J = 14.1, 6.6 
Hz, 1H), 6.27 (s, 1H), 3.90 (dd, J = 9.7, 6.6 Hz, 1H), 3.65 (s, 3H), 2.90 (dd, J = 12.7, 6.6 Hz, 
1H), 2.38 (dd, J = 12.7, 9.8 Hz, 1), 1.55 (d, J = 4.4 Hz, 18H).
13
C NMR (101 MHz, CHCl3): δ = 171.24, 152.22, 142.07, 137.62, 132.8, 129.3, 129.2, 128.9, 
124.1, 123.9, 123.5, 123.4, 123.0, 117.7, 117.6, 83.0, 82.7, 81.6, 80.9, 59.1, 52.1, 38.5, 28.3, 
28.2 
LC-MS (ESI): tR = 13.3 min, calcd. for C28H34N2NaO6Se
+
[M+Na]
+
, 597.15, found 597.00 
7. EXPERIMENTAL PART 119
(2S,3aR,8aR)-1,8-di-tert-butyl 2-methyl 3a-(2-methylbut-3-en-2-yl)-3,3a-dihydropyrrolo 
[2,3-b]indole-1,2,8(2H,8aH)-tricarboxylate (33):
A solution of 32a/b (588 mg, 1.02 mmol) and 2,6-di-tert-butylpyridine (1.03 ml, 4.59 mmol) 
in DCM (10 ml) was cooled under an argon atmosphere to -78 °C. Methyl 
trifuoromethanesulfonate (520 µl, 4.59 mmol) was added, followed by prenyl tributylstannane 
(1.5 ml, 3 mmol). The solution was allowed to warm to rt over 6 hours, and was then refluxed 
for 14 hours. The mixture was cooled to rt, quenched by addition of an equal volume of sat. 
NaHCO3 solution and the organic layer was separated. The aqueous layer was extracted with 
DCM (2 times). The combined organic layers were washed with brine, dried over Na2SO4, 
filtered, concentrated and purified by gel chromatography (silicagel, EA/CH 1:5) to give the 
title compound as a 9:1 mixture of diastereomers. 
Yield: 480 mg (0.98 mmol, 96%) as a white foam
TLC (EA/CH = 1:5): Rf = 0.53
1
H NMR (400 MHz, CDCl3): δ = 7.23 (d,J =8.0 Hz, 1H), 7.18 – 7.15 (m, 1H), 7.14 (d, J = 0.7 
Hz, 1H), 7.04  (t, J= 7.5 Hz, 1H), 6.14 (s, 1H), 5.86 (m, 1H), 5.07 (d, J = 10.8 Hz, 1H), 5.00 
(d, J=17.4 Hz,  1H), 3.80 (dd, J = 10.2, 6.6 Hz, 1H), 3.70 (s, 3H), 2.37 (dd, J = 12.4, 6.6 Hz, 
1H), 2.27 (dd, J = 12.4, 10.1 Hz, 1H), 1.52 (s, 9H), 1.43 (s, 9H), 0.97 (m, 6H) 
13
C NMR (101 MHz, DMSO): δ = 172.81, 152.55, 143.33, 143.10, 133.91, 128.63, 125.11, 
124.91, 123.52, 117.30, 114.38, 81.2, 81.0, 78.6, 61.3, 58.98, 51.95, 40.27, 34.89, 27.87, 
27.70, 22.36, 21.97 
LC-MS (ESI): tR = 9.09 min, calcd. for C27H38N2NaO6
+
[M+Na]
+
: 509.26, found 509.07
7. EXPERIMENTAL PART 120
(2S,3aR,8aR)-1,8-bis(tert-butoxycarbonyl)-3a-(2-methylbut-3-en-2-yl)-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid (34):
33 (146 mg, 0.30 mmol) was refluxed o.n. in a mixture of THF (2.5 ml), methanol (2.5 ml), 
1 N NaOH (1.5 ml) and water (1 ml). The mixture was allowed to cool to rt and was carefully 
acidified to pH 4 by addition of 5% citric acid solution. The resulting solution was extracted 
with ethyl acetate (4x10 ml), the combined organic layers were dried over Na2SO4, filtered, 
concentrated and purified by gel chromatography (silica gel, 35:60:5 EA:CH:AcOH) two 
times to separate the mixture of diastereomers.
Yield: 138 mg (0.29 mmol, 97%) as a white solid
TLC (EA/CH/AcOH = 35:60:5): Rf = 0.45
1
H NMR (400 MHz, CDCl3): δ = 7.35 (m, 1H), 7.23 (d, J = 7.8 Hz, 1H), 7.17 (d, J = 7.0 Hz, 
1H), 7.05 (t, J = 7.6, 1H), 6.15 (s, 1H), 5.91 – 5.80 (m, 1H), 5.13 – 4.96 (m, 2H), 3.81 (dd, J = 
10.2, 6.6 Hz, 1H), 2.43 (dd, J = 12.4, 6.6 Hz, 1H), 2.34 (dd, J = 12.4, 10.2 Hz, 1H), 1.68 –
1.60 (m, 2H), 1.54 (s, 9H), 1.25 (s, 9H), 0.92 (m, 6H).
13
C NMR (101 MHz, CDCl3): δ = 171.38, 152.38, 143.28, 128.73, 126.41, 124.86, 123.44, 
118.02, 114.57, 114.22, 100.14, 97.20, 81.64, 78.79, 60.57, 59.41, 40.50, 29.84, 28.52, 27.99, 
26.98, 23.15, 22.29
LC-MS (ESI): tR = 8.38 min, calcd. for C26H36N2NaO6
+
[M+Na]
+
: 495.25, found 495.13
7. EXPERIMENTAL PART 121
(2S,3aR,8aR)-di-tert-butyl 2-(((R)-1-methoxy-4-methyl-1-oxopentan-2-yl)carbamoyl)-3a-
(2-methylbut-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(35a):
To a solution of 34 (170 mg, 0.36 mmol) in DCM (10 mL) was added DCC (67 mg, 
0.33 mmol), HOBt (40.5 mg, 0.3 mmol), and D-leucine methylester (90.8 mg, 0.5 mmol). The 
resulting mixture was stirred at room temperature for 12 h, followed by dilution with ether 
(20 ml). The side product DCU was removed by filtration and the organic layer washed with 
1 N HCl, saturated aq. NaHCO3 solution, and brine. The organic layer was dried over 
Na2SO4, filtered, and concentrated under reduced pressure to yield a light yellow foam. Flash 
chromatography with acetone/CH (1:9) as the eluent then yielded the title compound. 
Yield: 139 mg (0.23 mmol, 93%) as a white foam
TLC (acetone/CH = 1:9): Rf = 0.22
1
H NMR (400 MHz, DMSO): δ = 7.36 (s, 1H), 7.32 (d, J = 7.4 Hz, 1H), 7.27 (t, J = 7.3 Hz, 
1H), 7.10 (t, J = 7.6 Hz, 1H), 5.98 (s, 1H), 5.83 (dd, J = 16.9, 10.7 Hz, 1H), 5.03 (d, J = 10.8 
Hz, 1H), 4.95 (d, J = 17.2 Hz, 1H), 4.33 (s, 1H), 3.61 (s, 1H), 3.59 (s, 3H), 2.41 (dd, J = 12.5, 
6.9 Hz, 1H), 2.16 – 2.04 (m, 1H), 1.85-1.6 (m, 3H), 1.57 – 1.27 (m, 18H), 0.95 – 0.81 (m, 
12H)
13
C NMR (101 MHz, DMSO): δ = 172.63, 167.11, 158.58, 147.37, 147.23, 146.45, 146.26, 
143.43, 128.38, 127.35, 125.23, 113.84, 94.13, 79.48, 52.21, 51.66, 51.45, 43.38, 27.92, 
26.32, 24.09, 22.78, 22.03, 21.81
LC-MS (ESI): tR = 12.73 min, calcd. for C33H49N3NaO7
+
[M+Na]
+
: 622.35, found 622.27
7. EXPERIMENTAL PART 122
Brevicompanine B (26):
To a stirred solution of 35a (50 mg, 0.083 mmol) in ACN (1 ml) at 0 °C was added TMSI 
(100 mg, 0.498 mmol). After 30 min of stirring, the reaction was allowed to warm to rt and 
stirred for further 3 h. The reaction was quenched by addition of saturated aq. NaHCO3
solution (1 ml) and then extracted twice with DCM. The combined organic layers were dried 
over Na2SO4 and concentrated to dryness. The residue was dissolved in methanol (1 ml) and 
ammonium hydroxide (0.1 ml) was added. The resulting mixture was stirred for 2 h at room 
temperature and concentrated to dryness under reduced pressure. The residue was taken up in 
ACN/H2O (1:1, 3 ml), filtered and purified directly via preparative RP-HPLC to yield the title 
compound. 
Yield: 3.5 mg (9.53 µmol, 12%) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.37 (d, J = 3.8 Hz, 1H), 7.16 (d, J = 7.4 Hz, 1H), 6.99 (t, J
= 7.5 Hz, 1H), 6.62 (t, J = 7.4 Hz, 1H), 6.53 (d, J = 7.8 Hz, 1H), 6.49 (s, 1H), 6.00 (dd, J = 
17.3, 10.8 Hz, 1H), 5.76 (s, 1H), 5.45 (s, 1H), 5.07 (dd, J = 17.2, 14.2 Hz, 2H), 3.79 (dd, J = 
11.1, 6.2 Hz, 1H), 3.64 (dt, J = 14.2, 8.1 Hz, 1H), 2.36 (dt, J = 12.8, 6.4 Hz, 1H), 2.23 – 2.14 
(m, 1H), 1.79-1.40 (m, 3H), 1.38 – 1.18 (m, 3H), 1.02 (s, 3H), 0.87 (m, 9H).
13
C NMR (101 MHz, DMSO): δ = 168.00, 165.72, 151.01, 144.07, 128.82, 128.42, 124.69, 
117.23, 114.03, 108.42, 76.41, 60.28, 57.15, 42.92, 40.71, 37.13, 23.59, 22.89, 22.61, 22.22, 
21.56
LC-MS (ESI): tR = 8.29 min, calcd. for C22H30N3O2
+
[M+H]
+
: 368.23, found 368.10
7. EXPERIMENTAL PART 123
(2S,3aR,8aR)-di-tert-butyl 2-(((S)-1-methoxy-4-methyl-1-oxopentan-2-yl)carbamoyl)-3a-(2-
methylbut-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (35b):
To a solution of 34 (30 mg, 0.064 mmol) in DCM (2.5 mL) was added DCC (16.8 mg, 
0.057 mmol), HOBt (10.1 mg, 0.053 mmol), and L-leucine methylester (22.7 mg, 
0.088 mmol). The resulting mixture was stirred at room temperature for 12 h and diluted with 
ether (10 mL). The side product DCU was removed by filtration and the organic layer washed 
with 1 N HCl, saturated aq. NaHCO3 solution, and brine. The organic layer was dried over 
Na2SO4, filtered, and concentrated under reduced pressure to yield the crude product. Flash 
chromatography with acetone/CH (1:9) as eluent yielded the title compound.
Yield: 16 mg (0,027 mmol, 62%) as a white foam
TLC (acetone/CH = 1:9): Rf = 0.22
1
H NMR (400 MHz, CDCl3): δ = 7.39 (m, 1H), 7.22 (t, J = 7.7 Hz, 1H), 7.16 (d, J = 7.5 Hz, 
1H), 7.05 (td, J = 7.5, 1.0 Hz, 1H), 6.14 (s, 1H), 5.87 (dd, J = 17.4, 10.8 Hz, 1H), 5.03 (dd, J
= 24.9, 14.1 Hz, 1H), 4.64 (td, J = 8.6, 5.4 Hz, 1H), 3.70 (m, 3H), 3.68 – 3.61 (m, 1H), 2.42 –
2.34 (m, 2H), 2.04 (s, 1H), 1.79 – 1.59 (m, 3H), 1.53 (s, 9H), 1.42 (s, 9H), 1.03 (s, 3H), 0.93 
(m, 9H).
13
C NMR (101 MHz, CDCl3): δ = 169.10, 157.46, 152.51, 143.48, 142.95, 129.73, 128.61, 
126.76, 125.02, 123.52, 118.80, 114.51, 81.65, 61.52, 60.54, 52.33, 50.63, 42.19, 40.48, 
28.58, 28.37, 24.69, 23.14, 23.01, 22.04.
LC-MS (ESI): tR = 12.74 min, calcd. for C33H49N3NaO7
+
[M+Na]
+
: 622.35, found 622.37
7. EXPERIMENTAL PART 124
allo-Brevicompanine B (29):
To a stirred solution of 35b (12 mg, 0.02 mmol) in ACN (0.3 ml) at 0 °C was added TMSI 
(19 µl, 0.12 mmol). After 30 min stirring, the reaction was allowed warm to room temperature 
and stirred for further 3 h. The reaction was stopped by addition of saturated aq. NaHCO3
solution (0.3 ml) and then extracted twice with DCM. The combined organic layers were
dried over Na2SO4 and concentrated to dryness. The residue was dissolved in methanol (1 ml) 
and then ammonium hydroxide (0.1 ml) was added. The resulting mixture was stirred for 2 h 
at room temperature and concentrated to dryness under reduced pressure. The residue was 
taken up in ACN/H2O (1:1, 3 ml), filtered and purified directly via RP-HPLC to afford the 
title compound.  
Yield: 2.1 mg (5.7 µmol, 30%) as a white solid
1
H NMR (400 MHz, DMSO): δ = 7.98 (s, 1H), 7.17 (d, J = 7.4 Hz, 1H), 7.04 – 6.96 (m, 1H), 
6.62 (td, J = 7.4, 1.0 Hz, 1H), 6.53 (d, J = 7.8 Hz, 1H), 6.44 (s, 1H), 5.99 (dd, J = 17.3, 10.8 
Hz, 1H), 5.39 (s, 1H), 5.11 – 5.00 (m, 2H), 4.00 (t, J = 5.2 Hz, 1H), 3.86 (dd, J = 10.8, 6.4 Hz, 
1H), 2.39 – 2.31 (m, 1H), 2.27 – 2.17 (m, 1H), 1.92 – 1.66 (m, 2H), 1.48 – 1.36 (m, 1H), 1.04 
(s, 3H), 0.91 – 0.80 (m, 9H)
13
C NMR (101 MHz, DMSO) δ 168.01, 165.73, 151.00, 144.08, 128.82, 128.43, 124.70, 
117.23, 114.04, 108.42, 76.42, 60.28, 57.14, 54.86, 42.91, 40.72, 37.14, 23.60, 22.88, 22.63, 
22.23, 21.56
LC-MS (ESI): tR = 8.62 min, calcd. for C22H30N3O2
+
[M+H]
+
: 368.23, found 368.07
7. EXPERIMENTAL PART 125
(2S,3aR,8aR)-di-tert-butyl2-(((2R,3S)-1-methoxy-3-methyl-1-oxopentanyl)carbamoyl)-
3a-(2-methyl-but-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-
dicarboxylate (35c):
To a solution of 34 (57 mg, 0.12mmol) in DMF (5 mL) was added PyBOP (75 mg, 
0.144 mmol), HOBt (19.4 mg, 0.144 mmol), D-isoleucine methylester (22 mg, 0.12 mmol) 
and DIPEA (61 µl, 0.36 mmol). The resulting mixture was stirred at room temperature for 
15 h. All volatiles were removed by reduced pressure and the crude product was taken up in 
EtOAc (15 ml). The organic layer was washed with 1 N HCl, saturated aq. NaHCO3 solution
and brine. The organic layer was dried over Na2SO4, filtered, and concentrated under reduced 
pressure to yield a pale yellow oil. Flash chromatography with the eluent acetone/CH (1:9) 
yielded the title compound.
Yield: 25 mg (0.042 mmol, 35%) as colorless oil
TLC (acetone/CH = 1:9): Rf = 0.23
1
H NMR (400 MHz, CDCl3): δ = 7.37 (m, 1H), 7.22 (dt, J = 14.3, 3.6 Hz, 1H), 7.17 (t, J = 6.3 
Hz, 1H), 7.11 – 7.02 (m, 1H), 6.31 – 6.08 (m, 2H), 5.86 (ddd, J = 17.5, 10.8, 6.7 Hz, 1H), 
5.11 – 4.97 (m, 2H), 4.67 (dd, J = 9.1, 3.9 Hz, 1H), 3.72 (s, 3H), 3.72 – 3.69 (m, 1H), 2.50 –
2.45 (m, 1H), 2.33 (dd, J = 12.7, 10.5 Hz, 1H), 1.99 – 1.86 (m, 1H), 1.62 (s, 2H), 1.55 (s, 9H), 
1.40 (s, 9H), 1.03 (d, J = 7.4 Hz, 3H), 0.97 (d, J = 7.8 Hz, 3H), 0.95 – 0.88 (m, 3H), 0.83 (d, J 
= 6.9 Hz, 3H)
13
C NMR (101 MHz, CDCl3) δ 172.72, 152.64, 143.33, 142.83, 133.92, 128.66, 125.07, 
123.58, 114.58, 81.78, 81.36, 79.53, 61.84, 55.09, 52.28, 40.48, 37.98, 28.59, 28.38, 27.06, 
26.14, 23.08, 22.37, 14.73, 11.86
LC-MS (ESI): tR = 11.65 min, calcd. for C33H49N3NaO7
+
[M+Na]
+
: 622.35, found 623.10
7. EXPERIMENTAL PART 126
Brevicompanine A (25):
To a solution of 35c (25 mg, 0.042 mmol) in dry DCM (4 ml) was added dropwise TMSOTf 
(76 µl, 0.42 mmol) under an argon atmosphere at 0 °C. This mixture was stirred for 1.5 h at 
0 °C. The reaction mixture was diluted with saturated aq. NaHCO3 solution and extracted 
three times with DCM. The combined organic layers were dried over Na2SO4, filtered and 
concentrated to dryness under reduced pressure. The resulting residue was dissolved in 
THF/MeOH (3:1, 4 ml) and cooled to 0 °C. To this solution, 0.5 N LiOH (252 µl, 
0.126 mmol) was added and the resulting mixture was stirred for 16 h at rt. 1 N KHSO4
(162 µl, 0.162 mmol) was added to the reaction mixture which was then diluted with saturated 
aq. (NH4)2SO4 solution and extracted with DCM. The extract was dried over Na2SO4, filtered 
and concentrated to dryness. The resulting residue was dissolved in DCM (4 ml). To this 
solution was added PyBOP (26 mg, 0.050 mmol) and DIPEA (21 µl, 0.126 mmol) under an 
argon atmosphere. The resulting solution was stirred for 16 h at rt and then diluted by addition 
of saturated aq. NaHCO3 solution. The resulting mixture was extracted with DCM, the 
organic layer was dried over Na2SO4, filtered and concentrated. The resulting crude product 
was purified by RP-HPLC to afford the title compound.
Yield: 1.7 mg (4.6 µmol, 11%) as colorless solid
1
H NMR (400 MHz, DMSO): δ = 7.15 (d, J = 6.9 Hz, 1H), 6.99 (t, J = 7.6 Hz, 1H), 6.61 (t, J 
= 6.9 Hz, 1H), 6.54 (d, J = 8.2 Hz, 1H), 6.00 (dd, J = 17.4, 10.8 Hz, 1H), 5.48 (s, 1H), 5.11 –
5.01 (m, 2H), 3.67 (d, J = 20.0 Hz, 2H), 2.41 (m, 1H), 2.03 – 1.96 (m, 1H), 1.41-1.23 (m, 2H),
1.04 (s, 3H), 0.88 (d, J = 10.7 Hz, 3H), 0.84 (q, J = 7.0 Hz, 3H), 0.67 (dt, J = 14.3, 6.9 Hz, 
3H)
LC-MS (ESI): tR = 8.20 min, calcd. for C22H30N3O2
+
[M+H]
+
: 368.23, found 368.32
7. EXPERIMENTAL PART 127
(2S,3aR,8aR)-di-tert-butyl 2-(((2S,3S)-1-methoxy-3-methyl-1-oxopentan-2-yl)carbamoyl)-3a-(2-
methyl-but-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (35d):
To a solution of 34 (57 mg, 0.12mmol) in DMF (5 ml) was added PyBOP (75 mg, 
0.144 mmol), HOBt (19.4 mg, 0.144 mmol), L-isoleucine methylester (22 mg, 0.12 mmol) 
and DIPEA (61 µl, 0.36 mmol). The resulting mixture was stirred at room temperature for 
12 h. All volatiles were removed by reduced pressure and the crude product was taken up in 
EtOAc (15 ml). The organic layer was washed with 1 N HCl, saturated aq. NaHCO3 solution, 
and brine. The organic layer was dried over Na2SO4, filtered, and concentrated under reduced 
pressure to yield a pale yellow oil. Flash chromatography with the eluents acetone/CH (1:9)
then yielded the title compound. 
Yield: 25 mg (0.042 mmol, 35%) as colorless oil
TLC (acetone/CH = 1:9): Rf = 0.23
1
H NMR (400 MHz, CDCl3): δ = 7.45 – 7.29 (m, 1H), 7.22 (dd, J = 14.3, 6.2 Hz, 1H), 7.16 (t, 
J = 7.7 Hz, 1H), 7.05 (td, J = 7.5, 0.8 Hz, 1H), 6.23 (d, J = 8.7 Hz, 1H), 6.15 (s, 1H), 5.88 (dd, 
J = 17.4, 10.8 Hz, 1H), 5.10 – 4.97 (m, 2H), 4.57 (dd, J = 8.6, 5.1 Hz, 1H), 3.70 (s, 3H), 3.66 
(dd, J = 15.7, 8.8 Hz, 1H), 2.49 – 2.25 (m, 2H), 1.93 – 1.80 (m, 1H), 1.63 (s, 2H), 1.56 – 1.52 
(m, 9H), 1.40 (s, 9H), 1.03 (s, 3H), 0.94 – 0.87 (m, 9H)
13
C NMR (101 MHz, CDCl3): δ = 172.39, 152.55, 143.49, 142.94, 128.62, 125.04, 123.47, 
114.58, 81.67, 81.24, 79.20, 61.67, 56.28, 52.12, 40.50, 38.45, 28.59, 28.38, 27.06, 25.23, 
23.15, 22.27, 15.48, 11.65
LC-MS (ESI): tR = 11.56 min, calcd. for C33H49N3NaO7
+
[M+Na]
+
: 622.35, found 623.14
7. EXPERIMENTAL PART 128
allo-Brevicompanine A (28):
To a solution of 35d (25 mg, 0.042 mmol) in dry DCM (4 ml) was added dropwise TMSOTf 
(76 µl, 0.42 mmol) under an argon atmosphere at 0 °C. The resulting mixture was stirred for 
1.5 h at 0 °C. The reaction mixture was diluted by addition of saturated aq. NaHCO3 solution
and extracted three times with DCM. The combined organic layers were dried over Na2SO4, 
filtered and concentrated to dryness under reduced pressure. The resulting residue was
dissolved in THF/MeOH (3:1, 4 ml) and cooled to 0 °C. To this solution, 0.5 N LiOH (252 µl, 
0.126 mmol) was added and the mixture was stirred for 16 h at rt. 1 N KHSO4 (162 µL, 
0.162 mmol) was added to the reaction mixture, followed by dilution with saturated aq. 
(NH4)2SO4 solution and the resulting mixture was extracted with DCM. The organic phase 
was dried over Na2SO4, filtered and concentrated to dryness. The resulting residue was
dissolved in DCM (4 ml). To this solution was added PyBOP (26 mg, 0.050 mmol) and 
DIPEA (21 µL, 0.126 mmol) under an argon atmosphere. The resulting solution was stirred 
for 16 h at rt and then diluted with saturated aq. NaHCO3 solution. Extraction with DCM, 
drying of the organic layer over Na2SO4, filtration and concentration to dryness then delivered 
the crude product which was purified by RP-HPLC to yield the title compound. 
Yield: 1.5 mg (4.1 µmol, 10%) as colorless solid
1
H NMR (400 MHz, DMSO): δ = 7.16 (d, J = 7.1 Hz, 1H), 6.99 (t, J = 7.6 Hz, 1H), 6.62 (d, J 
= 6.7 Hz, 1H), 6.53 – 6.43 (m, 1H), 5.97 (dd, J = 17.4, 10.8 Hz, 1H), 5.45 (s, 1H), 5.06 (dd, J 
= 14.1, 8.6 Hz, 2H), 3.89 (m, 1H), 3.66 – 3.55 (m, 1H), 2.41 (dd, J 0 12 Hz, J = 11 Hz, 1H), 
2.03 – 1.96 (m, 1H), 1.41-1.22 (m, 2H), 1.04 (s, 3H), 0.95 (d, J = 7.1 Hz, 3H), 0.84 (dd, J = 
12.3, 4.8 Hz, 6H)
LC-MS (ESI): tR = 8.54 min, calcd. for C22H30N3O2
+
[M+H]
+
: 368.23, found 368.49
7. EXPERIMENTAL PART 129
(2S,3aR,8aR)-di-tert-butyl 2-(((R)-1-methoxy-3-methyl-1-oxobutan-2-yl)carbamoyl)-3a-
(2-methylbut-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(35e):
To a solution of 34 (122.6 mg, 0.26mmol) in DCM (5 ml) was added PyBOP (162 mg, 
0.31 mmol), HOBt (42 mg, 0.31 mmol), D-valine methylester (44 mg, 0.26 mmol) and DIPEA 
(222 µl, 1.3 mmol). The resulting mixture was stirred at room temperature for 12 h and 
diluted by addition with ether (10 ml). The organic layer was washed with 1 N HCl, saturated 
aq. NaHCO3 solution and brine. The organic layer was dried over Na2SO4, filtered, and 
concentrated under reduced pressure to yield a light yellow foam. Flash chromatography, with 
the eluents DCM/MeOH (30:1) then yielded the title compound. 
Yield: 52.7 mg (0.098 mmol, 38%) as a white foam
TLC (DCM/MeOH = 30:1): Rf = 0.4
1
H NMR (400 MHz, CDCl3): δ = 7.36 (dd, J = 17.3, 9.9 Hz, 1H), 7.25 – 7.09 (m, 2H), 7.05 
(td, J = 7.5, 1.0 Hz, 1H), 6.20 (d, J = 8.9 Hz, 1H), 6.16 (s, 1H), 5.86 (ddd, J = 17.2, 10.8, 6.4 
Hz, 1H), 5.10 – 4.97 (m, 2H), 4.53 (dd, J = 8.9, 4.8 Hz, 1H), 3.72 (s, 3H), 3.71 (t, J = 1.8 Hz, 
1H), 2.44 (dd, J = 12.8, 6.6 Hz, 1H), 2.31 (dd, J = 12.7, 10.5 Hz, 1H), 2.21 – 2.06 (m, 1H), 
1.55 (d, J = 7.2 Hz, 9H), 1.41 (d, J = 6.7 Hz, 9H), 1.02 (d, J = 6.5 Hz, 3H), 0.96 – 0.86 (m, 
9H)
13
C NMR (101 MHz, CDCl3): δ = 172.35, 152.62, 143.31, 142.85, 133.88, 128.65, 125.05, 
123.52, 118.37, 114.57, 81.75, 81.35, 79.48, 61.79, 56.78, 52.20, 40.47, 31.54, 28.57, 28.39, 
23.08, 22.35, 18.99, 17.87
LC-MS (ESI): tR = 11.29 min, calcd. for C32H47N3NaO7
+
[M+Na]
+
: 608.33, found 608.23
7. EXPERIMENTAL PART 130
Brevicompanine C (27):
To a stirred solution of 35e (40 mg, 0.068 mmol) in DCM (4 ml) at 0 °C was added TMSOTf 
(75 µl, 0.41 mmol). The resulting reaction mixture was stirred for 1.5 h at 0 °C. The reaction 
was quenched by addition of saturated aq. NaHCO3 solution (1 ml) and then extracted twice 
with DCM. The combined organic layers were dried with Na2SO4 and concentrated to 
dryness. The residue was dissolved in methanol (1 ml) and ammonium hydroxide (0.1 ml) 
was added. The resulting mixture was stirred for 2 h at room temperature and concentrated to 
dryness under reduced pressure. The residue was taken up in ACN/H2O (1:1, 3 ml), filtered 
and purified directly via RP-HPLC to yield the title compound.
Yield: 3.2 mg (9.07 µmol, 13%) as a white solid
1
H NMR (400 MHz, DMSO): δ = 7.15 (d, J = 7.3 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.99 (m, 
2H), 6.61 (t, J = 7.0 Hz, 1H), 6.54 (s, 1H), 6.00 (dd, J = 17.4, 10.8 Hz, 1H), 5.47 (s, 1H), 5.07 
(ddd, J = 18.7, 14.1, 1.4 Hz, 2H), 3.68 (dd, J = 11.3, 5.9 Hz, 1H), 3.53 (dd, J = 9.7, 5.6 Hz,
1H), 2.38 – 2.31 (m, 1H), 2.18 (t, J = 11.9 Hz, 1H), 1.04 (s, 3H), 0.86 (m, 9H)
13
C NMR (101 MHz, DMSO): δ = 167.81, 164.51, 162.29, 151.21, 144.09, 128.66, 128.44, 
124.65, 117.23, 113.93, 108.24, 76.36, 61.57, 60.24, 57.43, 40.59, 38.23, 37.42, 35.76, 33.28, 
30.76, 22.61, 22.26, 18.58, 17.19
LC-MS (ESI): tR = 7.73 min, calcd. for C21H28N3O2
+
[M+H]
+
: 354.22, found 354.12
7. EXPERIMENTAL PART 131
(2S,3aR,8aR)-di-tert-butyl 2-(((S)-1-methoxy-3-methyl-1-oxobutan-2-yl)carbamoyl)-3a-
(2-methylbut-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate 
(35f):
To a solution of 34 (122.6 mg, 0.26 mmol) in DCM (5 ml) was added PyBOP (162 mg, 
0.31 mmol), HOBt (42 mg, 0.31 mmol), L-valine methylester (44 mg, 0.26 mmol) and DIPEA 
(222 µl, 1.3 mmol). The mixture was stirred at room temperature for 12 h and diluted by the 
addition of ether (10 ml). The organic layer was washed with 1 N HCl, saturated aq. NaHCO3
solution and brine. The organic layer was dried over Na2SO4, filtered, and concentrated under 
reduced pressure to yield a light yellow foam. Flash chromatography with the eluents 
DCM/MeOH (30:1) then yielded the title compound.  
Yield: 60 mg (0.102 mmol, 40%) as a white foam
TLC (DCM/MeOH = 30:1): Rf = 0.4
1
H NMR (400 MHz, CDCl3): δ = 7.40 (ddd, J = 21.0, 12.9, 4.7 Hz, 1H), 7.22 (dt, J = 7.4, 2.7 
Hz, 1H), 7.18 – 7.14 (m, 1H), 7.05 (td, J = 7.5, 0.7 Hz, 1H), 6.23 – 6.18 (m, 1H), 6.15 (s, 1H), 
5.88 (dd, J = 17.4, 10.8 Hz, 1H), 5.11 – 4.96 (m, 2H), 4.53 (dd, J = 8.7, 4.9 Hz, 1H), 3.70 (s, 
3H), 3.70 – 3.62 (m, 1H), 2.51 – 2.29 (m, 2H), 2.12 (qt, J = 13.7, 6.9 Hz, 1H), 1.55 (d, J = 6.2 
Hz, 9H), 1.41 (d, J = 6.2 Hz, 9H), 1.03 (s, 3H), 0.96 – 0.88 (m, 9H)
13
C NMR (101 MHz, CDCl3): δ = 172.40, 152.54, 143.47, 142.94, 128.61, 125.05, 123.47, 
114.59, 81.66, 81.23, 79.22, 61.71, 56.96, 52.16, 40.49, 31.91, 28.58, 28.47, 28.38, 23.14, 
22.27, 21.18, 19.03, 17.84
LC-MS (ESI): tR = 11.23 min, calcd. for C32H47N3NaO7
+
[M+Na]
+
: 608.33, found 608.21
7. EXPERIMENTAL PART 132
allo-Brevicompanine C (30):
To a stirred solution of 35f (40 mg, 0.068 mmol) in DCM (4 ml) at 0 °C was added TMSOTf 
(75 µl, 0.41 mmol). The resulting reaction mixture was stirred for 1.5 h at 0 °C. The reaction 
was quenched by addition of a saturated aq. NaHCO3 solution (1 ml) and then extracted twice 
with DCM. The combined organic layers were dried over Na2SO4 and concentrated to 
dryness. The residue was dissolved in methanol (1 ml) and ammonium hydroxide (0.1 ml) 
was added. The resulting mixture was stirred for 2 h at room temperature and concentrated to 
dryness under reduced pressure. The residue was taken up in ACN/H2O (1:1, 3 ml), filtered 
and purified directly via RP-HPLC to yield the title compound. 
Yield: 3 mg (8.5 µmol, 12%) as a white solid
1
H NMR (400 MHz, DMSO): δ = 7.16 (d, J = 7.3 Hz, 1H), 6.99 (m, 2H), 6.62 (t, J = 7.4 Hz, 
1H), 6.56 – 6.45 (m, 1H), 5.98 (dd, J = 17.3, 10.9 Hz, 1H), 5.46 (s, 1H), 5.13 – 4.98 (m, 2H), 
3.90 (s, 1H), 3.78 (dd, J = 11.0, 5.6 Hz, 1H), 2.36 – 2.29 (m, 1H), 2.25 – 2.14 (m, 1H), 1.04 
(s, 3H), 0.97 – 0.81 (m, 9H)
13
C NMR (101 MHz, DMSO): δ = 167.82, 164.61, 162.29, 151.21, 144.09, 128.66, 128.44, 
124.65, 117.23, 113.93, 108.24, 76.36, 61.57, 60.24, 57.43, 40.59, 38.23, 37.42, 35.76, 33.28, 
30.76, 22.61, 22.26, 18.58, 17.20
LC-MS (ESI): Rt = 8.03 min, calcd. for C21H28N3O2
+
[M+H]
+
: 354.22, found 354.23
7. EXPERIMENTAL PART 133
(2S,3aR,8aR)-di-tert-butyl 2-(((S)-1-methoxy-1-oxopent-4-yn-2-yl)carbamoyl)-3a-(2-
methylbut-3-en-2-yl)-3,3a-dihydropyrrolo[2,3-b]indole-1,8(2H,8aH)-dicarboxylate (36):
To a solution of 34 (190 mg, 0.4 mmol) in DCM (10 ml) was added EDC hydrochloride 
(99.32 mg, 0.52 mmol), HOBt (64.8 mg, 0.48 mmol) and L-propargylglycine methylester 
(130.4 mg, 0.8 mmol). The resulting mixture was stirred at room temperature for 12 h and 
diluted by addition of ether (10 ml). The organic layer was washed with 1 N HCl, saturated 
aq. NaHCO3 solution and brine, dried over Na2SO4, filtered, and concentrated under reduced 
pressure to yield a light yellow foam. Flash chromatography with acetone/CH (1:9) as eluent 
then yielded the title compound. 
Yield: 95 mg (0.17 mmol, 41%) as a white solid
TLC (acetone/CH = 1:9): Rf = 0.32 
1
H NMR (400 MHz, CDCl3): δ = 7.46 – 7.32 (m, 1H), 7.20 (dd, J = 19.6, 7.7 Hz, 2H), 7.05 (t, 
J = 7.8 Hz, 1H), 6.49 (d, J = 7.6 Hz, 1H), 6.16 (s, 1H), 5.86 (dd, J = 17.3, 10.8 Hz, 1H), 5.03 
(dd, J = 22.4, 14.1 Hz, 2H), 4.77 – 4.70 (m, 1H), 3.78 (d, J = 6.7 Hz, 3H), 3.70 (dd, J = 10.4, 
6.5 Hz, 1H), 2.76 (d, J = 2.3 Hz, 2H), 2.45 (dd, J = 12.6, 6.5 Hz, 1H), 2.32 (dd, J = 12.5, 10.6 
Hz, 1H), 2.01 (t, J = 2.5 Hz, 1H), 1.56 (d, J = 6.6 Hz, 9H), 1.42 – 1.39 (m, 9H), 1.03 (s, 3H), 
0.92 (s, 3H)
13
C NMR (101 MHz, CDCl3): δ = 170.72, 152.54, 143.36, 142.98, 128.67, 125.03, 123.52, 
114.55, 106.69, 100.14, 81.67, 78.66, 71.64, 61.64, 52.87, 50.53, 40.45, 28.57, 28.42, 27.06, 
23.12, 22.54, 22.35
LC-MS (ESI): tR = 11.83 min, calcd. for C32H44N3O7
+
[M+H]
+
: 582.32, found 582.07
7. EXPERIMENTAL PART 134
(3R,5aS,10bR,11aS)-10b-(2-methylbut-3-en-2-yl)-3-(prop-2-yn-1-yl)-2,3,5a,6,11,11a-
hexahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-1,4(10bH)-dione (37):
To a stirred solution of 36 (20 mg, 0.057 mmol) in ACN (0.5 ml) at 0 °C was added TMSI 
(54 µl, 0.342 mmol). After 30 min stirring, the reaction mixture was allowed to warm to room 
temperature and stirred for further 3 h. The reaction was quenched by addition of saturated aq. 
NaHCO3 solution (0.5 ml) and then extracted twice with DCM. The combined organic layers
were dried over Na2SO4 and concentrated to dryness. The residue was dissolved in methanol 
(1 ml) and then ammonium hydroxide (0.1 ml) was added. The resulting solution was stirred 
for 2 h at room temperature and concentrated to dryness under reduced pressure. The residue 
was taken up in ACN/H2O (1:1, 3 ml), filtered and purified directly via RP-HPLC to afford 
the title compound.
Yield: 2.9 mg (8.3 µmol, 15%) as a white solid
1
H NMR (400 MHz, DMSO): δ = 8.12 (s, 1H), 7.16 (d, J = 6.8 Hz, 1H), 7.00 (td, J = 7.7, 1.1 
Hz, 1H), 6.62 (td, J = 7.4, 1.0 Hz, 1H), 6.51 (d, J = 7.8 Hz, 1H), 5.97 (dd, J = 17.3, 10.8 Hz, 
1H), 5.48 (s, 1H), 5.06 (ddd, J = 18.8, 14.1, 1.3 Hz, 2H), 4.17 (s, 1H), 3.81 (dd, J = 5.7, 4.2 
Hz, 1H), 2.84 (t, J = 2.5 Hz, 1H), 2.79 – 2.64 (m, 1H), 2.56 – 2.52 (m, 1H), 2.34 (dd, J = 12.3, 
5.9 Hz, 1H), 2.20 (t, J = 11.9 Hz, 1H), 1.03 (s, 3H), 0.94 – 0.84 (m, 3H)
13
C NMR (101 MHz, CDCl3): δ = 167.63, 163.42, 151.19, 143.99, 137.64, 132.28, 128.85, 
128.38, 124.75, 117.23, 113.89, 108.22, 80.10, 76.35, 73.28, 60.88, 57.98, 53.62, 40.73, 
37.67, 22.69, 22.22, 21.64
LC-MS (ESI): tR = 8.58 min, calcd. for C21H24N3O2
+
[M+H]
+
: 350.19, found 350.00
7. EXPERIMENTAL PART 135
Alloc-D-Lys(Boc)-OH (38):
H-D-Lys(Boc)-OH (1 g, 4.06 mmol) was dissolved in water (10 ml) and NaHCO3 (1.023 g, 
12.18 mmol) was added under stirring. The resulting solution was cooled to 0 °C and allyl 
chloroformate (0.644 ml, 6.09 mmol) was slowly added as a solution in dioxane (10 ml). The 
resulting mixture was stirred for 1 h at 0 °C and allowed to warm to rt and stirred for further 
16 h at rt. Water (10 mL) was added and the aqueous layer was extracted twice with EtOAc. 
The organic layer was re-extracted twice with a saturated aq. NaHCO3 solution. The 
combined aqueous layers were acidified to pH of 1 with 10% HCl and extracted three times 
with EtOAc. The combined organic layers were dried over Na2SO4 and concentrated to 
dryness. The resulting residue was purified by flash chromatography (EtOAc/CH 1:1 + 0.1% 
AcOH) to yield the title compound. 
Yield: 1.33 g (4.03 mmol, 99%) as a colorless solid
TLC (EA/CH = 1:1 + 0.1% AcOH): Rf = 0.38
1
H NMR (400 MHz, CDCl3): δ = 5.88 (ddt, J = 16.1, 10.7, 5.6 Hz, 1H), 5.67 (d, J = 7.2 Hz, 
1H), 5.23 (d, J = 17.2 Hz, 1H), 5.14 (dd, J = 10.4, 1.0 Hz, 1H), 4.55 (d, J = 5.3 Hz, 2H), 4.36 
– 4.11 (m, 1H), 3.06 (d, J = 6.3 Hz, 2H), 1.77 (m, 2H), 1.46 (dd, J = 11.4, 5.2 Hz, 2H), 1.41 
(s, 9H), 1.39 (m, 2H)
13
C NMR (101 MHz, CDCl3): δ = 176.96, 176.58, 156.24, 132.69, 117.91, 65.99, 60.58, 
53.72, 31.87, 29.41, 28.46, 22.33, 20.87
LC-MS (ESI): tR = 5.41 min, calcd. for C15H25N2O6
-
[M-H]
-
: 329.17, found 329.13
Alloc-D-Lys-OMe (39):
A solution of 38 (1.33 g, 4.03 mmol) in MeOH (10 ml) was cooled to 0 °C. To this solution 
was added dropwise SOCl2 (1.37 ml, 18.9 mmol). The resulting mixture was allowed to warm 
to rt and then heated up to 50 °C for further 5 h. All volatiles were removed by reduced 
7. EXPERIMENTAL PART 136
pressure, affording the title compound which was used in the next steps without further 
purification. 
Yield: 0.903 g (3.9 mmol, 95%) as a colorless solid
1
H NMR (400 MHz, CDCl3): δ = 5.86 (s, 2H), 5.30 (d, J = 17.0 Hz, 1H), 5.20 (d, J = 10.0 Hz, 
1H), 4.56 (s, 2H), 4.25 (d, J = 48.2 Hz, 1H), 3.74 (s, 3H), 3.22 – 2.93 (m, 2H), 1.83 (s, 4H), 
1.50 (s, 2H)
13
C NMR (101 MHz, CDCl3): δ = 173.15, 156.25, 132.82, 117.97, 66.03, 53.93, 52.76, 39.97, 
31.73, 27.09, 22.53
LC-MS (ESI): tR = 3.33 min, calcd. for C11H21N2O4
+
[M+H]
+
: 245.15, found 244.89
Fmoc-L-propargyl glycine (39a):
To a solution of L-propargyl glycine (0.5 g, 4.42 mmol) in H2O (10 ml) was added NaHCO3
(0.744 g, 8.84 mmol). The resulting solution was cooled to 0 °C and Fmoc-Cl (1.71 g, 
6.63 mmol) was slowly added as a solution in dioxane (10 ml). The resulting mixture was
stirred at 0 °C for 1 h and then allowed to warm to rt overnight. Water (10 ml) was added and 
the aqueous layer was extracted two times with EtOAc. The organic layer was re-extracted 
twice with saturated aq. NaHCO3 solution. The combined aqueous layers were acidified to 
pH 1 by addition of 1 N HCl and then extracted three times with EtOAc. The combined 
organic layers were dried over Na2SO4, filtered and concentrated in vacuo. The product was 
used without further purification.
Yield: 1.12 g (3.34 mmol, 76%) as a colorless solid
1
H NMR (400 MHz, CDCl3): δ = 7.63 (d, J = 7.5 Hz, 2H), 7.49 (d, J = 7.4 Hz, 2H), 7.26 (t, J 
= 7.4 Hz, 2H), 7.18 (t, J = 7.4 Hz, 2H), 4.32 (dd, J = 10.3, 5.2 Hz, 1H), 4.25 (t, J = 6.6 Hz, 
1H),  4.11 (t, J = 7.0 Hz, 1H), 2.64 (d, J = 13.6 Hz, 2H), 1.99 (s, 1H)
13
C NMR (101 MHz, CDCl3): δ = 172.06, 156.11, 143.59, 141.15, 127.60, 126.96, 124.98, 
119.82, 78.52, 71.31, 67.04, 52.20, 46.95, 22.24
LC-MS (ESI): tR = 6.04 min, calcd. for C40H32N2NaO8
-
[2M-2H+Na]
-
: 691.21, found 692.01
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(R)-Methyl 6-((R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)pent-4-ynamido)-2-
(((allyloxy) carbonyl)amino)hexanoate (40):
39 (200 mg, 0.82 mmol), EDC*HCl (314.4 mg, 1.64 mmol) and HOBt (121.78 mg, 
0.902 mmol) were dissolved in DCM. To this solution, DIPEA (0.7 mL, 4.1 mmol) was added 
and the resulting mixture was stirred for 5 min at rt. In a separate flask, 23a (274 mg, 
0.82 mmol) was dissolved in DCM (3 mL) and added to the first reaction mixture. The 
resulting solution was stirred for 16 h at rt. All volatiles were removed by rotary evaporation. 
The resulting crude product was taken up in EtOAc (20 ml) and washed once with saturated 
aq. NaHCO3 solution, once with 1 N HCl and once with brine. The organic layer was dried 
over Na2SO4, filtered and concentrated to dryness. The resulting crude product was purified 
by flash chromatography with DCM/MeOH (50:1) as eluent to yield the title compound. 
Yield: 0.33 g (0.59 mmol, 72%) as a colorless solid
TLC (DCM/MeOH = 50:1): Rf = 0.33
1
H NMR (400 MHz, CDCl3): δ = 7.77 (d, J = 7.5 Hz, 2H), 7.57 (t, J = 16.4 Hz, 2H), 7.41 (t, J 
= 7.5 Hz, 2H), 7.31 (dd, J = 17.1, 9.7 Hz, 2H), 5.90 (ddd, J = 22.8, 10.9, 5.7 Hz, 1H), 5.31 (m, 
1H), 5.21 (dd, J = 10.4, 1.2 Hz, 1H), 4.56 (d, J = 5.3 Hz, 2H), 4.46 (m, 2H), 4.32 (m, 2H), 
4.23 (t, J = 6.8 Hz, 1H), 3.75 (s, 3H), 3.28 (m, 2H), 2.87 – 2.52 (m, 2H), 2.15 – 2.10 (m, 1H), 
1.87 – 1.78 (m, 2H), 1.55 (m, 2H), 1.41 (m, 2H) 
13
C NMR (101 MHz, CDCl3): δ = 173.00, 169.89, 156.09, 148.63, 143.83, 141.50, 132.70, 
127.95, 127.25, 125.17, 120.21, 118.10, 72.08, 67.36, 66.06, 53.66, 52.60, 47.29, 39.30, 
32.32, 28.87, 22.82, 22.38
LC-MS (ESI): tR = 8.92 min, calcd. for C31H36N3O7
+
[M+H]
+
: 562.25, found 563.04
7. EXPERIMENTAL PART 138
(R)-Methyl 2-(((allyloxy)carbonyl)amino)-6-((R)-2-(3-benzoylbenzamido)pent-4-
ynamido)hexanoate (41):
40 (330 mg, 0.92 mmol) was dissolved in ACN (9.2 ml). To this solution was added 
diethylamine (0.95 ml, 9.2 mmol) and the resulting mixture was stirred at rt for 2 h. The 
reaction mixture was concentrated to dryness and the resulting residue was dissolved in 90% 
aqueous ACN and washed three times with heptane. The heptane layer containing cleaved 
dibenzofulvene was discarded and the acetonitrile water phase was concentrated to dryness to 
yield the free amine (225 mg, 0.67 mmol) which was directly added to a solution of 3-
benzoylbenzoic acid (180 mg, 0.8 mmol), HBTU (365 mg, 0.96 mmol), HOBt (122 mg, 
0.9 mmol) and DIPEA (0.7 ml, 4.12 mmol) in DCM (8 ml). The resulting reaction mixture 
was stirred for 4 h at rt. The solvent was removed and the residue was taken up in EtOAc and 
washed sequentially with saturated aq. NaHCO3 solution, 1 N HCl and brine. The organic 
layer was dried (Na2SO4), filtered and concentrated. The crude product was purified by gel 
chromatography (DCM/MeOH 50:1) to yield 326 mg (0.6 mmol, 67% over 2 steps) of the 
desired product.
Yield: 326 mg (0.6 mmol, 65%) as a colorless solid
TLC (DCM/MeOH = 50:1): Rf = 0.14
1
H NMR (400 MHz, CDCl3):  δ =  7.94 (d, J = 8.2 Hz, 2H), 7.85 (d, J = 8.4 Hz, 2H), 7.83 –
7.77 (m, 2H), 7.65 – 7.59 (m, 1H), 7.49 (dd, J = 10.6, 4.7 Hz, 2H), 7.34 (d, J = 7.0 Hz, 1H), 
6.54 (s, 1H), 5.90 (ddd, J = 22.8, 10.8, 5.7 Hz, 1H), 5.41 (d, J = 8.1 Hz, 1H), 5.36 – 5.24 (m, 
1H), 5.24 – 5.17 (m, 1H), 4.75 (dd, J = 12.9, 7.5 Hz, 1H), 4.57 (d, J = 5.6 Hz, 2H), 4.34 (m, 
1H), 3.74 (s, 3H), 3.39 (m, 1H), 3.32 – 3.22 (m, 1H), 2.98 – 2.87 (m, 1H), 2.71 (ddd, J = 16.8, 
7.8, 2.4 Hz, 1H), 2.17 (t, J = 2.5 Hz, 1H), 1.92 – 1.80 (m, 1H), 1.77 – 1.65 (m, 1H), 1.58 (m, 
2H), 1.43 (m, 2H)
13
C NMR (101 MHz, CDCl3): δ = 196.00, 174.85, 173.02, 169.96, 166.52, 156.10, 140.71, 
137.12, 136.77, 133.08, 132.67, 130.30, 130.23, 128.62, 127.35, 118.13, 79.63, 72.19, 66.08, 
60.55, 53.67, 52.61, 52.32, 39.43, 32.29, 28.80, 22.68, 22.41, 21.19, 20.62, 14.34
LC-MS (ESI): tR = 8.01 min, calcd. for C30H34N3O7
+
[M+H]
+
: 548.24, found 548.09
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(R)-Methyl 2-amino-6-((R)-2-(3-benzoylbenzamido)pent-4-ynamido)hexanoate (42):
41 (326 mg, 0.6 mmol) was dissolved in dry THF (5 ml) under an argon atmosphere. 
Dimedone (589 mg, 4.2 mmol) followed by tetrakis(triphenylphosphine)palladium (70 mg, 
0.06 mmol) were sequentially added as a solution in dry THF. The resulting reaction mixture 
was stirred until TLC indicated consumption of the whole starting material (≈ 1.5 h). The 
reaction mixture was concentrated to dryness and purified by flash chromatography 
(DCM/MeOH 19:1) to yield the title compound.
Yield: 120 mg (0.26 mmol, 44%) as a colorless solid
TLC (DCM/MeOH = 19:1): Rf = 0.22
LC-MS (ESI): tR = 5.23 min, calcd. for C26H30N3O5
+
[M+H]
+
: 464.21, found 464.30
(2S,3aR,8aR)-di-tert-butyl 2-(((R)-6-((R)-2-(3-benzoylbenzamido)pent-4-ynamido)-1-
methoxy-1-oxo-hexan-2-yl)carbamoyl)-3a-(2-methylbut-3-en-2-yl)-3,3a-dihydropyrrolo 
[2,3-b]indole-1,8(2H,8aH)-di-carboxylate (43):
34 (61.3 mg, 0.13 mmol), PyBOP (81.12 mg, 0.156 mmol), HOBt (21.06 mg, 0.156 mmol) 
and DIPEA (111 µl, 0.65 mmol) were dissolved in DCM (4 ml). 42 (60 mg, 0.13 mmol) was 
dissolved separately in DCM (2 ml) and added to the reaction mixture. The resulting solution 
was stirred for 1.5 h at rt. The solvent was evaporated under reduced pressure and the 
resulting residue was taken up in EtOAc and washed sequentially with saturated aq. NaHCO3
solution, 0.5 N HCl and brine. The organic layer was dried over Na2SO4, filtered and 
concentrated to dryness. The resulting crude product was purified by flash chromatography 
(silicagel, DCM/MeOH 30:1) to yield the desired product. 
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Yield: 30 mg (0.033 mmol, 26%) as a colorless solid
TLC (DCM/MeOH = 30:1): Rf = 0.3
1
H NMR (400 MHz, CDCl3):  δ = 7.94 (t, J = 6.9 Hz, 2H), 7.87 – 7.77 (m, 5H), 7.61 (dd, J = 
16.1, 9.2 Hz, 2H), 7.49 (dd, J = 10.6, 4.4 Hz, 3H), 7.19 (dd, J = 14.2, 7.7 Hz, 1H), 7.11 – 7.01 
(m, 1H), 6.72 (s, 1H), 6.47 (d, J = 11.7 Hz, 1H), 6.27 – 6.13 (m, 1H), 5.85 (ddd, J = 15.6, 
10.7, 4.8 Hz, 1H), 5.14 – 4.94 (m, 2H), 4.73 (d, J = 6.7 Hz, 1H), 4.48 (d, J = 23.4 Hz, 1H), 
3.72 (s, 3H), 3.41 (d, J = 2.9 Hz, 2H), 3.29 – 3.20 (m, 1H), 2.99 – 2.88 (m, 1H), 2.45 (dd, J = 
12.5, 6.5 Hz, 1H), 2.32 (d, J = 12.4 Hz, 1H), 2.12 (dd, J = 20.5, 9.3 Hz, 2H), 1.95 (s, 2H), 1.89 
– 1.63 (m, 2H), 1.55 (m, 9H), 1.34 (s, 9H), 1.06 – 0.93 (m, 6H), 0.89 (d, J = 10.3 Hz, 2H)  
13
C NMR (101 MHz, CDCl3): δ = 196.04, 172.65, 171.94, 170.25, 166.70, 152.65, 143.28, 
140.52, 137.18, 133.03, 132.33, 130.23, 130.19, 128.75, 128.61, 128.59, 127.47, 127.34, 
125.07, 114.61, 81.85, 77.37, 53.56, 52.50, 48.77, 40.48, 28.58, 28.53, 28.49, 28.47, 28.39, 
28.09, 26.53, 26.44, 23.11, 22.34, 14.34
LC-MS (ESI): tR = 5.23 min, calcd. for C52H62N5O10
-
[M-H]
-
: 916.45, found 916.49
3-Benzoyl-N-((R)-1-((4-((3R,5aS,10bR,11aS)-10b-(2-methylbut-3-en-2-yl)-1,4-dioxo-
2,3,4,5a,6,10b,11,11a-octahydro-1H-pyrazino[1',2':1,5]pyrrolo[2,3-b]indol-3-
yl)butyl)amino)-1-oxopent-4-yn-2-yl) benzamide (44):
To a solution of 43 (25 mg, 0.027 mmol) in dry DCM (1.7 ml) was added dropwise TMSOTf 
(49 µl, 0.27 mmol) under an argon atmosphere at 0 °C. This mixture was stirred for 1.5 h at 
0 °C. The reaction mixture was diluted by addition of saturated aq. NaHCO3 solution and 
extracted three times with DCM. The combined organic layers were dried over Na2SO4, 
filtered and concentrated to dryness under reduced pressure. The resulting residue was 
dissolved in THF/MeOH (3:1, 2 ml) and cooled to 0 °C. To this solution, 0.5 N LiOH (162 µl, 
0.081 mmol) was added and the mixture was stirred for 3 h at rt. 1 N KHSO4 (162 µL, 
0.162 mmol) was subsequently added to the reaction mixture which was then diluted by 
addition of saturated aq. (NH4)2SO4 solution and extracted with DCM. The organic layer was
dried over Na2SO4, filtered and concentrated to dryness. The resulting residue was dissolved 
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in DCM (3 ml). To this solution was added PyBOP (16.8 mg, 0.032 mmol) and DIPEA 
(9.5 µl, 0.054 mmol) under an argon atmosphere. The resulting solution was stirred for 16 h at 
rt and was then diluted by addition of saturated aq. NaHCO3 solution and extracted with 
DCM. The organic layer was dried over NaSO4, filtered and concentrated. The resulting crude 
product was purified by flash chromatography (DCM/MeOH 19:1) and afterwards by RP-
HPLC to yield the desired product.
Yield: 3.7 mg (5.4 µmol, 20%) as a colorless solid
TLC (DCM/MeOH = 19:1): Rf = 0.4
1
H NMR (400 MHz, CDCl3):  δ = 8.18 (d, J = 7.9 Hz, 1H), 7.94 (d, J = 8.4 Hz, 1H), 7.90 –
7.84 (m, 2H), 7.82 – 7.78 (m, 2H), 7.66 – 7.59 (m, 1H), 7.50 (td, J = 7.7, 2.4 Hz, 2H), 7.31 
(dd, J = 11.1, 6.8 Hz, 1H), 7.20 – 7.07 (m, 2H), 7.02 (dd, J = 10.5, 8.6 Hz, 1H), 5.99 – 5.87 
(m, 1H), 5.67 (d, J = 3.8 Hz, 1H), 5.21 – 5.08 (m, 2H), 4.75 (dd, J = 13.6, 6.4 Hz, 1H), 3.95 
(dt, J = 28.5, 14.4 Hz, 2H), 3.39 (dd, J = 13.2, 6.7 Hz, 1H), 3.31 – 3.17 (m, 1H), 2.98 – 2.84 
(m, 1H), 2.75 (dd, J = 16.8, 7.7 Hz, 1H), 2.60 (dd, J = 12.7, 6.0 Hz, 1H), 2.54 – 2.28 (m, 2H), 
2.20 – 2.11 (m, 1H), 1.96 – 1.72 (m, 2H), 1.57 (s, 2H), 1.46 – 1.38 (m, 2H), 1.26 (s, 1H), 1.20 
– 1.07 (m, 3H), 1.03 (dd, J = 15.4, 8.6 Hz, 3H), 0.88 (dd, J = 7.5, 6.1 Hz, 2H)
LC-MS (ESI): tR = 8.62 min, calcd. for C41H41N5O5
+
[M+H]
+
: 686.33, found 686.26
7.4 Synthesis of acyl-ATP probes
Adenosine 5′-triphosphate triethyl-ammonium salt (45):
DEAE-Sephadex A-25 (purchased in the Cl
-
form) was added to distilled water and the 
resulting suspension was kept at rt overnight. It was then washed by ten times decantation 
with 0.5 N NaOH and three times with water. The ion-exchanger was then suspended in 2 M 
aq. NaHCO3 solution, packed into a column and washed extensively with 2 M NaHCO3
solution. The resin material was then transferred to a large beaker and suspended in 0.04 M 
NH(Et)3HCO3 buffer (pH~7). The suspension was allowed to settle for 15 min and the 
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supernatant was decanted off. This was repeated two further times. Subsequently, DEAE-
Sephadex A-25 was put into a glas-column and equilibrated additionally several times with 
0.04 M aq. NH(Et)3HCO3 solution. Adenosine 5′-triphosphate disodium salt hydrate (1 g, 
1.81 mmol) was dissolved in aq. 0.04 M NH(Et)3HCO3 solution (5 ml) and placed onto the 
column and allowed to seep into the column-material. The column-material was covered by a 
piece of cotton-wool to avoid flotation of the column material. The column was washed three 
times with a column volume of 0.04 M aq. NH(Et)3HCO3 solution. The product was eluated 
from column by applying 0.5 M aq. NH(Et)3HCO3 solution. Product containing fractions 
(UV-detection) were combined and lyophilized.
Preparation of 1 M NH(Et)3HCO3 -buffer, pH~7:
1 M aq. NH(Et)3HCO3 buffer was produced by adding gradually dry ice into a solution of 
H2O (480 ml) and TEA (70 ml) under vigorous stirring until a pH of ~7 was reached.
6-Aminohexanoic acid methylester hydrochloride (46):
Methanol (20 ml) was cooled in a dry ice-acetone bath and thionyl chloride (0.31 ml, 
4.191 mmol) was added dropwise over 30 min. At the same temperature, 6-aminohexanoic 
acid (500 mg, 3.81 mmol) was added portionwise and the dry-ice acetone bath was removed. 
The reaction mixture was allowed to warm to rt and then refluxed gently for 6 h. Removal of 
the volatiles under reduced pressure gave the title compound which was used in the next step 
without any further purification.
Yield: 889 mg (3.81 mmol, >99%) as a colorless crystalline solid  
7. EXPERIMENTAL PART 143
Methyl 6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido) 
hexanoate (47):
To a solution of 46 (284 mg, 1.56 mmol), biotin (366 mg, 1.56 mmol) and TEA (1.1 ml, 
8 mmol) in DMF (4 ml) was added HBTU (591 mg, 1.56 mmol) and HOBt (210 mg, 
1.56 mmol). After 0.5 h stirring at rt, water was added and the product was extracted with 
DCM. The organic phase was dried over Na2SO4, evaporated to dryness and the crude product 
was purified by silica gel chromatography (MeOH/DCM = 1:9) to obtain 47. 
Yield: 471 mg (1.27 mmol, 85%) as a colorless solid  
TLC (MeOH/DCM = 1:9): Rf = 0.3  
1
H NMR (400 MHz, CDCl3): δ = 4.65 (s, 1H), 4.47 (s, 1H), 3.66 (s, 3H), 3.29 (s, 2H), 3.21 (s, 
1H), 3.01 – 2.81 (m, 2H), 2.49 (s, 2H), 2.32 (t, J = 7.2 Hz, 2H), 1.84 – 1.53 (m, 8H), 1.48 (s, 
2H), 1.37 (d, J = 6.9 Hz, 2H)
13
C NMR (CDCl3): δ = 174.4, 173.4, 164.2, 62.0, 60.4, 55.9, 51.8, 40.8, 39.4, 36.3, 34.1, 
29.5, 28.4, 28.3, 26.6, 25.9, 24.7
LC-MS (ESI): tR = 6.40 min, calcd. for C17H30N3O4S [M+H]
+
372.19, found 372.07
6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido) 
hexanoic acid (48):
A solution of 47 (124 mg, 0.334 mmol) in H2O/MeOH (1:1, 4 ml) was cooled to 0 °C. A 1 M 
solution of LiOH (24 mg, 1 mmol) in H2O/MeOH (1:1, 1 ml) was added dropwise. The 
resulting solution was stirred for 1 h at rt until all starting material was used up (monitored by 
TLC; DCM/MeOH 9:1). MeOH was removed under reduced pressure and the aqueous layer
was acidified by addition of 1 M HCl. The desired product 48 precipitated and was filtered off 
and dried in vacuo.
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Yield: 119 mg (0.33 mmol, 99%) as a colorless solid  
1
H NMR (DMSO-d
6
) δ = 11.96 (s, 1H), 7.71 (s, 1H), 6.40 (s, 1H), 6.34 (s, 1H), 4.28 (m, 1H), 
4.11 (m, 1H), 3.08 (m, 1H), 3.00 (dd, J = 12.6, 6.2 Hz, 2H), 2.82 (dd, J = 12.3, 4.9 Hz, 1H), 
2.57 (d, J = 12.4 Hz, 1H), 2.18 (t, J = 7.4 Hz, 2H), 2.04 (t, J = 7.3 Hz, 2H), 1.68 – 1.42 (m, 
6H), 1.32 (m, 6H)
13
C NMR (DMSO-d
6
): δ = 174.4, 171.7, 162.7, 61.0, 59.2, 55.4, 38.2, 35.2, 33.6, 28.9, 28.2, 
28.0, 26.0, 25.3, 24.2
LC-MS (ESI): tR = 5.72 min, calcd. for C16H27N3O4S [M+H]
+
358.47, found 358.07
(+)-Biotin-Hex-acyl-ATP (BHAcATP) (49):
To a stirred suspension of 48 (30 mg, 0.085 mmol) in a dioxane/DMF/DMSO mixture (1:1:1, 
3 ml) was added triethylamine (47 µl, 0.34 mmol) and isobutyl chloroformate (33 µl, 
0.255 mmol) at 0 °C. The cloudy mixture was kept at this temperature for 20 min, allowed to 
warm to rt and then stirred for an additional 1.5 h. A solution of 45 (69 mg, 0.085 mmol) in 
anhydrous DMSO (1 ml) was added to the mixture. After 18 h, the reaction was quenched by 
addition of water (4 ml) and the solution was quickly extracted with ethyl acetate (3 x 4 ml). 
The aqueous layer was immediately frozen and lyophilized. The resulting solid was 
suspended in water (1 ml), transferred to a pre-equilibrated C18 column and eluted with 
water. Fractions containing product were immediately frozen and lyophilized.
Yield: 4.3 mg (5.1 µmol, 6%) as a colorless solid
LC-MS (ESI): tR = 2.16 min, calcd. for C26H40N8O16P3S
-
[M-H]
-
845.15, found 845.13
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Undec-10-ynoic-acyl-ATP (50):
To a stirred suspension of undec-10-ynoic acid (15.5 mg, 0.085 mmol) in a 
dioxane/DMF/DMSO mixture (1:1:1, 3 ml) was added triethylamine (47 µl, 0.34 mmol) and 
isobutyl chloroformate (33 µl, 0.255 mmol) at 0 °C. The cloudy mixture was kept at this
temperature for 20 min, allowed to warm to rt and then stirred for an additional 1.5 h. A 
solution of 45 (69 mg, 0.085 mmol) in anhydrous DMSO (1 ml) was added to the mixture. 
After 18 h, the reaction was quenched by addition of water (4 ml) and the solution was 
quickly extracted with ethyl acetate (3 x 4 ml). The aqueous layer was immediately frozen 
and lyophilized. The resulting solid was suspended in water (1 ml), transferred to a pre-
equilibrated C18 column and eluted with water. Product containing fractions were 
immediately frozen and lyophilized. 
Yield: 3.7 mg (5.5 µmol, 6.5%) as a colorless solid 
LC-MS (ESI): tR = 4.99 min, calcd. for C21H31N5O14P3
-
[M-H]
-
670.10, found 569.93
Bodipy(C3)-acyl-ATP (51):
To a stirred suspension of BODIPY
®
FL propionic acid (5 mg, 17.1 µmol) in a 
dioxane/DMF/DMSO mixture (1:1:1, 1.5 ml) under light exclusion were added at 0 °C 
triethylamine (11 µl, 0.0684 mmol) and isobutyl chloroformate (7.1 µl, 0.00936 mmol). The 
resulting cloudy mixture was kept at this temperature for 20 min, allowed to warm to rt and 
then stirred for an additional 1.5 h. A solution of 45 (13.5 mg, 39.3 µmol) in anhydrous 
DMSO (0.5 ml) was added to the mixture. After 18 h, the reaction was quenched by addition 
of water (4 ml) and the solution was quickly extracted with ethyl acetate (3 x 4 ml). The 
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aqueous layer was immediately frozen and lyophilized. The resulting solid was suspended in 
water (1 ml), transferred to a pre-equilibrated C18 column and eluted with water. Fractions 
containing the product were combined, immediately frozen and lyophilized. 
Yield: 1.8 mg (2.3 µmol, 14%) as a colorless solid
LC-MS (ESI): tR = 4.83 min, calcd. for C24H27BF2N7O14P3
-
[M-H]
-
780.09, found 779,87
Bodipy(C5)-Acyl-ATP (52):
To a stirred suspension of BODIPY
®
FL pentanoic acid (1 mg, 3.12 µmol) in a 
dioxane/DMF/DMSO mixture (1:1:1, 1.5 ml) under light exclusion at 0 °C were added 
triethylamine (2 µl, 0.0125 mmol) and isobutyl chloroformate (1.3 µl, 0.00936 mmol). The 
resulting cloudy mixture was kept at this temperature for 20 min, allowed to warm to rt and 
then stirred for an additional 1.5 h. A solution of 45 (2.5 mg, 7.12 µmol) in anhydrous DMSO 
(0.5 ml) was added to the mixture. After 18 h, the reaction was quenched by addition of water 
(4 ml) and the solution was quickly extracted with ethyl acetate (3 x 4 ml). The aqueous layer 
was immediately frozen and lyophilized. The resulting solid was suspended in water (1 ml), 
transferred to a pre-equilibrated C18 column and eluted with water. Product containing 
fractions were immediately frozen and lyophilized.
Yield: 0.75 mg (0.89 µmol, 28%) as a colorless solid
LC-MS (ESI): tR = 7.07 min, calcd. for C26H32BClF2N7O14P3
-
[M-H]
-
843.09, found 843,44
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7.5 Biological Procedures
List of buffers:
Phosphate buffered saline (10x PBS): 10.6 mM KH2PO4, 1552 mM NaCl, 30 mM 
Na2HPO4, pH 7.4. 
SDS-PAGE gel-loading buffer (4x GLB): 280 mM SDS, 400 mM Tris, 40% glycerol, 1.4 M 
DTT, 0.6 mM Bromophenol Blue, pH 6.8.
MOPS (20x MOPS): 50 mM MOPS, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 7.7.
Bis-Tris Buffer (1.25 M): 131 g Bis-Tris, 350 ml water, 40-50 ml HCl (25%), adjust to pH 
6.6, adjust to 500 ml with water.
Coomassie-stain: 0.08% Coomassie Billiant blue G250, 1.6% ortho-phosphoric acid, 8% 
ammonium sulfate, 20% methanol.
Preparation of functional protein extracts from Arabidopsis thaliana
50-100 mg leaf material of two weeks old Arabidospsis seedlings (Col-0, WT) were 
transferred into a fresh Eppendorf tube and 400 µl 1x PBS buffer were poured into the same 
vessel. The leaf tissue was grinded up with an appropriate mortar to form a homogenous 
solution. The extract was cleared by centrifugation (13k g, 5 min, 4 °C) which resulted in a 
greenish pellet and a clear supernatant. The pellet was discarded and the clear supernatant, 
containing the water-soluble protein fraction of the Arabidopsis leaf proteome was transferred 
to a fresh Eppendorf tube. This protein extract was used subsequently or otherwise kept on 
ice. 
Measuring protein concentration
The protein concentration was measured using a modified Bradford assay, called Roti-
Nanoquant®. The assay was conducted according to the instruction given by the supplier. 
(http://www.carlroth.com/media/_nl-nl/usage/K880.pdf)
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In vitro activity-based labeling of plant extracts 
1 step ABPP:
The equivalent of 50 µg protein from the leaf extracts were transferred to a designated 
Eppendorf tube. The volume of this solution was adjusted to 49 µl with 1x PBS-buffer. 1 µl of 
the corresponding probe (fluorescent) was added and agitated properly (all chemicals were 
added as a solution in DMSO). The reaction mixture was incubated at rt in the dark for 1 h. 
The reaction was stopped by adding 16.5 µl of 4x GLB. The mixture was then incubated for 
10 min at 70 °C and centrifuged briefly (10 s, 16k g) to spin down the water that condensed in 
the lid. The protein samples were resolved by gel-electrophoresis. Labeled proteins were 
detected by direct in-gel fluorescence scanning (532 nm) using a Typhoon® 9000 scanner 
(GE Healthcare). To ensure equal loading, a Coomassie stain was conducted. On that purpose
the SDS-gel was stained o.n. in the Coomassie-stain and washed afterwards several times 
with pure water.
2 step ABPP:
The equivalent of 50 µg protein from the leaf extracts were transferred to a designated 
Eppendorf tube. The volume of this solution was adjusted to 45 µl with 1x PBS-buffer. Then 
1 µl from an apropiate stock solution of the corresponding “click” probe was added and the 
mixture was agitated properly (all chemicals were added as a solution in DMSO). The 
reaction mixture was incubated at rt in the dark for 1 h. Subsequently, 1 µl rhodamine-azide 
(1 mM stock), 1 µl TBTA (5 mM stock), 1 µl TCEP (100 mM stock) and 1 µl CuSO4 (50 mM 
stock) were added. The reaction mixtures were agitated and incubated subsequently at rt in the 
dark for 1 h. The reactions were stopped by adding 16.5 µl of 4x GLB to each reaction vessel.
The mixture was then incubated for 10 min at 70 °C and centrifuged briefly (10 s, 16k g) to 
spin down the water that condensed in the lid. The protein samples were then resolved by gel-
electrophoresis. Labeled proteins were detected by direct in-gel fluorescence scanning 
(532 nm) using a Typhoon® 9000 scanner (GE Healthcare). To ensure equal loading, a 
Coomassie stain was conducted. On that purpose the SDS-gel was stained o.n. in the 
Coomassie-stain and washed afterwards several times with pure water.
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2 step photoaffinity ABPP:
The equivalent of 50 µg protein from the leaf extracts were transferred to a designated 
Eppendorf tube. The volume of this solution was adjusted to 45 µl with 1x PBS-buffer. 1 µl 
from an appropiate stock solution of the corresponding “photoaffinity” probe was added and 
the mixture was agitated properly (all chemicals were added as a solution in DMSO). The 
reaction mixture was incubated at rt and in the dark for 1 h. The samples were transferred into 
a shallow, translucent and uncovered 96-well plate. The plate was placed on ice subsequently 
and photoactivation was performed by placing a hand-held UV-lamp (λ = 360 nm) in a 
distance of 1 cm above the 96-well plate. A total UV irradiation time of 15 min was used.
Subsequently, 1 µl rhodamine-azide (1 mM stock), 1 µl TBTA (5 mM stock), 1 µl TCEP 
(100 mM stock) and 1 µl CuSO4 (50 mM stock) were added. The reaction mixtures were 
agitated and incubated subsequently at rt in the dark for 1 h. The reactions were stopped by 
adding 16.5 µl of 4x GLB to each reaction vessel. The mixture was incubated for 10 min at 
70° C and centrifuged briefly (10 s, 16k g) to spin down the water condensed in the lid. The 
protein samples were resolved by gel-electrophoresis. Labeled proteins were detected by 
direct in-gel fluorescence scanning (532 nm) using a Typhoon® 9000 scanner (GE 
Healthcare). To ensure equal loading, a Coomassie stain was conducted. On that purpose the 
SDS-gel was stained o.n. in the Coomassie-stain and washed afterwards several times with 
pure water.
SDS-gelectrophoresis
Continuous SDS-Gels (11%: 30 ml 30% acrylamide/Bis-acrylamide, 22.8 ml Bis-Tris 
(1.25 M), 320 µl APS (10%), 64 µl TEMED, water 27.4 ml) were loaded in each pocket with 
12 µl protein sample and transferred into designated devices (C.B.S Scientific). As running-
buffer 1x MOPS buffer was used. The power-supply Consort EV261 was utilized attuned to
120 V, 75 mA and 30 W. A complete protein separation was achieved after 90 min.
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9. APPENDIX 
9.1 Abbreviations 
The amino acids were abbreviated according to the 1-letter or 3-letter code recommended by 
the IUPAC-IUB joint commission on biochemical nomenclature.144
AA asymmetric aminohydroxylation
Å Ångström
A. thaliana Arabidopsis thaliana 
aa    amino acid(s) 
ABP    activity-based probe 
ABPP    activity-based protein profiling 
Ac     acyl-
AcOH    acetic acid 
ACN acetonitrile
ADP adenosine diphosphate
Alloc    allyloxycarbonyl-
AOMK acyloxymethyl ketone
aq.    aqueous 
ATP adenosine triphosphate
atm. standard atmosphere = 1,01325 x 105 Pa
b broad signal (NMR) 
BHAcATP (+)-Biotin-Hex-Acyl-ATP
Bn  benzyl-
Boc  tert-butoxycarbonyl-
CH cyclohexane
Cit    citrulline 
d     doublet 
Da    Dalton 
Dab diaminobutyric acid
DAG days after germination
DCC    N,N’-dicyclohexyl carbodiimide 
9. APPENDIX 162
DCM    dichloromethane 
DCU N,N’-dicyclohexylurea
dd    doublet of doublets 
DIPEA    N,N’-diisopropylethylamine 
DMAP  4-dimethylamino pyridine 
DMF    dimethyl formamide 
DMSO    dimethyl sulfoxide 
DNA    desoxyribonucleic acid 
dt   doublet of triplets 
E. coli Escherichia coli
EDC 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide 
eq.   equivalent(s) 
ESI    electrospray ionization 
Et    ethyl-
EtOAc    ethyl acetate 
EtOH   ethanol 
FA formic acid
Fmoc  9-fluorenylmethoxy carbonyl-
GUS β-glucuronidase
h   hour(s) 
HATU 2-(1H-azabenzotriazole-1-yl)1,1,3,3-tetramethylaminium hexafluorophosphate 
HBTU    2-(1H-benzotriazole-1-yl)1,1,3,3-tetramethylaminium hexafluorophosphate 
HOBt    N-hydroxybenzotriazole 
HOSu N-hydroxysuccinimide 
HPLC    high pressure liquid chromatography 
HR-MS    high resolution mass spectrometry 
Hz    Hertz 
IBCF isobutyl chloroformate
ICAT isotope-coded affinity tags 
iPr    iso-propyl-
J    coupling constant 
k    kilo-
LC-MS    liquid chromatography mass spectrometry 
LRD lateral root density
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m    multiplet 
M   molar 
Me    methyl 
MeOH    methanol 
MHz    Megahertz 
min minute(s) 
ml milliliter(s) 
MS    mass spectrometry 
MudPIT  multidimensional protein identification technology 
N   normal 
nm    nanometer
NMM N-methylmorpholine
NMR    nuclear magnetic resonance 
OD optical density
o.n. overnight
PEG polyethylene glycole
pH pondus Hydrogenii
PKA Protein Kinase A
ppm    parts per million 
PyBOP   benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate 
quant.    quantitative 
Rf retention factor
rt room temperature 
RuBisCo ribulose-1,5-bisphosphate carboxylase oxygenase
s    singlet 
SAR    structure-activity relationship 
SDS-PAGE  sodium dodecylsulfate polyacrylamide gel eletrophoresis 
sp.   species 
SPPS    solid-phase peptide synthesis 
t    triplet 
tR retention time
TMSI trimethylsilyl iodide
TMSOTf trimethylsilyl trifluoromethanesulfonate
TBTA    tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
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tBu    tert-butyl 
tBuOH    tert-butanol 
TCEP    tris(2-chloroethyl)phosphate 
TEA    triethylamine   
Tf    triflyl-
TFA    trifluoroacetic acid 
TFE    trifluoro ethanol
THF   tetrahydrofuran   
TIS    triisopropyl silane 
TLC    thin layer chromatography 
tR retention time
Trt    trityl-, triphenylmethyl-
UV     ultraviolet 
WT    wild type 
X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
°C    degrees Celsius  
δ    chemical shift 
ε    extinction coefficient 
μ    micro-
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